Biomedical aspects of membrane chemistry by McEwan, Corrine Evelyn Anne
  
 
 
 
 
BIOMEDICAL ASPECTS OF MEMBRANE 
CHEMISTRY 
 
 
A thesis submitted in part fulfilment of the degree of                                      
Doctor of Philosophy 
 
CORINNE E. A. MCEWAN 
 
Department of Chemistry 
 
Supervised by: Professor H. M. Colquhoun and Professor W. Hayes 
 
Sponsored by: BioInteractions Ltd, Reading 
 
 
2017 
 
 
 
ii 
 
Declaration of Original Authorship 
I confirm that the research described in this thesis is my own work and that the use of 
all materials from other sources has been properly and fully acknowledged.  
 
………………………………………. 
Corinne E. A. McEwan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Abstract 
This thesis is focused on the development of a prototype membrane medical device for 
the treatment of oedema and lymphoedema via interosmolar fluid removal. These 
medical disorders disrupt body fluid regulation causing excess fluid to accumulate in 
the body’s tissues resulting in swelling of affected areas and can severely impact 
quality of life of affected patients. 
The device concept was based on a US patent (No. 8,211,053 B2) licensed to 
BioInteractions Ltd which proposes, but does not exemplify, an implantable medical 
device based on a semipermeable membrane compartment containing trapped 
osmotic solutes which can act as a draw solution for the abnormally accumulated fluid 
in the tissues surrounding the device, allowing the fluid to be drained from the body. 
Following extensive literature research and consultation with experts in the field 
(detailed in Chapter 1) it became apparent that alongside the oedema fluid, 
accumulated plasma proteins would also require removal to prevent oedema reforming 
as a result of protein oncotic pressure. To accommodate this, a design modification 
was proposed; employing porous membranes to enable to removal of proteins 
alongside the fluid. This adaptation necessarily affected the draw solution selection 
limiting the options to high molecular weight species which could be retained by the 
porous membrane.  
Alongside this clinically-oriented project, a secondary project involved the development 
of thin-film composite membranes using novel coatings based on hydrophilic poly-ylids 
as well as investigations into a new solvent resistant support membrane.  
Chapter 2 focused on investigating the forward osmosis process using a novel 
combination of porous ultrafiltration membranes and high molecular weight polymer 
and polyelectrolyte draw solutions. The best-performing draw solution and membrane 
was found to be 225K sodium polyacrylate and a 50K MWCO polyethersulfone (PES) 
UF membrane which were then further studied to determine model oedema fluid 
removal performance, membrane fouling properties, osmotic pressure characteristics 
and protein transport.  
Chapter 3 involved the synthesis and characterisation of novel hydrophilic poly-ylids 
derived from the interfacial polycondensation of 1,1’-diamino-4,4’-bipyridinium with 
aromatic di-sulfonyl chlorides and di-isocyanates. These poly-ylids were then used to 
fabricate thin-film composite nanofiltration membranes, alongside a number of 
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previously reported acid chloride based poly-ylids for comparison, which were then 
analysed in terms of their flux and salt rejection properties. Additionally investigations 
into pH effects, surface morphology and biocompatibility were carried out. 
Chapter 4 describes the development of solvent resistant thin-film composite 
membranes based on poly-ylids synthesised in Chapter 3, in combination with a novel 
polyetherketone support membranes. This system enabled the fabrication of 
nanofiltration membranes using monomers that were incompatible with a traditional 
PES membrane support. The membranes were analysed as described in Chapter 3 
and were found to have reasonable flux and salt rejection properties. Additionally, 
initial biocompatibility testing found that all three PEK TFC poly-ylid membranes were 
able to reduce protein adhesion relative to an uncoated PEK support membrane. 
Chapter 5 details the design, fabrication and testing of two generations of device 
prototypes using both an in vitro and ex vivo model, both developed specifically for the 
project. This chapter provides proof-of-concept for the device, as fluid removal was 
successfully demonstrated using a second generation prototype tested in an ex vivo 
perfused limb. 
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Acronyms and Abbreviations 
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GPC  gel permeation chromatography   
h  height 
Δh  change in height 
ICF  intracellular fluid 
i  van’t Hoff Factor 
IF  interstitial fluid 
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IPC   intermittent pneumatic compression 
IR  infra-red  
Kc  capillary filtration coefficient 
K-PA  potassium polyacrylate 
m  multiplet 
M  molarity 
MF  microfiltration  
MLD  manual lymphatic drainage 
MWCO molecular weight cut-off 
MW   molecular weight  
n  moles 
Na-PA  sodium polyacrylate 
NIPAM  N-isopropylacrylamide 
NMP   N-methylpyrrolidone 
NMR  nuclear magnetic resonance 
P   pressure 
PA  polyamide  
PAEK  polyaryletherketone 
PAES  polyarylethersulfone 
PBS  phosphate buffered saline 
PEG  poly(ethylene glycol) 
PEK  polyetherketone  
PES   polyethersulfone 
PEO   poly(ethylene oxide) 
PGs  proteoglycans  
pm  picometers 
ppm   parts per million 
PPS   polyphenylenesulphide  
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PSF   polysulfone 
PSSA  polystyrene sulfonic acid sodium salt 
PVP    polyvinylpyrrolidone 
R   rejection 
R  gas constant 
RI  refractive index 
RO  reverse osmosis 
s  singlet 
SEM  scanning electron microscopy  
SD  standard deviation 
SDS  sodium dodeceyl sulfate  
t  triplet 
t1  absolute viscosity of solvent 
t2  absolute viscosity of polymer solution 
T  temperature 
Tdeg  degradation temperature  
Tg  glass transition 
Tm  melting temperature 
TEM  transmission electron microscopy  
TFC  thin-film composite  
TGA  thermal gravimetric analysis  
TMC  trimesoyl chloride  
UBK  unbuffered Krebs solution 
UF  ultrafiltration 
UV/Vis  ultraviolet/visible 
V  volume 
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Å  angstroms  
η  viscosity  
ηabs  absolute viscosity 
ηinh  inherent viscosity  
π  osmotic pressure 
ρ  density 
σ  retention coefficient  
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Chapter 1 - Introduction 
1.1 Research Motivation 
Oedema and lymphoedema are medical conditions which can have a severe impact on 
quality of life. These disorders cause excess fluid to accumulate in the bodies’ tissues - 
rather than being returned back to the circulatory system, which thus leads to swelling 
in the affected areas. Current treatments for these conditions are labour- and time-
intensive, often requiring high patient compliance to be effective. In this thesis, a new 
approach is proposed based on an implantable medical device with a semipermeable 
membrane containing an osmotic driving solution which can remove accumulated fluid 
in oedema. The main advantage of this approach is that the conditions for fluid removal 
do not require harsh suction or pumping and therefore may be more compatible with 
treating these conditions. 
The device concept for this novel treatment is based on a US patent licenced to 
BioInteractions Ltd (Figure 1.1)1 for interosmolar fluid removal which proposes, but 
does not exemplify, an implantable medical device based on a semipermeable 
membrane compartment containing trapped osmotic solutes which can act as a draw 
solution, removing abnormally accumulated fluid in the tissues surrounding the medical 
device, allowing them to be drained from the body via a tube in communication with an 
external reservoir.  
                              
Figure 1.1: Schematic from US Patent 8,211,053,B2 showing sketches of possible device design and 
configuration and potential implantation sites. Note that this patent simply introduces a concept. No actual 
device or process was reported in the patent. 
 
2 
 
The aims of this project were principally to provide proof of concept to support this 
proposed device design. In order to achieve this several objectives had to be met: 
investigation into the forward osmosis process itself, analysis of potential membranes 
and draw solutions, development of bench top model systems and device prototypes, 
exploration of device design and finally the development of an ex vivo porcine limb 
oedema model for prototype device testing.  
Additionally in this thesis, research on membrane modification via interfacial 
polymerisation coating techniques has led to the development of two new classes of 
poly-ylid membrane coatings for the fabrication of thin-film composite nanofiltration 
(NF) membranes (Figure 1.2). Analysis of these membranes showed them to have 
good flux and salt rejection properties. Furthermore some of these new coatings were 
combined with novel PEK support membranes to create solvent resistant nanofiltration 
membranes which were demonstrated to have reasonable flux and rejection 
properties. Studies were carried out to investigate these novel NF membranes’ 
biocompatibility, examining the adsorption of different proteins. 
 
Figure 1.2: Schematic depicting the fabrication of novel thin-film composite membranes using two 
different asymmetric support membrane; PES and PEK and a new class of poly-ylid coatings based on the 
polymerisation of 1,1’-diamino-4,4’-bipyridylium di-iodide with various acid chloride, sulfonyl chloride and 
isocyanate monomers to give the corresponding amide, sulfonamide and urea poly-ylids. 
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1.2 Membrane Technology 
1.2.1 Overview and History 
Membranes can be described as semi-permeable interfaces separating two phases, 
only allowing certain components to permeate through.2 Whilst there are both synthetic 
and biological membranes this review will focus on the former.  
Early investigations into membrane science in the 18th century involved experiments 
with animal intestines and bladders3 and led to the discovery of the phenomenon which 
drives the permeation of water through a semipermeable membrane from an area of 
high water concentration to an area of lower water concentration, a process known as 
osmosis. The first semisynthetic membranes were developed a century later.4 These 
‘collodion’ (nitrocellulose) membranes became commercially available in the 1930’s5 
and soon this technology was applied to other polymers. 
The next significant breakthrough came in the 1960’s with the development of the first 
high flux anisotropic reverse osmosis membrane. Loeb and Sourirajan are widely 
credited with making reverse osmosis a practical process for industrial use.2,6,7 With 
their development of an anisotropic cellulose acetate membrane (also known as a 
Loeb-Sourirajan membrane)8 they were able to make the possibility of desalination by 
reverse osmosis an economically viable process. 
Michaels at Amicon realised the potential of the asymmetric RO Loeb-Sourirajan 
membrane and applied this technology to create asymmetric ultrafiltration membranes 
with a skin layer containing pores in the 10-200 Å range.9 These UF membranes 
exhibited high retention of macromolecules including proteins and synthetic water-
soluble polymers whilst demonstrating excellent hydraulic permeability.10 Michaels and 
his co-workers were able to produce asymmetric cellulose acetate UF membranes 
along with other polymers such as polysulfones (PSF), aromatic polyamides (PA) and 
polyacrylonitrile.11 These types of membranes are now also used as supports in 
composite reverse osmosis membranes. 
Another key breakthrough in membrane science was the development of the interfacial 
polymerization (IP) technique which lead to the creation of the first non-cellulosic 
membrane with comparable flux and salt rejection.12 This type of polymerization was 
initially reported by Morgan in 1965.13 However, it was not until it was further developed 
by Cadotte at FilmTec Corporation that its potential for RO membrane production was 
fully realised.14 Interfacial polymerisation, involving the spontaneous growth of a semi-
permeable polyamide membrane on the surface of a supporting UF membrane, is 
currently the most widely used method to manufacture high performance thin-film 
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composite reverse osmosis and nanofiltration membranes.6 The significance of these 
membranes is that the two layers (skin layer and microporous substrate layer) of the 
anisotropic membrane are prepared separately allowing for individual optimization 
before combination to form the asymmetric membrane.6,7 This allows for a great deal of 
customisation, and a wide variety of these thin-film composite (TFC) membranes have 
since been developed.15 
In order to develop a high-performing membrane, there are several factors which need 
to be considered. These include the selectivity, defined as the rate at which different 
species permeate relative to each other, the permeability which is the absolute rate at 
which a permeate traverses a membrane and the flux which is the amount of permeate 
that is transported through the membrane per unit membrane area per unit time.16,17 
Other practical aspects to consider include; reproducibility, mechanical stability, 
resistance to fouling, resistance to chemicals and temperature stability18. 
1.2.2 Membrane Classification 
Membranes can be classified in a variety of ways. Many membrane classifications 
stem from the membrane materials and structure. When considering synthetic 
membranes the first key distinction is whether they are based on organic19 or inorganic 
materials (such as oxides, ceramic and metals).20 This review will focus on synthetic 
polymeric materials which have many advantages including low cost, ease of 
manufacture and ability to create a wide range of pore sizes.12  
An alternative membrane classification system is based on the composition and 
structure of the membrane cross section (Figure 1.3). There are two broad classes; 
isotropic (symmetric) which have a uniform composition and structure throughout the 
membrane cross-section and anisotropic (asymmetric) which can be homogenous in 
chemical composition but not structure (phase separation or Loeb-Sourirajan 
membranes). The latter may also be chemically and structurally heterogeneous (thin 
film composite).21 Isotropic membranes can further be classified into either 
microporous or dense/non-porous membranes.  
Anisotropic membranes made of two or more materials are also known as composite 
membranes. A classic example of this membrane type is the thin-film composite 
membrane as prepared by the interfacial polymerisation technique. As mentioned 
above these types of membranes have a significant advantage in that the layers can 
be prepared separately. Composite membranes can also have a biocompatible coating 
applied to the skin layer for use in medical devices, i.e. dialysis membranes.22 A major 
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disadvantage of many types of membrane is their susceptibility to fouling which leads 
to a rapid decline in permeate flux: strategies to reduce this often include surface 
modifications or coatings to reduce fouling.23 
 
 
 
 
Figure 1.3: Schematic diagrams of cross sections of isotropic vs. anisotropic membranes.
2
 
Another way of distinguishing between membrane types is in terms of the method by 
which they are prepared: the most common technique being phase-separation, 
although other methods include interfacial reaction, track etching, extrusion and 
stretching.6,19 Membranes can also be classified by the shape of the membrane 
module into which they are configured. There are two main geometries; flat including 
flat sheet, disc, spirally wound and plate & frame, and cylindrical which comprise 
tubular and capillary/hollow fibre modules.6 Finally, membranes are frequently 
described by the process in which they are used, e.g. reverse osmosis membranes, 
nanofiltration membranes, ultrafiltration membranes or microfiltration membranes. 
Figure 1.4 summarises the classification of synthetic polymer membranes. 
 
Figure 1.4: Classification of synthetic polymer membranes, adapted from reference.
18
 
 
Isotropic membranes Anisotropic membranes 
Microporous 
membrane 
Non-porous/dense 
membrane 
Loeb-Sourirajan 
membrane 
Thin-film composite 
membrane 
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1.2.3 Membrane Processes 
Membrane filtration involves the flow of fluid from a bulk (feed) solution, often 
comprising a single phase containing dissolved species, through a semipermeable 
membrane to give a purified permeate (Figure 1.5). Membrane separations can be 
driven by either a concentration, electrical or pressure gradient.2  
 
Figure 1.5: Membrane filtration process, adapted from reference.
24
 
Membrane filtration processes rely on the ability of membranes to control the rate of 
permeation of different chemical species resulting in the separation of a mixture of 
components.2 There are two main mechanisms of membrane permeation; solution-
diffusion and porous flow (Figure 1.6). In the solution-diffusion model; separation is 
achieved by differences in the solubility of components within the membrane itself and 
the rate at which the material diffuses through the membrane.25 This model is 
commonly used to describe transport through dense or non-porous membranes. For 
membranes which contain pores an alternative model is used known as the porous or 
pore flow model. Separation in this case is based on size-exclusion and is related to 
the pore size. 
The porous flow model can be broken down into several sub-models such as; finely 
porous, preferential sorption-capillary flow, and surface force-pore flow models.26 In 
reality the actual mechanisms of mass transport of selected components through a 
membrane is much more complex and can often be a combination of both models.27 
 
Figure 1.6: Molecular transport through membranes can occur either via a) solution diffusion  - separation 
results from differences in the solubility and mobility of the permeates in the membrane materials or b) 
porous flow – separation by molecular filtration, adapted from reference.
28
 
a) b) 
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Another key consideration when discussing membranes is the electrical double layer 
which is the name given to two parallel levels of charged particles which form on a 
surface when it is exposed to an electrolyte solution. Polymeric membranes will 
acquire a characteristic surface charge when in contact with an aqueous solution which 
will influence the ion distribution at the membrane-solution interface resulting in the 
formation of this electrical double layer.29 The membrane surface charge will result in 
the accumulation of an excess of counter-ions adjacent to the membrane-solution 
interface.30 This surface charge can occur via several mechanisms including: ionisation 
of membrane surface groups or adsorption of ions, polyelectrolytes and charged 
macromolecules from solution.31 The surface charge can be characterised by 
measurement of the membrane zeta potential.7 
Another important principle of membrane chemistry is the concentration polarisation 
effect which can be defined as the phenomenon which occurs when the solute 
concentration on the membrane surface is higher than the solute concentration in the 
bulk solution, resulting in a concentration gradient at the membrane/solution interface 
(Figure 1.7).32 This effect arises due to preferential loss of solvent from the solution on 
the membrane surface accompanied by an increase in the solvent concentration on the 
permeate side of the membrane.33 The presence of this gradient at the interface can 
dramatically decrease the rate of flux by reducing the permeating component 
concentration difference across the membrane.  Formation of this boundary layer can 
in some cases be irreversible, resulting in the development of an insoluble gel layer. 
 
Figure 1.7: Concentration polarisation leading to a build-up of solutes forming a boundary layer where CB 
is the bulk solute concentration and CMS is the membrane surface solute concentration, adapted from 
reference.
34
 
When a semi-permeable membrane is placed between two phases; one comprising 
pure solvent and the other being a solution, the osmotic pressure generated will result 
in diffusion of the solvent into the solution phase in order to reach an equilibrium 
pressure-distribution. However if a pressure gradient (greater than the osmotic 
pressure) is applied across the membrane i.e. against the direction of the osmotic 
8 
 
pressure gradient, then this tendency is reversed (hence "reverse osmosis") resulting 
in concentration of the solution and dilution of the solvent.35 When a pressure gradient 
is imposed to drive filtration this is known as a pressure-driven membrane process. 
Pressure-driven membrane processes are well-established in industry and are widely 
used in applications such as desalination and water treatment,21,35,36 the food 
industry37–40 and in the biotechnology sector.17,40,41 Major advantages of membrane 
technologies in separation include: i) their comparatively low energy cost (since no 
phase change is required), ii) the ability to carry out these processes at ambient 
temperatures (making this process suitable for filtration of temperature-sensitive 
mixtures – particularly useful in the biotechnology field) and iii) the ease of integration 
of membrane filtration into other separation processes.19,42 
In pressure-driven membrane processes, the flux of the permeate across a membrane 
is driven by a difference in hydrostatic pressure which is induced between the bulk and 
the permeate sides of the membrane.24 There are two main methods of carrying out 
pressure-driven experiments; dead-end filtration and cross-flow filtration. Dead-end 
filtration involves the bulk solution being forced (i.e. pumped or pressurised) through 
the membrane in a perpendicular fashion with one stream entering the system (the 
feed) and one stream leaving the filter (the permeate).24 A major disadvantage of this 
method is the build-up of retained particles on the surface of the membrane, forming a 
‘cake layer’ which eventually results in reduced filtration rate.43 For this reason dead-
end filtration is usually employed in batch processes allowing the membrane to be 
changed between batches. Most pressure-driven membrane processes are carried out 
using cross-flow filtration. In this configuration the feed is pumped tangentially across 
the membrane surface with one stream entering the system (the bulk) and two streams 
leaving (the permeate and the retentate).44 The main advantage of this system is that 
cross-flow reduces the accumulation of retained particles on the membrane surface 
decreasing the likelihood of the formation of a ‘cake layer’ and therefore allowing the 
membrane to be used for much longer than when dead-end filtration is used.45  
 
Figure 1.8: Schematic of a) cross-flow and b) dead-end filtration systems. F: feed, M: membrane, P: 
permeate R: retentate, adapted from reference.
16
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Pressure-driven processes have many advantages; the permeate can be obtained 
extremely pure, the process can be carried out at moderate temperatures so that the 
energy requirements are reasonably low and finally such processes are suitable for 
easy scaling up or combination with other processes.46 
A major disadvantage of pressure-driven membrane processes is their susceptibility to 
membrane fouling through the accumulation of retained species on the membrane 
surface or within the membrane matrix resulting in a decrease in membrane 
permeability.47 There are several different types of foulant; colloidal fouling from 
particles such as clay or silica, organic fouling from hydrocarbons and proteins, 
inorganic fouling from precipitation and deposition of dissolved salts in scaling (arises 
due to changes in pH) or oxidation and finally biofouling from plant matter such as 
algae or microbial contamination (biofilm formation).23,47,48  
The issue of fouling can be overcome by two main approaches; either pre-treatment of 
the feed solution to remove contaminants or modification of operating conditions to 
promote membrane cleaning through backwashing or forward flushing to avoid long-
term build-up of deposited matter or by additional chemical/air scouring membrane 
cleaning procedures.47 A common pre-treatment in drinking water production is 
sterilisation by chlorine. However, this may shorten the membrane usage lifetime since 
certain membranes (notably those based on aromatic polyamides) are very susceptible 
to degradation by chlorine. 
There are several types of pressure-driven membrane processes; reverse osmosis, 
nanofiltration, ultrafiltration and microfiltration.  Their corresponding membranes can be 
distinguished by their pore size. These processes can also be divided into Low-
pressure (microfiltration and ultrafiltration) and High-pressure methods (reverse 
osmosis and nanofiltration) due to the differing operating pressures required.  
 
Figure 1.9:  Pressure-driven membrane processes and their pore size ranges. Adapted from reference.
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Low-Pressure Membrane processes (typically 0.5-2 bar) 
Microfiltration 
Microfiltration retains and concentrates  particles in the “micron” range which typically 
encompasses suspended particles or colloids with a radius of 0.10 µm to 5 µm 
(depending on the particular membrane pore size) and can include microorganisms 
such as bacteria and viruses as well as other particles.49  Although both dead-end and 
cross-flow configurations can be used, the latter configuration is preferred as this 
avoids the build-up of retained particles on the membrane surface which can reduce 
the rate of filtration.50 Microfiltration is used in many industrial applications, including 
sterile filtration of pharmaceutical products to produce injectable drug solutions,51 and 
in the dairy industry where cross-flow MF is used to remove bacteria from milk.37 
Ultrafiltration 
Ultrafiltration membranes have a pore diameter in the range 2 - 100 nm.52  Over the 
past two decades UF has been widely used in the food processing industry due to its 
significant advantages over other separation processes including non-harsh conditions 
(ambient temperatures, no need for addition of chemicals) and low energy 
requirements.39 UF is used in the dairy industry to fractionate milk for cheese 
production and to produce high-calcium milk.38 
High-Pressure Membrane Processes (typically 5-100 bar) 
Nanofiltration 
Nanofiltration is characterised by a membrane pore size range which corresponds to a 
molecular weight cut-off of approximately 200 – 1000 Da.53 Nanofiltration is used 
primarily in water treatment either to produce drinking water from ground and surface 
water or as a pre-treatment for desalination.54  A moderately high pressure of 10-40 
bar is typically required.55  
Reverse Osmosis 
Currently reverse osmosis is the most widely used desalination technology globally.12 
Unlike the above three membrane types (NF,UF and MF) reverse osmosis membranes 
are non-porous and instead have a complex ‘web-like’ molecular structure forcing the 
permeating water through a tortuous pathway between hydrated polymer chains.56 
Reverse osmosis requires relatively high operating pressures in comparison to the 
other pressure-driven processes both because of the membrane’s inherently low 
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permeability and in order to overcome osmotic pressure.57 Commercial RO 
membranes are mainly based on two different types of polymers; cellulose acetate 
(CA) or aromatic polyamides (PA). However, the former are limited by their 
susceptibility to microbiological attack and sensitivity to pH, so most industrial 
applications will preferentially use PA thin film composite RO membranes.58  One 
disadvantage of PA membranes is that they are degraded on prolonged exposure to 
oxidising agents such as chlorine which is often used as a biocide in water 
treatment.59,60 
1.2.4 Membrane Fabrication and Characterisation 
1.2.4.1 Membrane Fabrication  
The most commonly used methods in polymer membrane synthesis include phase 
inversion, interfacial polymerisation, stretching, track-etching and electrospinning.7 This 
review will focus on the first two methods since they were used to fabricate 
membranes for this project. Phase inversion and interfacial polymerisation are used to 
produce asymmetric (anisotropic membranes).18  
Phase Inversion 
Phase inversion involves the controlled conversion of a homogenous polymer solution 
from a liquid to a solid state. Although there are several techniques to achieve this, 
each involves first casting a film of the polymer solution usually onto a non-woven 
backing paper support (in the case of ultrafiltration membrane fabrication) or directly 
onto a sheet of glass. Following the film casting the polymer is precipitated which can 
be done in a variety of ways:7,18,61 
 Immersion precipitation 
 Thermally induced phase separation 
 Evaporation-induced phase separation 
 Vapour-induced phase separation 
The most common technique – immersion precipitation – involves immersing the 
polymer film in a non-solvent bath (typically water). Precipitation occurs due to the 
exchange of solvent (within the polymer solution) and non-solvent which therefore 
requires these two solvents to be miscible. During this solvent exchange the polymer 
solution itself is separated into two phases; a solid polymer-rich phase which forms the 
matrix and a liquid polymer-poor phase which forms the pores.62 This process results 
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in the formation of an asymmetric membrane consisting of a dense skin layer on top of 
a porous sub layer containing structures such as macrovoids, pores and micropores.63 
Membranes created by immersion precipitation have been found to contain key 
structural elements such as;  cellular structures, nodules, bicontinuous structures and 
macrovoids.64 Macrovoids are large conical ‘finger-like cavities’ which can extend 
throughout the entire thickness of the membrane and are generally unfavourable as 
they are considered to be structural flaws resulting in mechanical weaknesses in the 
membrane.64,65 Figure 1.10 shows scanning electron micrographs of two lab-fabricated 
asymmetric polysulfone membranes and demonstrates the presence of pores and long 
finger-like macrovoids in 1.10 a), as well as the dense surface skin layer in 1.10 b). 
  
Figure 1.10: a) Scanning electron micrograph of edge and underside of gold-coated asymmetric 
polysulfone membrane (PSF with 5%wt PEG 600 pore-forming additive) (x1170) b) Scanning electron 
micrograph of edge and underside of gold coated asymmetric polysulfone membrane (PSF with 5%wt 
PEG 35,000 pore-forming additive) (x1091) (author images). 
The occurrence of these microstructures can be controlled by the precipitation process 
and is affected by several variables such as the casting solution composition and 
concentration, the non-solvent used and its temperature as well as by organic and 
inorganic additives.7,62,63  Membranes formed by rapid solvent exchange generally 
have a highly porous sub-structure, containing macrovoids, with a finely porous, thin 
skin layer whilst membranes formed by a delayed de-mixing mechanism show a 
porous, macrovoid-free, substructure with a dense, relatively thick skin layer.61,66 
The first phase inversion RO membrane was developed by Loeb and Sourirajan in the 
late 1950’s using cellulose acetate dissolved in a water-miscible solvent which was 
cast as a thin film on a glass plate before being submerged in a water bath where the 
polymer precipitated forming a “skinned” asymmetric membrane.62 
a) b) 
50 µm 50 µm 
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Interfacial Polymerisation  
Interfacial polymerisation is a step-growth polymerisation technique which involves 
dissolving the monomer reagents in two different insoluble solvents before combining 
them to produce a polymer at the solvent interface. The classic example of this 
technique is the ‘nylon rope trick’, discovered by Morgan et al. in 1959, which involves 
interfacial polymerisation at the interface formed between an aqueous solution of a 
diamine and a diacid chloride in organic solvent to produce a nylon filament.67 Before 
this discovery, condensation polymerisations usually required high temperatures and 
reduced pressures to remove low molecular weight by-products such as water, and so 
drive the reaction forward, thus limiting the substrates that could be used. Morgan’s 
method, however, allowed such chemistry to be carried out at atmospheric conditions 
using basic laboratory equipment.68,69 This novel approach was based on the Schotten-
Bauman reaction where an acid chloride is reacted with a compound containing an OH 
or NH bond to form the corresponding esters and amides. In these reactions the two 
reactants are dissolved in immiscible solvents so that the reaction occurs at the 
interface of a heterogeneous liquid system.  If a di-acid chloride and a diol or diamine 
are used, then polymers are generally formed.  
This technique is often employed in the fabrication of reverse osmosis (RO) and 
nanofiltration (NF) membranes by polymerising a thin polymer skin layer on the surface 
of a microporous polymer support membrane. This support membrane is often an 
ultrafiltration membrane which itself consists of a woven or non-woven polyester paper 
coated with a porous polysulfone or polyethersulfone.70 These types of anisotropic 
membrane are also known as thin film composite (TFC) membranes.  
 
Figure 1.11: Structure of a thin film composite membrane.
71
 
The thin-film polymer layer is most often derived from the in situ interfacial 
polycondensation of aromatic diamines with aromatic di- and/or tri-acid chlorides to 
give a porous cross-linked polyamide on the solid support surface. Commonly used 
diamines have included both aliphatic and aromatic species including triethylamine, 
piperazine and meta/para-phenylene diamine.7 The preferred acid chloride monomer is 
trimesoyl chloride.  
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A major advantage of the TFC membranes relative to earlier, integral-asymmetric RO 
membranes is that the two layers can be independently modified and optimised 
allowing for control of properties such as permeability and selectivity 15.  
1.2.4.2 Membrane Characterisation  
Membranes can be characterised in a variety of ways which are commonly classified 
into three main categories; morphology (physical), composition (chemical) and 
performance based characterisation techniques (i.e. permeation/flux, fouling and 
filtration properties). In order to truly understand all of a membrane’s properties it is 
necessary to investigate all three aspects of characterisation. 
Membrane Morphology 
Membrane morphology characterisation techniques can examine either the membrane 
surface or bulk physical structure (see below). When examining the membrane face or 
topmost portion responsible for membrane selectivity, electron microscopy and 
scanning probe microscopy techniques can be used.  
In electron microscopy the sample surface is exposed to a beam of electrons within a 
vacuum. There are two basic techniques; transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM). In the former a detector will register electrons 
passing through the sample whilst in SEM, interaction between the electron beam and 
the sample causes the emission of secondary electrons which are then detected and 
can be converted into an image. Figure 1.12 shows a SEM micrograph of a gold-
coated polytetrafluoroethylene (PTFE) microfiltration membrane. 
In SEM the electron beam is scanned across the surface of the sample and has a 
resolution limit of 10 nm allowing for the imaging of pores in microfiltration membranes 
which have a size range of 100-10,000 nm.72 Ultrafiltration membranes, however, have 
a pore size range between 1 nm-30 nm which is much more difficult to resolve.73  In 
addition the membrane cross section can also be imaged and together with surface 
images these micrographs can provide information on pore size distribution, surface 
porosity (number of pores per unit area34) and pore geometry. It is worth noting these 
micrographs can only provide information on a very limited surface area and therefore 
are not necessarily representative of the entire membrane surface as highlighted in a 
review by Tang et al.74 This review also noted that the sample preparation 
(metallization via sputter coating) can affect the pore size distribution determination. 
Similarly cross section preparation either by cutting with a razorblade or through the 
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freeze fracture method can result in membrane compression and tearing.75 An 
alternative form of SEM known as environmental scanning electron microscopy 
(ESEM) can allow for sample analysis under less harsh conditions as the specimen 
chamber is separated from the electron source allowing for a reduced working 
pressure.76 
 
Figure 1.12: Scanning electron micrograph of a gold-coated microfiltration membrane (Omnipore™ - 
PTFE, pore size 0.1 μm) with retained 0.6 μm latex particles (x 50,000) (author image). 
Scanning probe microscopy methods exploit interactions (electromagnetic or 
mechanical) between the sample surface and a probe mounted on a flexible cantilever 
to map the surface morphology. Atomic force microscopy (AFM) is perhaps the most 
well-researched technique and employs a piezo-electric scanner to move the probe 
relative to the sample whilst measuring mechanical interactions.76 A great advantage of 
the AFM technique is the ability to examine membranes whilst wet, thus simulating 
conditions under which the membrane will operate, unlike the electron microscopy 
methods which require a dry sample.76 AFM has also been used to determine various 
membrane surface characteristics including surface roughness, pore density and pore 
size. However this technique is limited by restrictions on the scanning probe tip size 
which can affect the scanning depth. Additionally there can be distortion effects which 
can lead to overestimation of pore size relative to other techniques.77–79   
When investigating the bulk properties of a membrane it is important to distinguish 
between porous and dense membranes. The former type are used for microfiltration 
and ultrafiltration processes and are identified by the presence of permanent voids or 
pores which can be classed as either macropores (r > 50µm), mesopores (2µm ≤ r ≤ 
50µm) and micropores (r < 2µm).76  These membrane pores can be quantified in 
various ways and a common term used to describe the pores is the membrane porosity 
(also known as bulk porosity to distinguish from surface porosity) which is defined as 
5 µm 
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the volume of the pores divided by the total volume of the membrane (void volume).80 
Since the pores are not all of the same size and shape they can also be described by 
other means such as the pore size distribution, average pore radius and pore geometry 
(i.e. dead or dead-end pores which are not connected to the surface or are only 
connected at one end, respectively).  
To describe the pore size a system has been developed in order to quantify membrane 
filtration properties whereby macromolecules of known molecular weights are filtered 
through the membrane and the feed solution is compared with the permeate in order to 
determine percentage rejections. From this the membrane molecular weight cut-off 
(MWCO) is assigned – a value which corresponds to the minimum molecular weight of 
a solute which is 90% rejected. This method is widely accepted and is also used by 
membrane manufacturers to classify their products. The most common probe 
macromolecules are dextrans and polyethylene glycols (PEGs) and the feed/permeate 
solutions are typically analysed using aqueous gel permeation chromatography (GPC) 
which can separate these polymers based on their size via a filtration through a column 
containing porous beads. Smaller analytes will enter the pores and take longer to 
traverse through the column whereas larger polymers will pass through the column 
rapidly. The polymers are detected after exiting the column and each one will have a 
unique retention time range which can be used to compare the amount of each 
polymer within the feed solution and the permeate after filtration through the 
membrane. An example of this is shown in Figure 1.13 where a) shows the GPC 
chromatograms of individual PEG solutions whilst b) shows the traces produced after 
filtration of these PEG feed solutions through a commercial 50K MWCO PES UF 
membrane. In the permeate chromatograms the 100K PEG peak is greatly reduced 
since the PEG molecular weight is above the membrane MWCO and therefore the 
sample is retained by the membrane. 
 
 
Figure 1.13: Comparison of a) feed and b) permeate GPC traces of indevidual PEG solutions (0.1% w/v in 
GPC mobile phase) after filtration with a commercial 50K MWCO PES UF membrane (present project). 
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Morphology characterisation methods can allow for the investigation of mechanisms 
which lead to changes in membrane performance or to quantify the effects of 
modification (i.e. coatings on surface modified membranes) or even to examine the 
effects of membrane ageing and changes caused by fouling or exposure to 
chemicals.76 
Membrane Chemistry 
In order to understand the chemistry of membrane materials it is important to fully 
characterise these materials and to understand their properties before they are 
incorporated into a membrane. Since this review is focused on synthetic polymer 
membranes the analysis can involve a wide range of standard polymer 
characterisation techniques including NMR and IR spectroscopies, viscosity studies, 
thermal analyses, GPC characterisation. The membrane polymers can also be 
characterised after incorporation into the membranes themselves. For example, IR 
spectroscopy can be used to examine the surface chemistry of membranes. In 
particular IR is useful for examining chemical changes in a membrane surface, e.g. as 
a result of processes such as chlorination, irradiation or hydrolysis.76 It has also been 
used to examine fouling processes: for example Belfer et al. were able to use IR to 
identify the presence of adsorbed albumin on surface-modified PES UF after first using 
IR to characterise the pristine functionalised membranes.81 This group also monitored 
the removal of preservatives from commercial membranes using IR spectroscopic 
analysis.  
Membrane Performance  
In order to fully characterise membranes it is important to understand how they will 
function when used in separation processes. Key parameters that need to be 
determined for pressure-driven membrane separation processes are described below. 
The first key parameter to be measured is usually the membrane flux which relates to 
the water permeability and is defined as the amount of permeate produced per unit 
area of membrane surface per unit time. This can be measured by filtering deionised 
water under standard membrane operating conditions and calculating the average 
volume per hour of permeate. Standard units of this parameter are L/m2/h.  
A second key parameter is the % rejection which relates to solute permeability. For 
dense membranes salt rejection is measured, usually for both mono and divalent salts. 
The divalent salts will have a larger hydrated radius and higher rejection rates are 
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expected for them relative to monovalent salts.  For porous membranes 
macromolecule rejection is measured (i.e. dextrans or PEGs) which can then be used 
to determine the MWCO. The salt rejection can be calculated using Equation (1), 
where Cp and Cf are the concentrations of the permeate and the feed, respectively:
82  
𝑅 = (1 −
𝐶𝑝
𝐶𝑓
) ⨯  100%                                                            (1) 
An ideal membrane will exhibit both high flux and high rejection of the target solute. 
1.3 Forward Osmosis 
1.3.1 Overview 
As described above, osmosis is the movement of water through a semipermeable 
membrane driven by a difference in osmotic pressure which is generated by differing 
solute concentration across the membrane. Forward (direct) osmosis is the term used 
to describe a membrane separation process which is driven by a concentration 
gradient across a semi-permeable membrane via this naturally occurring phenomenon 
of osmosis.83  
Osmotic pressure (Π) can be defined as the minimum pressure that must be applied to 
the draw solution to prevent the influx of solvent from the feed solution in a system 
such as the one in the image below where a solution and solvent are separated by a 
semipermeable membrane.84 
 
Figure 1.14: Equilibrium involved in calculation of osmotic pressure (Π), adapted from reference.
84
 
Figure 1.14 demonstrates the equilibrium involved in the calculation of osmotic 
pressure Π. This equilibrium exists between pure solvent A at pressure p on the left 
hand side of the semipermeable membrane (in black) and solvent A as a component of 
a solution (containing dissolved solutes) at pressure p+Π on the right hand side of the 
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semipermeable membrane.84 Osmosis is a colligative property meaning it depends 
only on the number of solute “particles” (i.e. ions or molecules) present in solution, not 
their identity.  
Forward osmosis processes rely on the use of a concentrated "draw" solution which 
has a higher osmotic pressure than the feed solution therefore allowing it to draw water 
out of the feed. This results in dilution of the draw solution and concentration of the 
feed as illustrated in Figure 1.15. 
 
Figure 1.15: The process of forward osmosis relies on the use of a concentrated draw solution to move 
fluid from the feed into the draw (diluting it) across a semipermeable membrane, adapted from reference.
83
  
Forward osmosis has attracted increasing attention in recent years due to its many 
advantages over the pressure-driven membrane processes. The major benefit of FO 
technology is that it operates at no or very low hydraulic pressures since the process is 
driven by the concentration gradient. The low hydraulic pressure conditions result in 
reduced operating costs, less irreversible fouling and therefore less need for 
cleaning.85 Overall these advantages make FO processes potentially much cheaper 
and much more energy efficient to run.  
Despite these advantages FO technology has been slow to advance since its initial 
proposition as an alternative to the energy intensive pressure-driven membrane 
processes decades ago.86,87 This is due in part to the fact that (unlike RO) it is not a 
route to pure water, and in part to a lack of effective semi-permeable membranes and 
draw solutions88 – the two key components of a FO process.  
1.3.2 FO Membranes 
Any non-porous, selectively permeable membrane can be used for FO and historically 
much FO research has been carried out using commercial RO membranes.83 For two 
decades the only commercially available FO membrane was a cellulose triacetate 
membrane from Hydration Technology Innovations (HTI, Oregon, USA).89  In recent 
years however there has been more research into membranes specifically designed for 
FO.90 Considerations when designing such membranes include; reduction of the 
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concentration polarisation effect (described above) which results in decreased flux and 
inhibiting reverse solute diffusion which decreases the osmotic driving force.90,91 
1.3.3 FO System configuration 
An ideal draw solution will exhibit the following properties;  
1) A significantly higher osmotic pressure than the feed solution, to drive high 
permeate flux;92 
2) Minimal reverse diffusion, as osmotic draw solutes lost in this way will need 
replenishing, which increases cost. Moreover accumulation of these solutes in the feed 
may cause problems with disposal or continued processing of the feed;93 
3) When FO is used in water purification, a second step will be required to isolate the 
water from the diluted draw solution (i.e. re-concentration of draw).  
This second step would need to be inexpensive, and result in high recovery of draw 
solution, whilst also generating high purity water, for this process to be economic.83,94 
This re-concentration step is usually achieved through  reverse osmosis or distillation 
for standard electrolyte draw solutions which are based on aqueous solutions of 
inorganic compounds such as sodium chloride (highly soluble, nontoxic and easily 
reconstituted).83,94  Other draw solutions have been explored, including thermolytic  
draw solutes such as ammonium carbonate which decompose into volatile gases on 
gentle heating.95,96  
Although most traditional draw solutions are based on salts or small molecules, some 
research has also been done into polymeric draw solutions using hydrogels97,98 and 
polyelectrolytes.82,98,99 It is proposed that these high molecular weight draw solutions 
may provide an easier route to draw solution regeneration/water isolation and could 
avoid issues of draw solution leakage/backflow into the feed. A new class of draw 
solutions has been explored by Wang et al. where thermo-sensitive polymer hydrogels 
were synthesised and were found to induce high water permeation in osmosis 
processes whilst also demonstrating high water release rates under a combination of 
pressure and thermal stimuli allowing for the regeneration of the draw solution.97  
Chung et al. investigated an alternative strategy - polyelectrolyte draw solutions, in this 
case sodium salts of polyacrylic acid (sodium polyacrylate – NaPA) which is known to 
be highly water soluble and can therefore create high osmotic pressures whilst being 
retained by a forward osmosis membrane due to the expanded confirmation of the 
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polyelectrolyte chain resulting from charge-charge repulsions.82 In experiments using 
deionised water feed solutions and forward osmosis membranes the group found that 
NaPA was able to generate high water flux with insignificant back diffusion. To 
subsequently separate the water from the polyelectrolyte the group employed a 
pressure-driven ultrafiltration process although it is reported that increasing the feed 
concentration reduced the water production and rejection of the polyacrylate which is 
attributed to concentration polarization and fouling effects. Wang et al. also 
investigated an alternative draw solution strategy this time using novel thermo-
sensitive polyelectrolytes based on copolymerised N-isopropylacrylamide (NIPAM) the 
polymer form of which (PNIPAM) can be used to create a thermo-sensitive hydrogel 
which was combined with different amounts of sodium acrylate.100 
As mentioned above, a major drawback of the pressure-driven membrane processes is 
their susceptibility to fouling. Membrane fouling in FO has also yet to be fully explored 
and understood.101  However, for osmotically driven processes fouling is potentially 
less of an issue as it is usually more reversible than in membrane processes reliant on 
applied hydraulic pressure. This is due to the rejected solutes forming a far less 
compacted ‘cake layer’ in osmotically-driven membrane processes than in pressure-
driven membrane processes. It can thus be re-dispersed by simple physical methods 
such as hydraulic flushing, without the need for harsh chemicals which could degrade 
the membrane.101–103  
1.4 Membrane Modification 
1.4.1 Overview  
In order to achieve the best possible membrane properties it is sometimes beneficial to 
either modify the polymers used or to blend them with another polymer or non-polymer 
additive. This can allow control of the membrane structure, porosity, pore distribution 
and thickness, as well as other properties which will affect the overall selectivity of the 
membrane.104 There are several strategies which can be employed to modify 
membranes and they can be loosely classed as either bulk or surface modifications. 
Membrane surface modifications allow for the retention of desirable bulk mechanical 
properties of the polymer whilst achieving suitable surface properties for the end 
application105.  Surface modification strategies include; membrane coating, grafting and 
chemical modification. One of the main applications of membrane surface modification 
is to decrease membrane fouling and this is often done through increasing the polymer 
surface hydrophilicity.106 The following approaches can be used to modify membranes;  
 
22 
 
Bulk Modification 
Additives - where organic (hydrophilic/amphiphilic polymers) or inorganic substances 
are mixed with the membrane casting solution to give either polymer blend or 
composite membranes, respectively. In composite membranes the two or more 
materials have different chemical and/or physical properties allowing them to remain 
distinct at a macroscopic level.105   
Surface Modification  
Coatings - Polymers or small molecules are deposited on the membrane surface 
where they adhere through non-covalent interactions to form a membrane coating. 
There are several  types of coating techniques; hydrophilic thin layer (physical 
absorption), coating with a monolayer (Langmuir-Blodgett), deposition from glow 
discharge plasma and casting of two or more polymer solutions using simultaneous 
spinning equipment.105  
Grafting - Grafting involves the addition of polymer chains onto the membrane surface 
where they are bound via covalent interactions.  There are two key types; ‘grafting-
from’ where active species on an existing membrane surface initiate the polymerisation 
of monomers  from the surface (graft polymerisation) and ‘grafting-to’ where polymer 
chains with reactive side groups are covalently coupled to the membrane surface.107  
There are several ways to initiate the polymerisation reaction giving rise to different 
sub-categories of grafting; chemical, radiation, plasma photochemical or enzymatic 
induced grafting.108 It is also possible to graft either one monomer or a mixture of two 
or more. 
Chemical modification - This involves treating the membrane with chemical species 
which will introduce new functionality on the membrane surface. Reactions which have 
been applied to membrane functionalisation include; sulfonation, chloromethylation, 
aminomethylation and lithiation.105 Sulfonation of membrane polymers can be achieved 
by either post-sulfonation of the final polymer or through copolymerisation with 
sulfonated monomer (pre-sulfonation).109 Both strategies involve electrophilic aromatic 
substitution (EAS) reactions to introduce the sulfonic acid groups. Poly(arylsulfones) 
which include PSF and PES are widely used membrane materials due to their 
relatively low cost but, as mentioned above, the hydrophobic nature of these polymers 
makes them highly susceptible to fouling. Sulfonation offers a route to increased 
membrane surface hydrophilicity therefore decreased fouling tendency.  
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1.4.2 Interfacial Polymerisation 
Interfacial polymerisation is an alternative form of membrane modification which not 
only modifies the membrane surface but also alters the membrane application. As 
outlined in Section 1.2.1 and Section 1.2.4, interfacial polymerisation involves the 
spontaneous growth of a semi-permeable polyamide membrane on the surface of a 
supporting ultrafiltration membrane effectively converting the UF membrane into a 
reverse osmosis membrane or nanofiltration membrane. The porous support is coated 
with an ultra-thin yet dense polyamide film allowing this composite membrane to now 
reject much smaller solutes such as hydrated ions. Figure 1.16 illustrates the two step 
process involved in coating an ultrafiltration membrane to produce an interfacially 
polymerised thin-film composite membrane. The microporous support membrane is 
first impregnated with an aqueous solution of the amine. After the membrane is 
drained, the membrane surface is contacted with an organic solution of a multivalent 
crosslinking species allowing a polymer film to form on the surface of the membrane. 
 
Figure 1.16: Schematic of thin film composite anisotropic membrane fabrication using the interfacial 
polymerisation technique, adapted from reference.
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1.5 Oedema 
1.5.1 Overview 
Oedema can be defined as the abnormal accumulation of fluid in the body’s tissues or 
cavities which causes swelling of the affected areas. Oedema can occur within cells 
(intracellular oedema) but more commonly develops within tissues (extracellular 
oedema)110 which is the focus of the present literature survey. Intra- and extra-cellular 
oedema are, however, often not mutually exclusive; the extracellular oedema in the 
body’s tissues results in swelling which will affect blood supply therefore leading to 
intracellular oedema.111  
Oedema can be caused by several mechanisms and is usually the symptom of an 
underlying pathological condition. Consequently classification of oedema is not well 
defined due to lack of standardised definitions and methods of quantification. Currently 
there is no cure and only very limited methods of treatment for a condition which can 
have a severe impact on quality of life. 
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1.5.2 Fluid Homeostasis 
Oedema arises when systems maintaining fluid homeostasis in the body malfunction, 
causing disruption of normal body fluid distribution, and ultimately resulting in the 
accumulation of fluid in the affected area. The human body consists of approximately 
60% water by weight, or 42 litres for an average 70 kg adult male. The amount is 
slightly less in females (55%) due to a higher fat content.111 The principle of 
homeostasis requires that total body fluid volume and osmolarity (osmotic 
concentration) remain relatively constant. This is achieved by the regulation of two 
main factors; sodium balance and water balance. Sodium salts are the principal 
paracellular solutes and the regulation of sodium concentration is related to the 
circulating fluid volume.112 Proper maintenance of sodium balance ensures that all 
tissues are sufficiently perfused with fluid.113 The regulation of water balance is related 
to the osmolarity of body fluids and is essential in maintaining normal cell volume.114 
The overall volume and osmolarity of the body fluids is regulated by a complex system 
involving the brain, the central nervous system and hormones which are responsible 
for controlling water and salt excretion by the kidneys in response to detected volume 
and osmolarity.115,116 
The distribution of the fluid throughout the body is also important in maintaining optimal 
physiological conditions. The body fluid is divided between two compartments; the 
intracellular (ICF) and extracellular (ECF) spaces as illustrated by the diagram below 
(Figure 1.17). The intracellular fluid is the larger compartment and consists of the 
liquid component within cells, otherwise known as the cytosol. The extracellular fluid  
can be further split into two major components; intravascular blood plasma in the 
blood vessels (~25%)  and the extravascular interstitial fluid in the tissue spaces 
(~75%).117 There are also additional minor compartments within the ECF including 
lymph fluid and transcellular fluid. 111 
 
Figure 1.17: Body fluid distribution in an average lean adult male, ICF – intracellular fluid, ECF – 
extracellular fluid, IF – interstitial fluid, adapted from reference.
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The different compositions of these  fluids are essential in maintaining normal 
physiological conditions and are maintained by the physiological barriers (e.g. cell 
membranes, blood vessel walls) separating them. However, all body fluids will have 
approximately the same osmolarity, which is essential in preventing net movement of 
water in or out of the cells, which would result in cell shrinkage or swelling.119 
There are three key extracellular body fluids which are relevant to extracellular oedema 
formation. These include the two major ECF components; blood plasma and interstitial 
fluid along with the lymph fluid (a lesser component of the ECF).  These fluids are able 
able to exchange through a specialised microvascular exchange system (see below), 
so that changes in the volume and composition of one fluid will impact on the volume 
and composition of the others. It is important to note that the interstitial fluid can also 
exchange with the ICF compartment within the cells. The ability for exchange between 
all these fluids is paramount to their function; the blood transports substances such as 
nutrients, metabolites and oxygen to the cells in the tissues whilst simultaneously 
removing cellular waste. The exchange of these substances between the blood plasma 
in the capillaries and the intracellular fluid within the cells occurs via an intermediate 
fluid – the interstitial fluid bathing the tissue cells. The majority of the interstitial fluid is 
returned to the circulation via the lymphatic system.  
Compositions of Body Fluids  
The blood plasma and the interstitial fluid, being the two major components of the ECF 
compartment, can be exchanged across the selectively permeable blood capillary wall 
which separates them. These two fluids have similar compositions, although due to the 
selective barrier dividing them there is one major difference – the protein content. The 
diffusion of blood plasma proteins into the interstitium is severely restricted by their 
large molecular size relative to the capillary pores (see Table 1.2). However there are 
other routes by which proteins can traverse the membrane and enter the tissues; 
specialised vesicles can transport proteins out of the capillary and into the tissues, or 
the action of neurotransmitters such as histamine and serotonin can increase capillary 
permeability.120–122  Despite this, in normal tissues the rate of protein extravasation is 
relatively low and the concentration of protein in the blood plasma is usually 2 to 3 
times greater than in the interstitial fluid.123 It is important to note, however, that the 
total protein content in the 12 L of interstitial fluid is greater than in the plasma but 
because the volume of IF is four times that of the plasma (3 L) the average protein 
concentration of the IF is approximately 3 g/dL, i.e. 40% of that in plasma.124 
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Other plasma components are able to traverse the capillary much more freely through 
various mechanisms discussed below. These include: hormones, gases (carbon 
dioxide and oxygen) and nutrients such as fatty acids, amino acids and glucose.125 The 
blood also contains ‘non plasma’ components; white and red blood cells (leukocytes 
and erythrocytes) and platelets (thrombocytes)126 which are also not able to readily 
permeate through the capillary walls, again due to their large size. 
The interstitial fluid is also able to exchange with the intracellular fluid within the tissue 
cells themselves. The barrier separating these two fluids is the cell membrane which 
has many mechanisms for transporting components in and out of the cell as required, 
resulting in a significant difference in the compositions of these two fluids. The major 
difference between the ICF and the tissue fluid is in salt composition. Unlike the 
extracellular fluids the ICF is high in K+ and low in Na+/Cl- which differs significantly 
from the high Na+/Cl- and low K+ levels found in both the tissue fluid and blood plasma. 
The intracellular fluid also has a higher amount of protein than both the plasma and the 
interstitial fluid (see Table 1.1).  
Table 1.1: Body fluid compositions, adapted from reference.
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Plasma 
(mOsm/L H2O) 
Interstitial Fluid 
(mOsm/L H2O) 
Intracellular Fluid 
(mOsm/L H2O) 
Na+ 142 139 14 
K+ 4.2 4.0 140 
Mg2+ 1.3 1.2 0 
Cl- 108 108 4 
HCO3
- 24 28.3 10 
HPO4
-,H2PO4
- 2 2 11 
SO4
- 0.5 0.5 1 
Phosphocreatine   45 
Carnosine   14 
Amino acids 2 2 8 
Creatine 0.2 0.2 9 
Lactate 1.2 1.2 1.5 
Adenosine 
triphosphate 
  5 
Hexose 
monophosphate 
  3.7 
Glucose 5.6 5.6  
Protein 1.2 0.2 4 
Urea 4 4 4 
Others 4.8 3.9 10 
Total mOsm/L 301.8 281.0 281.0 
Total osmotic 
pressure at 37⁰C 
(mm Hg) 
5443 5423 5423 
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Finally the interstitial fluid can be converted into lymph fluid. Unlike the above 
exchanges between the blood plasma/interstitial fluid or the interstitial fluid/intracellular 
fluid, the conversion of interstitial fluid into lymph fluid is a one-way process. This is 
due to the structure of the initial lymphatics which consist of overlapping endothelial 
cells forming a valve and preventing back-flow of fluid and solutes which, once within 
the lymphatic vasculature, from then on is referred to as lymph fluid.128  The fluid 
collected is generally thought to have a similar composition to the interstitial fluid111 but 
it has been well-documented that the lymph fluid is modified by passage through the 
lymph node. This results in changes in protein concentration which are thought to be 
involved in establishing the equilibrium of Starling’s forces (see Section 1.5.3).129 Few 
studies have analysed the composition of lymph fluid, but analysis of ovine samples 
has shown that lymph contains a wide variety of proteins, not all of which are derived 
from plasma, suggesting lymph fluid is more than just an ultrafiltrate of plasma.130  As 
with plasma, however, the major protein was found to be albumin.   
Lymph fluid also contains other components which can include; cytokines (signalling 
proteins) extracellular matrix constituents, proteases, intracellular proteins, plasma 
proteins, erythrocytes and lymphocytes.130–133 
Barriers in Fluid Homeostasis 
The blood plasma in the capillary is separated from the interstitial fluid in the tissue 
spaces by the capillary wall which consists of a single layer of endothelial cells, less 
than 2µm thick, supported on the basement membrane which is part of the surrounding 
extracellular matrix (see below) and is secreted by the endothelial cells themselves.125 
The basement membrane prevents the passage of macromolecules from within the 
blood into the extracellular space.134 The diameter of the blood capillary forces blood 
cells to pass in single file.135 There are three types of capillaries with differing 
permeabilities according to their function; continuous capillaries, fenestrated 
capillaries and sinusoid (discontinuous) capillaries, see Figure 1.19.  All three 
types have leaky junctions between the endothelial cells creating small pores known as 
intracellular junctions (clefts) which allow the diffusion of water, ions and small 
hydrophilic molecules,  such as urea and glucose, into the interstitium - a process 
known as the paracellular pathway.136 These clefts represent 1/1000 of the capillary 
surface area and have a radius of 6-7 nm, which is slightly smaller than the diameter of 
albumin.124 Clearly the molecular size of plasma components will affect their ability to 
pass through the intracellular junctions. The relative permeabilities of a range of 
substrates are given in Table 1.2. 
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Table 1.2: Relative permeability of skeletal muscle capillary pore to molecules of different sizes.
124,137
 
Substance Molecular Mass (Da) Relative Permeability 
Water 18 1.00 
NaCl 58.5 0.96 
Glucose 180 0.6 
Albumin 69,000 0.001 
 
Water is also transported through specialised water-selective protein channels called 
aquaporins,138 whereas lipid-soluble substances such as dissolved oxygen and carbon 
dioxide can passively diffuse through the endothelium cells themselves – this is known 
as the transcellular route.137  All three capillary types also have specialised vesicles 
that can transport various substances across the capillary wall.139 
Continuous capillaries are found almost everywhere in the body, particularly in muscle, 
connective tissue and neural tissue.140  Fenestrated capillaries have large pores 
(fenestrae) with diameters of between 500 and 600 Å125 which allow larger volumes of 
fluid to be exchanged between the plasma and the interstitium, this type of capillary is 
found in the kidney and the intestine.135 Sinusoidal capillaries are found in bone 
marrow, liver and spleen and have large gaps which allow blood cells through, as 
these types of tissues are involved in blood processing.141 The rate of fluid exchange is 
highest in the sinusoidal capillaries, followed by fenestrated then continuous 
capillaries. However, net rate of diffusion of substances will be dependent on the 
concentration gradient across the capillary wall. 
 
Figure 1.19: Cross-sections of different capillary types, BM- basement membrane, ICJ – intercellular 
junction, V – vesicles, OF –open fenestrae, DF – diaphragmmed fenestrae, G – gap, adapted from 
reference.
125
  
As discussed above, the interstitial fluid and intracellular fluid have significantly 
different salt concentrations maintained by the barrier which separates them - the cell 
membrane.  The cell membrane has many mechanisms in place to transport different 
substances in and out of the cell. These include active carrier systems (e.g. the Na-K 
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pump) which can transport specific substances through the cell membrane as 
illustrated in Figure 1.20.142  Other substances such as water can move freely between 
the intracellular compartment and the interstitial fluid due to the high hydraulic 
permeability of the cell membrane. If the osmotic concentration of either the interstitial 
fluid or ICF changes, water can traverse the semipermeable cell membrane until 
equilibrium is attained.143  The cell membrane is also known to be permeable to solutes 
which contribute to the osmotic concentration of the interstitial fluid.144 Thus, it is clear 
that the osmolarity and volume of the IF will affect cell volume and osmolarity which is 
significant since changes in cell volume can impair cell function.145 A decrease in IF 
osmolarity will result in net movement of water into the cells increasing cell 
volume/decreasing the cell osmolarity. An increase in IF osmolarity will cause water to 
move out of the cell decreasing the cell volume and increasing the cell osmolarity.146 
The volume of the ECF (plasma and IF) is primarily determined by the total body 
sodium content as well as by the total body water content.147 
 
Figure 1.20:  Active and passive transport across a plasma cell membrane, adapted from reference.
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Gibbs-Donnan Effect 
The presence of barriers separating fluids, such as the capillary wall or cell membrane, 
gives rise to the so-called Gibbs-Donnan effect.148 The Gibbs-Donnan effect is a 
phenomenon responsible for the behaviour of charged particles near the surface of a 
semi-permeable membrane resulting in the uneven distribution of the particles on both 
sides of the membrane, usually due to the presence of a charged substance on one 
side of the membrane which cannot traverse it.149 The ions which can traverse the 
membrane will redistribute in order to preserve electro-neutrality.  
 This effect exists across the capillary wall, between the blood plasma and interstitial 
fluids as well as across the cell membrane separating the interstitial fluid and the 
cytosol.150 In the case of the capillary wall, the low permeability to plasma proteins 
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results in an ionic concentration difference between the plasma and the IF. This is 
caused by the highly negatively charged proteins attracting positively charged ions, 
whilst repelling negatively charged ions to give uneven distributions of ions across the 
capillary membrane despite it being freely permeable to the ions.150  With cell 
membranes, the effect is similar; negatively charged cytoplasmic proteins will have an 
effect on the distribution of ions across the membranes causing positively charged IF 
ions to enter the cell, whilst repelling negatively charged ions.151  Although overall 
electro-neutrality will be maintained, the high intracellular osmolarity should cause an 
influx of water into the cell which would disrupt the Gibbs-Donnan equilibrium, causing 
more ions to diffuse eventually resulting in cell swelling (cellular oedema).150 This 
undesirable effect is mitigated by the action of the Na-K pump which removes sodium 
ions from the cell to balance the Gibbs-Donnan effect by restricting sodium to the ECF; 
intracellular chloride ions are forced out of the cell cytoplasm, the overall effect of 
which is to decrease the osmotic burden.150,151  
1.5.3 Physiology 
As discussed above, the total body fluid is normally divided between the intracellular 
and extracellular spaces. These fluids can exchange through the microvascular fluid 
exchange system (Figure 1.21 below) which is involved in the regulation of blood flow 
in individual organs as well as the transport of nutrients to the tissue cells and the 
removal of cellular waste products.126 
 
Figure 1.21: Microvascular fluid exchange system, adapted from reference.
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The microvascular fluid exchange system consists of three ECF components;  blood 
plasma in the capillaries, interstitial fluid bathing the tissue cells and lymph fluid in the 
lymphatic vessels.152 The exchange process involves; capillary filtration (fluid moving 
into the interstitium) to give interstitial fluid which can exchange with intracellular fluid 
within the tissue cells before returning to the circulation either through capillary 
absorption or via the lymphatic system.  
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The Interstitium 
The interstitium occupying the space between the vascular and lymphatic systems has 
a complex structure and although the composition can vary between tissues, the basic 
components of all connective tissue are similar. These  include the tissue cells which 
are supported on a skeleton of insoluble fibres, surrounded by a soluble polymer gel 
and the interstitial fluid containing solutes and plasma proteins (See Figure 1.22).124,153 
The fibres and the polymer gel together are known collectively as the extracellular 
matrix (ECM). As noted above, the basement membrane  is also considered to be part 
of the ECM.154,155 
The ECM fibrils form a meshwork consisting of polyamides such as elastin and 
collagen which is the most abundant protein in animal tissue.155–157  The soluble 
polymer component of the ECM, otherwise known as ‘ground substance’, is a 
hydrophilic amorphous gel phase occupying the space between the cells and the 
fibres.158   The ground substance is made up of: 
 
1. Glycosaminoglycans (GAGs) - repeating disaccharide units forming un-
branched polysaccharide chains. The majority of the GAGs are highly 
negatively charged, causing the chains to repel each other due to the presence 
of sulfate and carboxylate groups and therefore bind cations such as Na+ and 
trap water molecules in the  interstitial fluid to form hydrogels.155,159  Hyaluronan 
(hyaluronic acid) is an exception in that it does not contain sulfate groups and is 
therefore less negatively charged than the other GAGs, allowing it to form 
infinite meshworks in dilute solution.155,158 Within connective tissues, GAGs do 
not appear as free polymers and are found in the form of proteoglycans.160 
 
2. Proteoglycans (PGs) formed from GAGs covalently bonded to a protein to give 
a highly cross-linked gel.154,161 
 
3. Multiadhesive glycoproteins responsible for linking  components of the ECM 
and the cells.155 
 
Figure 1.22: Interstitium structure, adapted from reference.
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A major role of the ECM component of the interstitium is the regulation of the interstitial 
fluid volume which it achieves through the specialised physical and biochemical 
properties of its components.162 The proteoglycans are known to immobilise water 
molecules, resisting flow through the interstitium and therefore affecting hydraulic 
conductivity.160 The polysaccharides can also ‘relax’ the concentration gradient and 
therefore the reduce osmotic pressure of the tissue causing water to be drawn in.163 
The fibrous component of the ECM also has a role. The entangled structure of the 
fibres results in the formation of pores approximately 200-250 Å in diameter.164 
Macromolecules such as extravasated plasma proteins, present in the interstitial fluid, 
can only reside in regions of the interstitium unoccupied by the structural components 
of the ECM and consequently these macromolecules will only occupy a fraction of the 
interstitial fluid volume. The larger proteins will remain in the solution phase, as the gel 
phase prevents bulk flow of fluid through the interstitium.165  This phenomenon is 
known as interstitial exclusion.162 Solute exclusion will vary with hydration state. In 
states of increased hydration, the effective pore radii of the gel phase will increase to 
give a larger volume for the fluid to be distributed in and in dehydration the reverse is 
true.164  Hence, the tissue water content is important as it defines the tissue volume 
and controls the space available for molecular transport processes.163 
The significance of solute exclusion is related to an oedema-preventing mechanism. 
As fluid accumulates in the interstitium, the accessible volume will increase thus 
reducing the tissue oncotic pressure making capillary filtration less favourable and 
protecting against oedema formation.164 This effect is often referred to as ‘wash-down 
of interstitial protein concentration’ and can withstand an increase in capillary pressure 
corresponding to 7 mm Hg.111 There are another two safety factors which normally 
prevent oedema formation. These include; 1) low tissue compliance when the 
interstitial fluid pressure is in the negative pressure range corresponding to 3 mm Hg 
and  2) the ability of lymph-flow to increase 10-50 fold to accommodate large 
fluctuations in fluid corresponding to 7mm Hg.110,111 Overall, this results in a total safety 
factor of 17mm Hg, theoretically allowing the capillary pressure to rise by this amount 
before oedema will occur.  
Although the fluid in the interstitium is usually found trapped within the ECM to form a 
gel there are still small rivulets and vesicles of “free” fluid not associated with 
proteoglycan molecules and therefore able to flow freely. This free fluid accounts for 
less than 1% in normal tissues, but in oedema, the pockets of free fluid will expand to 
give large volumes of freely flowing oedema fluid.124 
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The extracellular matrix has many complex functions and, as well as regulation of  
water content of tissues, it is particularly important for the maintenance of shape and 
protection of the organs of the circulatory, nervous and digestive systems.159,166 
The Lymphatic System 
As discussed previously, the major function of the lymphatic system is the removal of 
excess interstitial fluid from the tissues and returning this fluid along with extravasated 
plasma proteins and other large molecules to the circulation. This means the lymphatic 
system has a key role in control of; interstitial fluid protein concentration, volume and 
pressure.  In normal conditions these three factors are balanced in steady state levels; 
leaked proteins cause the interstitial fluid oncotic pressure to rise, causing increased 
capillary filtration resulting in increased interstitial fluid volume and pressure, the latter 
of which will increase the rate of lymph flow.124  
The lymphatic system originates in the interstitial tissues with the initial lymphatics 
(lymphatic capillaries) which merge to give collecting lymphatics which will go on to 
give way to lymph nodes, trunks and ducts which return the lymph to the circulation.167 
Figure 1.23 shows a cross-section of skin showing the relative positions of both the 
lymphatic and blood capillaries in the dermis. The thoracic duct is the final branch of 
the lymphatic system and is connected to the subclavian and jugular veins near their 
junctions in the neck allowing the lymph fluid to be returned to the circulation.168  
Lymph formation is a passive process involving a hydraulic pressure gradient 
developing between the  hydrated tissue and the lumen of the lymph vessel causing 
the endothelial cell valves in the initial lymphatics to be pulled open, trapping fluid and 
solutes.128  Unlike the circulatory system the lymphatic system has no central pump, 
although the main lymphatic vessels contain valves to prevent lymph backflow.169 
 
Figure 1.23: Cross-section of skin showing relative positions of lymphatic capillaries and blood capillaries 
in dermis made up of connective tissue consisting of cells and the ECM, adapted from reference.
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Microvascular Exchange 
Fluid exchange between the blood plasma in capillary and the interstitial fluid in the 
tissue spaces is controlled by the opposing forces of hydrostatic pressure and oncotic 
(colloid osmotic) pressure also known as Starling Forces, see Figure 1.24.171 
Hydrostatic pressure is generated by the heart pumping blood through the arteries so 
that in the arterial end of the capillary the blood plasma fluid is forced out into the 
interstitial space (filtration).  
 
Figure 1.24: Microvascular fluid exchange system, adapted from reference.
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The blood plasma proteins are mostly retained within the capillary as they are too large 
to traverse the pores in the capillary wall. These proteins will generate the  oncotic 
pressure at the venous end of the capillary causing the interstitial fluid to be drawn 
back into the capillary (adsorption).173 Filtration is usually greater than adsorption 
resulting in more fluid moving out of the capillary than is returned, and therefore the 
lymphatic system has a role in the removal of interstitial fluid from the tissue spaces 
and returning it to the circulatory system.135 Since some proteins will still leak out of the 
capillary and cannot be reabsorbed into the capillary the lymphatic system has a key 
role in returning these proteins to the circulation, thereby maintaining the oncotic 
pressure of the blood.174 There are three major types of blood plasma protein; albumin, 
globulin and fibrinogen.175 Albumin (68 kDa) accounts for 50% of the plasma protein 
present in healthy individuals and it is this high concentration combined with its high 
negative charge which results in albumin generating approximately 70% of the plasma 
oncotic pressure.176 
The forces which determine fluid movement through the capillary membrane can be 
described by the Equation (2);  
𝐹𝑙𝑜𝑤 𝑝𝑒𝑟 𝑢𝑛𝑖𝑡 𝑎𝑟𝑒𝑎 = 𝐾𝑐[(𝑃𝑐 − 𝑃𝑖𝑓) − 𝜎(𝛱𝑐 − 𝛱𝑖𝑓)]                         (2) 
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Where Kc is the capillary filtration coefficient, P is the hydrostatic pressure for the 
capillary and interstitial fluid whereas Π is the oncotic pressure again for the capillary 
and interstitial fluid.148 The symbol σ represents a retention coefficient which quantifies 
the ratio of the oncotic pressure exerted by a given concentration of protein to the 
theoretical oncotic pressure expected for a capillary wall which did not allow proteins to 
leak through.173,148 This is required as Πc is affected by the permeability of the capillary 
since in reality the capillary wall is not a perfect semipermeable membrane and the 
plasma proteins are able to leak into the interstitium.173 According to Guyton et al. 
normal values for these pressures are; Pc 17-25mm Hg, Pif -3mm Hg, Πc 28mm Hg 
(19mm from dissolved proteins and 9mm from the Gibbs-Donnan effect) and Πif 8mm 
Hg.124 
A positive value for the flow per unit area indicates that capillary filtration is favoured 
and a negative value is obtained when capillary absorption is favoured.  
1.5.4 Pathophysiology 
There are two types of mechanisms which can lead to the development of extracellular 
(interstitial) oedema;  
1. Non-Inflammatory 
a) Disruption of the capillary dynamics resulting in abnormal leakage of plasma 
fluid into the interstitium. This can be caused by excessive capillary filtration 
due to increased hydrostatic pressure (hydrostatic oedema) or decreased 
oncotic pressure preventing reabsorption of fluid back into the capillary, or a 
combination of both effects.177 
b) Lymphatic obstruction resulting in failure of lymphatic system to return fluid 
from the interstitial space back into the blood. This gives rise to a specific form 
of oedema known as lymphoedema.111,178  
 
2. Inflammatory 
a) Stimulation of the inflammatory immune response resulting in histamine release 
which will increase the permeability  of the capillary (permeability oedema) 
allowing plasma proteins to diffuse into the interstitium.179–181 
Causes of non-inflammatory oedema include renal disorders, cirrhosis, congestive 
heart failure, nephrotic syndrome and chronic venous insufficiency.177,182  When 
caused by right-sided heart failure or other systemic disease the oedema will be 
symmetrical and will develop from the ankles upwards.183 Unilateral oedema will 
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usually result from a local cause such as deep vein thrombosis, venous insufficiency or 
lymphedema.183,184 
Inflammatory oedema is caused by physical damage to the tissue from sprains, 
freezing injuries and thermal damage.161,180  
1.5.5 Clinical Symptoms And Diagnosis 
Initially it can be difficult to distinguish between chronic peripheral oedema and 
lymphoedema. The differential diagnosis of swollen limbs includes systemic and local 
causes. The former comprising of heart failure, renal disorders, hypoalbuminemia 
whereas the latter includes primary and secondary lymphoedema, venous disorders, 
bacterial infections and complications following surgery.185,186 A thorough medical 
history is required along with a physical examination of the affected area. This 
information is usually enough to make a diagnosis, but in some cases if the cause is 
not known lymphoscintigraphy may be used to image the lymphatic system and check 
for abnormalities. This technique involves an intradermal injection of radiolabelled 
colloid into the affected area followed by imaging using a gamma camera to trace the 
lymphatic transport of the radiotracer.187 Other techniques which can be used to image 
the lymphatic system include magnetic resonance imaging (MRI), computed 
tomography (CT) and ultrasound examination.185,187,188 
Chronic Oedema 
Chronic oedema is a broad term used to describe oedema not caused by lymphatic 
obstruction/defects lasting 3 months or more  which is not relieved by elevation or bed 
rest.189 There are a mixture of causes and ultimately the lymphatic system will be 
impacted by the condition if it is not treated.190 Oedema is often not clinically apparent 
until at least 2.5-3 L of fluid has accumulated in the interstitium.191 Clinically there are 
two types of oedema; pitting and non-pitting oedema, over time pitting oedema can 
develop into non-pitting oedema as the subcutaneous tissue becomes fibrotic.192,193 
Pitting oedema can be differentiated from non-pitting oedema with a simple test which 
involves the physician pressing the affected area with their thumb for a set time then 
seeing whether a ‘pit’ is formed. In pitting oedema the resistance to tissue fluid 
displacement is lowered by the accumulation of fluid in the interstitium resulting in 
dilution of the interstitial gel compartment to produce pockets of water which are easily 
displaced by the application of pressure therefore forming a pit.194 The duration that the 
pit lasts can also be used to assign the oedema a number in the ‘Pitting Oedema 
Scale’ which gives some idea of the severity of the oedema.195  
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Pitting oedema is often caused by systemic diseases such as heart failure and kidney 
and liver disorders which result in decreased serum protein, increased systematic 
venous pressure.184,196  Other causes of pitting oedema include venous insufficiency 
and deep vein thrombosis (DVT).182,197 The accumulated oedema fluid is of low 
viscosity and is protein poor.184  Non-pitting oedema occurs in advanced 
lymphoedema. Initially the lymphedematous swelling shows pitting, but with time the 
tissue becomes fibrotic to give non-pitting oedema.192 
Lymphoedema 
Lymphoedema can be classed as primary or secondary. Primary lymphoedema 
encompasses genetic abnormalities and syndromes and can be further subdivided into 
categories based on the age of the patient when the symptoms began to develop.188 
Congenital lymphoedema can be detected at birth or within the first two years of life, 
lymphoedema praecox usually develops during puberty although can occur into the 
early 30’s, and the final type - lymphoedema tarda is detectable after 35 years.198 
Secondary or acquired lymphoedema develops as a consequence of disruption or 
obstruction of the lymphatics and has many causes. These include; traumatic 
lymphoedema in response to direct injury to the lymphatic system, post-infection 
lymphoedema often as a result of recurrent cellulitis infections or infection by a 
parasitic worm (filariasis) and finally cancer and cancer treatments.187 In the western 
world most diagnosed forms of lymphoedema are malignancy-related, but it is thought 
that non-cancer forms of the condition are likely to be more prevalent but poorly 
recognised and underdiagnosed.199 In developing countries the most common cause is 
infection by filariasis which is in fact the most common cause worldwide with an 
estimated 120 million people currently infected and nearly 947 million people at risk in 
54 countries.200 The clinical classification of lymphedematous swelling is defined by the 
stages of lymphoedema outline by the International Society of Lymphology:201 
Stage 0 Latent or subclinical condition where swelling is not evident despite impaired 
lymph transport. Can exist months or years before overt oedema occurs (stages I–III). 
 Stage I Early accumulation of fluid relatively high in protein content (e.g. in comparison 
with “venous” oedema) that subsides with limb elevation. Pitting may occur.  
Stage II Pitting may or may not occur as tissue fibrosis develops. Limb elevation alone 
rarely reduces tissue swelling. 
 Stage III Lymphostatic elephantiasis - pitting is absent. Trophic skin changes, fat 
deposits, and warty overgrowths often develop. (Adapted from references188,201) 
38 
 
Oedema can also be classified by its localisation; generalized oedema – involving 
multiple organs as well as peripheral (subcutaneous) oedema and organ-specific 
oedema – i.e. cerebral, pulmonary and peritoneum (ascites).147 The present research 
project will focus on the treatment of peripheral oedema, i.e. subcutaneous oedema in 
the limbs. 
Accumulation of excess interstitial fluid increases the diffusion distance for oxygen and 
other nutrients to reach the cells as well impeding the removal of toxic cellular waste 
products. In severe cases this disturbance in blood supply to the tissues is known as 
ischemia and can result in cell damage and death.202,203  
1.5.6 Treatment 
Current treatments for oedema/lymphoedema are very limited, and at present there is 
no satisfactory resolution for either condition. Since oedema is often the sign of an 
underlying medical condition, initial strategies generally aim to treat and manage the 
primary cause. Other approaches involve restricting dietary sodium to reduce water 
retention, weight loss for obese patients and in certain cases, such as hydrostatic 
oedemas caused by congestive heart failure or venous disorders such as chronic 
venous insufficiency, the use of diuretics to promote fluid excretion through 
kidneys.184,204 Diuretics will have little effect on lymphedematous oedema as 
pathogenesis of this condition relies on elevated tissue oncotic pressure from 
accumulated macromolecules (mainly proteins) and not excess water retention.205 
Lymphoedema treatment can be divided into conservative (non-operative) and 
operative approaches, although underpinning both methods is a meticulous skin care 
regime along with careful exercise and compression.201 The main approach is Complex 
Decongestive Therapy (CDT) which should be performed by a certified therapist and 
involves a combination of: lymphatic-specific massage known as manual lymphatic 
drainage (MLD), compression in the form of multilayer bandaging and specially 
designed compression garments along with the above mentioned exercise and skin 
care regimes.205–207  After an intensive CDT course in a clinical setting, the treatment is 
adapted to include self-management at home.208 The use of additional compressive 
devices alongside the CDT may also be appropriate – intermittent pneumatic 
compression (IPC) therapy in particular is considered a safe and effective addition 
which has the advantage of being designed for use at home.209 If properly executed 
this approach can have very good results, but it is very time- and labour intensive, 
requiring specially trained personnel, personalised treatment plans and high patient 
compliance to ensure effectiveness.  
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Benzo-pyrones have been investigated as potential drugs for lymphoedema treatments 
as they act by reducing vascular permeability, thereby reducing fluid accumulation in 
tissues.210 It has also been suggested that they may increase macrophage activity 
leading to proteolysis in the interstitium and therefore reducing the tissue oncotic 
pressure.211 A recent review of benzo-pyrones as treatment for lymphoedema was 
unable to draw conclusions about the effectiveness of the drugs from the available 
clinical research and additionally there are concerns regarding side-effects affecting 
liver function.210 
In extreme cases, or for patients who have not responded to standard treatments, 
surgical procedures may be used to reduce limb volume by removing excessive 
tissues (debulking procedures) or to bypass lymphatic defects.206 Other indicators for 
surgery include recurrent infections, impaired movement or for cosmetic 
purposes.206,209   
Future approaches in lymphoedema treatment include molecular strategies, and much 
research has focused on the identification of molecular targets.212 One such approach 
is uses gene therapy particularly for therapeutic lymphangiogenesis where growth 
factors can be used to stimulate lymphatic vessel growth.213,214 
1.5.7 Fluid Composition  
Studies investigating the composition of these fluids are limited by difficulties in 
isolating the interstitial fluid in both normal and oedematous tissues. Although many 
techniques exist for this purpose they all have their inherent weaknesses, meaning 
there is no universally accepted method of interstitial fluid collection.129,165 Techniques 
for direct sampling include the wick technique215 and suction blister techniques.216 
Many studies also use lymph fluid since it is more accessible and, as discussed above, 
the initial lymph fluid is thought to be representative of the interstitial fluid. Microdialysis 
is another widely used technique for indirect sampling of fluid from the interstitium. This 
minimally invasive technique allows for continuous sampling of small (endogenous and 
exogenous) water soluble molecules within the interstitial fluid.217 The technique 
involves the insertion of a dialysis catheter (probe) into the tissue of interest using a 
guide cannula.218 The probe consists of a shaft with a semipermeable hollow fibre 
membrane tip and mimics the structure of a blood capillary.219 The probe has an inlet 
and outlet tube and is continuously perfused with a solution with an ionic composition 
similar to that of the surrounding tissue fluid (perfusate).218 Water soluble molecules 
within the tissues can passively diffuse through the pores of the membrane and leaves 
the probe as a dialysate where it can be analysed.  Providing there is a suitable assay, 
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virtually any water-soluble molecule in the interstitium can be sampled.218 Commercial 
polyethersulfone microdialysis probes are available with a MWCO of 6,000-
100,000 Da.217 This technique has been used to investigate the role of histamine in 
oedema formation after thermal injury.121   
Normal interstitial fluid protein levels have been quoted as 0.6-3.49 g/dL derived from 
normal leg lymph (including plasma protein, cytokine and cellular content)220 and 
2.06  g/dL estimated from average protein content of plasma in 20 subjects.221 
In the past it was thought that the composition of the accumulated oedema fluid would 
vary with the mechanism of oedema formation. Non-inflammatory oedema from 
enhanced capillary filtration (increased hydrostatic pressure) or decreased 
reabsorption (decreased plasma protein) was thought to result in the accumulation of a 
protein-poor fluid know as a transudate.222 In contrast, inflammatory oedema 
mechanisms result in increased capillary permeability, therefore allowing plasma 
proteins to leak into the interstitium to give a protein rich fluid known as exudate.222 In 
lymphoedema it is thought that insufficient interstitial fluid drainage results in the 
accumulation of the extravasated proteins resulting in a protein rich fluid.198 
Early studies into primary lymphoedema fluid composition corroborated this theory. 
Taylor et al. analysed the protein content of fluid obtained from 38 patients with primary 
lymphoedema and found an average protein content of 2.8 g/dL although the range 
was from 1-5.5 g/dL.223 
More recent studies have found the protein content of lymphoedema fluid to be the 
same or even lower in comparison to fluid extracted from an unaffected limb. These 
studies have often focused on secondary or obstructive lymphoedema. Olszewski et al. 
found that the lymph protein content in patients with postoperative and inflammatory 
lymphoedema was similar to that found in the controls although cytokine levels were 
found to be different with significantly higher levels found in those suffering from 
lymphoedema.224 In another study Olszewski et al. reported that the peripheral ‘tissue 
fluid-lymph’ of 15 patients suffering from filarial lymphoedema had a total protein 
content of 2.37 g/dL with a lymph: serum protein ratio of 0.48 ,whereas controls 
exhibited a total protein content  of 2.39 g/dL.225 Bates et al. found reduced colloid 
osmotic pressures in post-mastectomy arm lymphoedema fluid in comparison to the 
normal arm, which again goes against the theory of a high protein concentration.226 
There are many theories to explain these findings. One proposal is that, particularly in 
the early stages of lymphoedema, the interstitial and lymphatic spaces can expand and 
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accumulate the excess fluid, causing the protein concentration to remain within normal 
limits as it is diluted by the accumulated fluid.224 Other theories include: reduced 
capillary permeability to plasma proteins, proteolysis within the interstitium, and 
increased capillary filtration rate which decreases the transendothelial transfer of 
protein.226,227 
Other components which have been investigated include lipoproteins, which are 
present in the interstitium due to their role in peripheral cell cholesterol 
metabolism,165,228 and immune cells (i.e. lymphocytes)  to investigate inflammatory 
processes and susceptibility to infections.229 
1.6 Project Aims and Objectives 
The core aim of the project was to develop and test a prototype membrane medical 
device for interosmolar fluid removal to treat oedema and related conditions. The major 
objective was to obtain proof-of-concept. Though the device concept was described by 
a patent, no supporting evidence or data had yet been produced and so all aspects of 
the device and process required fundamental investigation. To achieve this, the 
following project aims were proposed: 
1. thorough background research into the conditions of oedema and 
lymphoedema as well as membrane technology, including both literature 
research and consultation with clinicians and researchers in the field; 
2. practical laboratory work including investigation into the process of forward 
osmosis (in particular, using UF membranes and specifically to transport model 
oedema fluid and proteins), membranes and membrane modifications and 
potential draw solutions; 
3. the development of a prototype design and fabrication process, assisted by key 
findings from this laboratory work and background research; 
4. the development of both an in vitro and ex vivo model in order to test the 
prototype devices; 
5. prototype testing to attain proof-of-concept. 
Alongside the above clinically-oriented project, a secondary project was proposed 
involving an investigation into thin-film composite membrane fabrication, to explore 
new thin film coatings made from novel poly-ylids and a new solvent resistant support 
membrane. 
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Chapter 2 – Forward Osmosis Processes with Ultrafiltration Membranes 
2.1 Abstract 
Forward osmosis (FO) processes employing a novel combination of porous 
ultrafiltration membranes and high molecular weight draw solutions are described in 
this Chapter. This strategy was used to investigate the possibility of transporting 
macromolecules, especially proteins along with the water during the forward osmosis 
process. This represents an attempt to solve a key issue in oedema treatment; the 
presence of excess proteins in the interstitium which generate high oncotic pressures 
causing further water accumulation. Investigations compared polymer and 
polyelectrolyte solutions to determine the best-performing draw solution. This was 
found to be a polyelectrolyte: 225K sodium polyacrylate. This draw solution was 
investigated in a variety of studies exploring performance with a model oedema 
solution consisting of a physiological salt solution containing 2% high molecular weight 
polymer to model the protein content as established by the combination of a literature 
survey and consultations with clinicians and researchers in the field. The chosen 
physiological salt solution was Krebs solution and the protein model was a synthetic 
polymer, 100K polyethylene oxide (PEO). Following studies employing this model 
solution it was found that PEO exhibited unwanted complexation behaviour with the 
sodium polyacrylate which led to further studies in order to understand both PEO and 
sodium polyacrylate behaviour in solution. After employing the PEO based model 
oedema solution to optimise the novel FO system (UF membrane with high molecular 
weight polymer draws) real proteins were substituted for the model PEO’s. Finally 
studies into membrane fouling, system osmotic pressure characteristics and protein 
transport were carried out. 
2.2 Introduction 
Forward osmosis is the naturally occurring phenomenon which takes place when a 
semi-permeable membrane is placed between a pure solvent and a solution 
containing dissolved solutes; the solvent (usually water) moves from an area of high 
water potential to an area of low water potential in the mixture across the 
semipermeable membrane (See Figure 2.1). Forward osmosis has been the focus of 
significant research in recent years for water purification applications in the hope that it 
may provide a low energy alternative to currently used high pressure water purification 
processes1–3. 
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Figure 2.1: The process of forward osmosis relies on the use of a concentrated draw solution to move 
fluid from the feed into the draw (diluting it) across a semi-permeable membrane, adapted from 
reference.
2
  
Forward osmosis is driven by an osmotic pressure gradient created by a concentrated 
draw solution which requires much less energy. A major limitation of this process is 
that it is not a route to pure water and an additional draw re-concentration/water 
isolation step is required. The use of forward osmosis in order to move physiological 
fluids has received less attention, indeed to this author’s knowledge this application of 
forward osmosis has not previously been investigated.  
The overall aim of this project was to create an implantable medical device which can 
be used remove excess accumulated fluid in the limbs of patients suffering from 
conditions such as oedema and lymphoedema. The device concept was based on a 
US Patent licensed to Biointeractions Ltd which describes an implantable medical 
device for interosmolar fluid removal.4 The theory proposed that a device based on an 
implantable semipermeable membrane containing trapped osmotic solutes could be 
used to remove excess accumulated fluid in tissues surrounding the device allowing 
them to be removed from the body via a tube connected to an external reservoir.  
 
Figure 2.2: Image from US Patent No. US 8,211,053 B2 showing a sketch of potential device 
configuration; internally implanted portion consisting of a membrane with trapped osmotic solutes 
connected to an external reservoir for fluid collection. 
Although the patent details only the removal of water, after a comprehensive literature 
review and consultation with clinicians and researchers in the field5–7 it became 
apparent that removal of the fluid alone would not solve the issue as proteins left in the 
interstitium would generate an osmotic pressure gradient capable of drawing more 
fluid into the tissue. The device design was thus adapted to probe the use of porous 
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ultrafiltration membranes for forward osmosis in order to remove proteins along with 
the solution. 
The use of porous membranes presented a new challenge in draw solution selection 
as it was essential to use a high molecular weight draw to prevent backflow/leakage 
through the membrane. For this reason polymeric draw solutions in combination with 
porous ultrafiltration membranes were chosen as a test system for investigation.  
 
Figure 2.3: a) Traditional FO system using non-porous dense membrane and salt based draw solution vs. 
b) novel FO system employing porous UF membrane with high molecular weight polymer draw solution.  
Furthermore two types of high molecular weight draw solutions were investigated; 
neutral but strongly hydrophilic polymers and polyelectrolytes - a type of polymer with 
positive or negative charges on its repeat units. In water polyelectrolytes can 
dissociate to give a charged poly-ion surrounded by a cloud of small, mobile counter-
ions.8 It was proposed that the counter-ions present in polyelectrolytes could help 
produce the high osmotic pressures required to drive the forward osmosis process, as 
they hugely increase the concentration of solute particles compared to a neutral 
polymer of similar molecular weight. 
 
2.3 Results and Discussion  
 
2.3.1 Initial FO Studies using Ultrafiltration Membranes 
Initial forward osmosis experiments were carried out to investigate potential draw 
solutions using deionised water feed solutions as a control. These experiments 
involved evaluating different polymer and polyelectrolyte draw solutions of varying 
concentrations to determine which could produce the highest flow rates. It was 
decided that 5% w/v solutions would be the standard but for some of the higher 
molecular weight polymers the percentage was reduced to decrease the viscosity and 
allow for more effective stirring. In total seven different draw solutions were 
investigated. Four polymer draw solutions consisting of; three polyethylene glycol 
PEG/ (poly(ethylene oxide)PEO draws of different molecular weights (5% w/v 35K 
a) b) 
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PEG, 5% w/v 100K PEO and 1% w/v 1 million PEO), thus allowing for the investigation 
into the effect of increasing molecular weight on membrane flux. The fourth polymer 
draw was 5% w/v 160K polyvinylpyrrolidone (PVP), another water soluble polymer. 
Three polyelectrolyte draw solutions were also investigated; 5% w/v 1 million MW 
polystyrene sulfonic acid sodium salt (PSSA) and two different sodium polyacrylate 
salts (NaPA) 5% w/v 225K MW NaPA and 6 million MW NaPA.   
 
Experiments were carried out using a modified stirred-cell system usually employed for 
pressure driven ultrafiltration experiments. The stirred cell was adapted for use in 
forward osmosis experiments by connecting it to a reservoir containing the feed 
solution via a tube and placing the membrane face down in the membrane holder, with 
the draw solution within the stirred cell (see Figure 2.4).  
 
Figure 2.4: Schematic showing stirred cell modified for forward osmosis studies.  
The membrane was also varied to investigate the effect of the membrane material and 
molecular weight cut off (MWCO) - a property related to pore size. Five commercially 
available ultrafiltration membranes with different MWCO were investigated, two 
regenerated cellulose (10K and 100K MWCO) and three polyethersulfone (PES) 
membranes (30K, 50K and 100K MWCO). 
General observations from these forward osmosis experiments include that; 
 1) The polyelectrolytes as a rule generated higher flow rates than the neutral 
polymers. This corresponds with the fact that polyelectrolytes have free ions 
associated with each polymeric repeat unit, vastly increasing the number of osmolytes 
in solution in comparison with a neutral polymer of the same molecular weight without 
the associated ions.9,10   
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 2) For uncharged polymeric draw solutions, the average flow rate decreased with 
increasing molecular weight of the draw solution, and the 1% w/v 1 million MW PEO 
draw solution was unable to generate flow in any experiments with either type of 
membrane.  
3) For polyelectrolytes, the viscosity of the higher molecular weight materials (6 
million), even at reduced concentrations, made these solutions unsuitable candidates 
for draw solutions. This was due to the fact that, in spite of their high flow rates, these 
solutions could not be measured, poured or stirred efficiently.  
4) The PES membranes were more robust and less prone to fouling than the cellulose 
membranes which often showed a tendency to block after the first hour, giving zero 
flow after the first measurement (denoted by * after average flow rate). This is 
unexpected as the more hydrophilic cellulose membranes are normally considered 
less prone to fouling than the hydrophobic PES.  
5) As the membrane MWCO increased, the average flow rates generally decreased. 
The trends within each set of data for a particular membrane (i.e. 10K cellulose) are 
discussed allowing comparison between draw solutions of varying types, molecular 
weights and concentrations. Additionally trends between the membrane data sets are 
also explored to assess the effects of membrane materials and MWCO.  
2.3.1.1 Cellulose Membranes 
Forward osmosis measurements with the 10K cellulose membrane demonstrated 
that, for the polymeric PEG/PEO draw solution series, the average flow rate decreased 
with increasing molecular weight (see Table 2.1). This may be attributed to the 
increasing viscosity which decreases stirring efficiency and reduces membrane wetting 
therefore creating a less efficient interface between the draw solution and membrane 
surface. Indeed, it was observed that the 1% w/v 1 million MW PEO was unable to 
generate flux in any experiment. The 5% w/v 160K PVP had a similar average flow 
rate to the 5% w/v 100K PEO solution (5 mL/h and 3 mL/h respectively, consistent with 
their similar molecular weights and the fact that they are both neutral polymers rather 
than polyelectrolytes.  The highest average flow rate was produced by the 1% w/v 
solution of 6 million MW sodium polyacrylate. The 5% w/v 225K NaPA experiment 
appeared to experience membrane fouling after only one hour i.e. zero flux after the 
first hour, symbolised by the * following the average flux. 
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For the 100K cellulose membrane two experiments resulted in fouling; 5% w/v 100K 
MW PEO and 5% w/v 225K NaPA, with zero flow after the first hour (denoted by *, see 
Table 2.1 below). The 35K PEG was not a high enough MW to be retained by the 
membrane therefore resulting in leakage of the draw solution into the feed. As for the 
10K cellulose membrane, the highest flow rate for the 100K cellulose membrane was 
achieved with the 1% w/v solution of 6 million MW NaPA although the 5% w/v 1 million 
MW PSSA experiment generated a reasonably high average flow rate of 7.1 mL/h. 
However when this result is compared with the PSSA flow rates across all the 
membranes it appears to be in contrast with the average fluxes generated in other 
experiments which tended to be less than 4 mL/h. 
Table 2.1:  Results from initial forward osmosis experiments with 10K and 100K cellulose membranes. 
 Draw solution Average Deionised Water Flow (mL/h) 
  10K cellulose 100K cellulose 
P
o
ly
m
e
r 
5% 35K MW PEG 10 - 
5% 100K MW PEO 3 1.4* 
1% 1 million MW PEO 0 0 
5% 160K MW PVP 5 2.5 
    
P
o
ly
e
le
c
tr
o
ly
te
 5% 1 million MW  
PSSA 
3.4 7.1 
5% 225K NaPA 1.4* 1.4* 
1% 6 million MW  
NaPA 
20 25 
 
A general observation for the regenerated cellulose membranes was that in three of 
the 13 experiments the membrane appeared to foul, with flux observed for the first 
hour but for the following hours zero flux was detected (denoted by * after the average 
flux). In these cases approximately 10mL of the feed was absorbed into the draw 
during the first hour after which the flux fell to zero.  Two of the latter experiments were 
with the same draw solution; 5% w/v 225K MW NaPA suggesting some interaction 
between the draw and the membrane although the higher molecular weight version of 
the same polymer (1% w/v 6 million MW NaPA) did not exhibit the same issues. This 
problem was not observed with the PES membranes.  
 
2.3.1.2 PES Membranes 
For the 30K PES membrane, as for the other two PES membranes (Table 2.2), there 
were no experiments with zero flow after the first hour suggesting these membranes 
are less susceptible to fouling than the cellulose membranes. The two lower MW 
PEG/PEO draw solutions (35K and 100K) had similar average flow rates and, as in all 
62 
 
experiments, the 1 million MW PEO had zero flow. The 5% w/v 225K NaPA generated 
an average flow rate of 24mL/h, comparable to the 30mL/h flux generated by the much 
more viscous and less practical 1% w/v 6 million MW NaPA. Following which, for the 
subsequent experiments, it was decided that as the 6 million MW NaPA was not 
practical to use and as the 225K NaPA could conceivably generate a similar result, the 
6 million MW draw solution could be omitted from further PES studies. 
The 50K PES membrane when used in conjunction with the lower MW PEG/PEO draw 
solutions gave similar average flow rates to the 30K PES membrane whilst the 
1 million MW PEO again gave zero flow. The 5% w/v 225K NaPA again resulted in a 
high average flow rate of 26 mL/h, far surpassing the flow rates generated by the other 
draw solutions in this data set. As discussed previously this is attributed to the high 
osmotic pressure generated by polyelectrolytes, as a result of the associated counter-
ions, relative to neutral polymers.  
For the 100K PES membrane the average flow rate generated by the 5% w/v 225K 
NaPA was lower than with the lower MWCO PES membranes (30K and 50K MWCO), 
but this was in agreement with an observed general trend of average flow rate 
decreasing with increasing membrane MWCO, as discussed in Section 2.3.2 and it 
was still the highest flow rate for this data set. As with the other membrane data sets, 
the 35K PEG and 100K PEO gave similar flow rates. 
Table 2.2:  Results from initial forward osmosis experiments with 30K, 50K and 100K PES membrane.  
 Draw solution Average Deionised Water Flow (mL/h) 
  30K PES 50K PES 100K PES 
P
o
ly
m
e
r 
5% 35K PEG 2.3 3.7 3.6 
5% 100K PEO 2.4 5 3 
1% 1 million MW 
PEO 
0 0 0 
5% 160K MW PVP 5 3.6 2.3 
     
P
o
ly
e
le
c
tr
o
ly
te
 5% 1 million MW 
PSSA 
4 2.6 2.3 
5% 225K MW NaPA 24 26 10.4 
1% 6 million MW 
NaPA 
30 - - 
 
As mentioned previously none of the PES experiments demonstrated fouling 
behaviour that resulted in the discontinuation of flux.   
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When comparing results between membrane data sets it is possible to observe some 
additional trends which result from membrane material and MWCO effects. For 
example a simple plot of draw molecular weight vs. average flux (mL/h), see Figure 
2.5, clearly demonstrates that overall the PES membranes had generally higher fluxes, 
particularly since they were compatible with the 5% w/v 225K NaPA which appeared to 
foul both the cellulose membranes.  
 
Figure 2.5: Graph showing average flux (mL/h) vs. draw molecular weight for different membrane types 
10K and 100K cellulose in comparison with 30K, 50K and 100K PES. 
Figure 2.5 also demonstrates that the higher MWCO membranes produce lower 
membrane fluxes, with both 100K membranes exhibiting much lower fluxes generally 
than their respective lower MWCO equivalents.  This can be shown more clearly by 
comparing an example of a polymer draw (PVP) and a polyelectrolyte draw (NaPA) of 
roughly similar molecular weights – 160K and 225K NaPA as shown in Figure 2.6.  
When comparing data from both cellulose membranes with results obtained using the 
PES membranes both membrane types exhibit a similar general trend; as the 
membrane MWCO increases the average flow rate decreases regardless of the nature 
of the draw solution.  
 
Figure 2.6: Average deionised water flow rate (mL/h) for 5% 160K PVP and 5% 225K NaPA draw 
solutions for different MWCO cellulose and PES membranes. 
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Figure 2.6 highlights the large difference between fluxes produced by similar 
molecular weight polymer and polyelectrolyte draws with the ionic polymer producing a 
fivefold increase in flux from 5 mL/h to 24 mL/h when using a 30K PES membrane. 
After comparing the different membrane materials and MWCO it was evident that a 
lower MWCO was favourable due to the higher fluxes when compared with higher 
MWCO membranes regardless of the material. Additionally from these initial studies it 
is clear the regenerated cellulose membranes are prone to fouling when used for 
forward osmosis with polymeric draw solutions, thus rendering them unsuitable for 
application in this project. Having identified the optimal membrane material and 
MWCO the final component to be optimised was the draw solution.  
 
A general observation, when comparing the different types of draw solutions 
investigated, was that the polyelectrolytes generate highest fluxes. Whilst the best 
performing draw was the 6 million MW NaPA the high viscosity of these solutions 
made them an impractical choice. The 1 million MW PEO failed to produce any flux in 
any experiment. Plotting the average fluxes for the remaining polymers and 
polyelectrolytes when used in conjunction with the optimal membrane; 50K MWCO 
PES UF membrane as decided previously it is clear that the only possible choice 
capable of generating the high fluxes required is the 5% w/v 225K NaPA (Figure 2.7).   
 
Figure 2.7: Average deionised water flow rate (mL/h) for polymers and polyelectrolytes using a 50K 
MWCO PES UF membrane. 
After identifying the best draw solution (5% w/v 225K NaPA) and the best-performing 
membrane material (PES) the next step was to carry out studies using the ‘model 
oedema solution’ which as explained above consists of an (unbuffered) Krebs (UBK) 
solution with 2% w/v 100K PEO to simulate the protein content. A lower MWCO 
membrane was initially studied due to the observed decrease in average flow rates 
with increasing MWCO. In preliminary model oedema fluid experiments with 30K PES 
membranes zero flow was observed. It was proposed that the 100K PEO modelling 
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the protein was fouling the membranes, blocking the pores and preventing feed 
permeation. To investigate this, a series of fouling studies with higher MWCO 
membranes (50K and 100K) were carried out using PEGs and PEO’s of different 
molecular weights. 
2.3.2 Ultrafiltration Membrane Fouling Studies  
In order to investigate potential membrane fouling by the 100K PEO in the original 
model oedema solution (Krebs buffer with 2% w/v 100K PEO), forward osmosis 
experiments were carried out using the same membrane and draw (50K MWCO PES 
UF membrane and 5% w/v 225K NaPA) with feed solutions containing different MW 
PEGs/PEOs. The volume of the feed solution was measured hourly and this was 
plotted against time in order to determine the average flux (mL/h).   Figure 2.8 shows 
that the feed volume decreased with time as fluid from the feed moved into the draw. 
However, it also demonstrates that, as the molecular weight of the PEG/PEO 
increases, the feed flow rate decreases resulting in a levelling out of the feed solution 
volume with time. There is a significant drop in the flow rate for the higher MW 
PEGs/PEOs (35K and 100K) when compared with the 6K PEG and the unbuffered 
Krebs alone. This effect is proposed to be due to membrane fouling caused by higher 
MW PEGs blocking the membrane pores.  
 
Figure 2.8: Forward osmosis membrane fouling study results showing feed volume decrease vs. time, 
testing a 50K PES UF membrane with a  5% w/v 225K NaPA draw solution using different  feed solutions; 
unbuffered Krebs solution(UBK) and UBK containing increasing molecular weight PEGs (6K, 35K and 
100K), an average of 2 experiments run in parallel. 
This theory appears to be in good agreement with the limitations imposed by the 
MWCO of the membrane which, at 50K, would easily allow the UBK and 6K PEG 
through whereas the 35K PEG is approaching the MWCO and would be expected to 
have limited permeability. Furthermore it was observed in Section 2.3.1 that the 50K 
PES membrane was capable of retaining the 35K PEG when it was explored as a 
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draw solution suggesting this polymer cannot freely traverse through the 50K PES 
membrane. Evidently the 100K PEO is well above the 50K MWCO limit of the 
membrane and zero permeation would be expected. The effect of PEG/PEO molecular 
weights on membrane flux is most clearly illustrated in Figure 2.9 which shows how 
the average hourly flow rate is decreasing with increasing PEG/PEO molecular weight.  
 
 
Figure 2.9: Forward osmosis membrane fouling study results showing average membrane flux (mL/h, 
determined from data in Figure 2.8) for different draw solutions, testing 50K PES Membrane with 5%225K 
NaPA draw using different feed solutions; unbuffered Krebs solution (UBK) and UBK containing 
increasing molecular weight PEGs, (6K, 35K and 100K).  
To further investigate the effects of PEG MW on fouling, the same PEG/PEO feed 
solutions were tested with a 100K PES membrane to determine whether a larger pore 
size would result in less fouling and therefore a reduction in the associated decrease 
in flow rate. As before, plotting the feed volume against time shows a similar result; the 
flow rate decreases as the PEG MW increases resulting in a levelling out effect in the 
feed volume associated with reduced/halted flux. However, it is worth noting that there 
is no sudden drop in flow rate for the higher MW PEG/PEO (35K and 100K) as 
observed with the 50K PES UF membrane where the two higher MW PEG/PEO data 
sets diverge from the UBK/UBK +2% 6K PEG data sets. 
  
Figure 2.10: Forward osmosis membrane fouling study results showing feed volume decrease vs. time, 
testing a 100K PES UF membrane with a  5% w/v 225K NaPA draw solution using different  feed 
solutions; unbuffered Krebs solution(UBK) and UBK containing increasing molecular weight PEGs (6K, 
35K and 100K), an average of 2 experiments run in parallel. 
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Furthermore when the overall average hourly flow rate is considered there is little 
difference between the solutions’ flow rates as illustrated in Figure 2.11. There is a 
slight decrease across the series, but this is far less significant than with the 50K PES 
suggesting that fouling alone may not causing the limited flow rates in this case.   
 
 
Figure 2.11: Forward osmosis membrane fouling study results showing average membrane flux (mL/h, 
determined from data in Figure 2.10) for different draw solutions, testing 100K PES Membrane with 
5%225K NaPA draw using different feed solutions; unbuffered Krebs solution (UBK) and UBK containing 
increasing molecular weight PEGs, (6K, 35K and 100K). 
In order to understand other potential limiting factors for the 100K MWCO membrane 
comparison between both membranes is required. When comparing results for the 
50K PES membrane and 100K PES membrane it can be observed that the flow rate is 
generally lower for the higher MWCO membrane with the UBK flow rate being on 
average 7mL/h for the 50K membrane dropping to 1.15mL/h for the 100K membrane.   
2.3.3 PEG Behaviour in Solution 
Following system configuration determination and model solution testing in Sections 
2.3.1 and 2.3.2 other aspects of the system were then examined. The following two 
sections describe the solution behaviour of both the draw and feed solutions and how 
the draw solution is affected when diluted by the feed as a result of forward osmosis. 
 
In order to examine PEG/PEO behaviour in solution, inherent viscosity measurements 
were obtained to ensure there were no changes in secondary structure with increasing 
PEG/PEO molecular weight. Changes in polymer structure may increase the risk of 
fouling for example if the polymer were to become more globular in shape it may be 
more likely to block the membrane pores. Changes in polymer structure can affect the 
inherent viscosity of the polymer in solution, leading a sudden change in viscosity 
which can be detected by measuring the viscosity of different molecular weight 
solutions of the same polymer (at the same concentration). From the viscosity 
measurements in deionised water the linear relationship observed for the increasing 
polymer MW demonstrates there is no change in structure as the molecular weight 
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increases thereby eliminating this possibility (Figure 2.12). Additional measurements 
were carried out for PEG/PEO in the Krebs solution used in the model oedema studies 
confirming that the salts do not affect the inherent viscosity of the polymers and 
therefore also suggesting there are no structural effects. 
 
Figure 2.12: Inherent viscosity of solutions of 6K, 35K and 100K PEG (0.1% w/v) in deionised water 
and unbuffered Krebs solution (UBK) at 25⁰C. 
 
2.3.4 Sodium Polyacrylate Behaviour in Solution 
In addition to understanding the feed solution behaviour, understanding the draw 
solution and how it is affected by dilution with the feed is essential to the end 
application of the system as an implantable membrane device for the treatment of 
oedema.  The use of polyelectrolytes as draw solutions has yet to be fully explored 
and never have they been studied in FO applications with porous membranes.     
 A polyelectrolyte is a type of polymer with ionisable groups which can dissociate in 
solution to give positive or (in this case) negative charges on its repeat units. 
Polyelectrolytes in aqueous solution will dissociate to give a charged poly-ion 
surrounded by a cloud of small, mobile counter-ions.8 Well-known naturally occurring 
polyelectrolytes include proteins and nucleic acids, illustrating the fundamental 
importance of such molecules. However despite much scientific interest and study they 
remain one of the least understood systems in macromolecular science.11,12 When 
compared to neutral polymers, the complexity of polyelectrolytes arises from a 
combination of long range coulombic interactions, excluded volume effects and solvent 
induced interactions.11,13 Electrostatic interactions between charged groups of the 
polyelectrolyte result in unusual solution behaviour which can affect their bulk 
properties such as turbidity, viscosity and light scattering behaviour. In turn these 
properties are themselves affected by multiple factors such as the solvent suitability in 
terms of solvating the polymer backbone and the salt concentration.10   
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In spite of these challenges in studying polyelectrolytes it is their osmotic properties 
which make them a desirable as potential draw solutions for forward osmosis. When 
dissolved in salt free or low salt solutions the osmotic pressure of polyelectrolytes 
exceeds the osmotic pressure of neutral polymers of equivalent concentrations by 
several orders of magnitude.9,10  However, there are key differences between the 
osmotic behaviour of salt-containing and salt-free polyelectrolyte solutions and both 
types of solutions exhibit concentration-dependent osmotic effects. This present 
discussion will focus on salt-containing polyelectrolyte solutions which are more 
relevant to the project.  
In solutions of polyelectrolytes the osmotic pressure is dominated by the counter-ions 
but only when they are below the counter-ion condensation (CC) threshold and are 
therefore essentially free in solution.11 Above the CC threshold the counter-ions in 
solution become localised around the polyelectrolyte chain and a certain fraction of 
ions condenses onto the polyelectrolyte chain until the charge density of the macroion 
is reduced below a critical point known as the counter-ion condensation point.14,15 This 
phenomenon occurs as a result of electrostatic interactions between polyelectrolyte 
chains and counter-ions in solution. Counter-ion condensation is associated with a 
loss of entropy in the system which is balanced by the electrostatic attraction between 
the ions and the polyelectrolyte chain.10 
The concentration of the polyelectrolyte solution will influence the likelihood of this 
phenomenon occurring. In dilute solutions the loss of entropy associated with counter-
ion condensation will be significantly higher than for concentrated polyelectrolyte 
solutions where the entropic penalty will decrease, making counter-ion condensation 
more favourable.10 Additionally, for dilute polyelectrolyte-salt solutions, the osmotic 
pressure scales linearly with the polymer concentration and is independent of the 
chain degree of polymerisation.9 Counter-ion condensation  processes will affect both 
the osmotic pressure and the electrical conductivity of the solution.11  
Sodium polyacrylate is an example of a polyelectrolyte and is produced by a reaction 
between poly(acrylic acid) and a base such as sodium hydroxide to afford an anion 
polyelectrolyte.  
 
Figure 2.13: Poly(acrylic acid) neutralisation with sodium hydroxide to afford sodium polyacrylate anionic 
polyelectrolyte. 
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Polyacrylic acid is soluble in water and in solution adopts the shape of a coiled chain 
but increasing the pH by neutralisation with sodium hydroxide will cause a change in 
the polymer conformation and the coil will be transformed into a highly extended 
chain.16 This occurs as each negative charge is paired with a sodium cation making 
the polyelectrolyte electrically neutral. The counter-ions are electrostatically attracted 
to the carboxylate group through long-ranged Coulomb interactions and will be 
retained either within the polymer coil or surrounding it within a counter-ion cloud.17 
However when the polyelectrolyte is in solution there will also be an osmotic effect on 
the ions which will favour their dissociation into the bulk solution where the ion 
concentration will be lower in order to equilibrate the system. Further dilution of the 
polyelectrolyte results in an increase in osmotic pressure causing more ions to move 
from the polymer coil into solution which changes the overall net charge on the 
polymer from neutral to negatively charged. The unshielded negative charges repel 
each other which causes the chain to expand from its typical Gaussian coil 
dimensions.18 Complete ionisation of the carboxylic acid groups does not occur as,  
when ionisation increases to high levels, it becomes less favourable for further 
charges to be created due to the close proximity between the carboxylate groups 
along the polymer back bone.19 
 
Figure 2.14: Polyelectrolyte coil expansion as a result of counter-ion diffusion away from polymer 
backbone ‘un-shielding’ negatively charged moieties on chain which will repel each other causing the 
chain to expand away from its typical Gaussian coil dimensions.
19
  
It is well documented that polyelectrolytes can interact with a variety of salts and metal 
cations in solution in a different ways. It has also been shown that the valency of the 
counter-ions can affect polyelectrolyte behaviour.  Simple monovalent cations have 
generalised electrostatic interactions with the polyelectrolyte whereas multivalent 
cations are known to form specific interactions with the carboxylate anion of sodium 
polyacrylate. For example ionised carboxylic acid groups such as those found in 
polyacrylate salts have been shown to have a high tendency to interact with calcium 
ions.16,20,21 For multivalent ions such as Ca2+ these interactions result in two well 
documented effects; (1) precipitation behaviour and (2) changes in chain confirmation 
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(reduced coil dimensions).16 Precipitation occurs when salt binding capacity is 
exceeded (however, binding to calcium ions can be inhibited in the presence of 
carbonate anions which allow for the formation of soluble macroscopic CaCO3) and it 
has been shown that Ca2+ can produce polyelectrolyte coil shrinking.
21 
 
Additionally, molecular modelling has shown that the polyelectrolyte chain structure is 
affected by ion density near the chain.22 As discussed above, at high ionic densities 
ions can ‘condense’ (counter-ion condensation) onto the chain causing the chain to 
contract due to charge screening effects. The presence of counter-ions reduces 
repulsive forces between charged monomer units making up the polyelectrolyte 
allowing them to move closer together and thus resulting in chain contraction. 
Pochard et al. have explored the effects of mono- and divalent cations (K+ and Na+ 
from KNO3/NaCl and Ca
2+ and Ba2+ from CaCl2/BaCl2 respectively) on sodium 
polyacrylate.20 They propose that monovalent ions will experience generalised 
electrostatic interactions with polyelectrolytes whereas divalent ions can form 
complexes with the polyelectrolytes. They also found that complexation effects were 
not disrupted by electrostatic interactions between the polyelectrolyte and 1:1 
electrolytes i.e. addition of a monovalent salt such as NaCl did not affect complexation 
behaviour.  
Shao et al. exploited interactions between sodium polyacrylate and Ni2+ in order to 
recover nickel from dilute aqueous solutions.23 They report a complexation-filtration 
process based on a simple concept wherein polyelectrolytes such as sodium 
polyacrylate which are known to bind heavy metals to form complexes are explored as 
a route to metal removal from water using a membrane filtration process.24,25  As these 
polymers have high molecular weights they can be retained by ultrafiltration 
membranes with a sufficiently lower MWCO to isolate a metal free permeate whilst 
concentrating the metal in the polyelectrolyte. This metal-polymer mixture is then at 
low pH ‘decomplexed’ to recover the nickel, and the polyelectrolyte salt can then be 
regenerated by increasing the pH. They found that adding sodium chloride reduced 
the transition metal removal rate and attributed this to an electrical double layer 
suppression mechanism rather than competitive complexation (which as explained 
above may be favoured by multivalent rather than monovalent cations). 
This literature study provided the precedent, in the present work, for a series of 
experiments investigating the effects of different salts on solutions of sodium 
polyacrylate. The purpose of these studies was to investigate whether interactions 
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between multivalent salts and the polyacrylate draw solution could be producing large 
ionic aggregates capable of fouling the membrane and obstructing the pores 
preventing effective filtration. Solutions of the sodium polyacrylate were diluted with 
sodium chloride and magnesium sulfate solutions of different concentrations. These 
solutions were then transferred to an ultrafiltration stirred cell containing a 100K 
MWCO PES membrane and pressurised using nitrogen. The resulting permeate was 
collected and the conductivity measured and compared with that of the feed solution to 
determine % salt rejection. The ultrafiltration experiment was also performed with the 
salt solutions before mixing with the sodium polyacrylate (i.e. ’salt only’ solutions) and 
a further control was to test the permeation from polyacrylate feeds with no added salt 
(i.e. dilution with just deionised water). 
 
 Salt only solutions  NaPA-Salt solution 
NaCl Deionised 
water 
10mM 
NaCl 
100mM 
NaCl 
 NaPA-DI NaPA-
10mM 
NaCl 
NaPA-
100mM 
NaCl 
MgSO4 Deionised 
water 
10mM 
MgSO4 
100mM 
MgSO4 
 NaPA-DI NaPA-
10mM 
MgSO4 
NaPA-
100mM 
MgSO4 
Figure 2.15: NaPA-Salt chelation study schematic showing: 1. Feed solution conductivity measurement 2. 
Stirred cell ultrafiltration of feed solutions at 1 bar pressure through a 100K MWCO PES UF membrane 3. 
Permeate solution conductivity measurement – three samples per feed solution to determine average, 
Table showing compositions of feed solutions; controls in italics, NaPA-Salt solutions consist of 5% 225K 
NaPA (diluted from 20% with either 10 or 100mM salt solutions resulting in final salt concentrations of 
8mM and 80mM, respectively). 
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In both cases (NaCl and MgSO4) the ‘salt only’ (i.e. polymer free) solutions exhibited 
similar conductivities for both feed and permeate confirming that both salts were able 
to freely permeate through the membrane.  
 
An initial observation from the polyelectrolyte-salt studies is that flux was observed in 
both the NaCl- and MgSO4-NaPA solution ultrafiltration experiments. However, in both 
cases the flux was reduced by a factor of 100 relative to the salt-only solutions such 
that it took several days to collect enough permeate to measure the conductivity (i.e. 
from several 100 mL/h to only1-2 mL/h or even less). It was difficult to compare the 
NaPA-NaCl and NaPA-MgSO4 fluxes due to this extended ultrafiltration period so we 
cannot be sure whether there was an increased risk of membrane fouling in the 
divalent system relative to the monovalent system. However, direct evidence suggests 
this may be occurring as it was observed that for the NaPA-MgSO4 solutions the flux 
stopped and could only be resumed after membrane cleaning where the feed and 
draw solutions were removed and  the membrane direction was reversed and flushed 
with deionised water. 
 
In the salt-polyacrylate studies a large difference was observed between the feed and 
permeate conductivities with the permeate having a significantly lower conductivity 
than the feed solution: on average the conductivity of the permeate was around 50% 
less than the conductivity of the feed. Excluding the NaPA-deionised water controls, 
the conductivity of the permeate was 51% less on average for the two NaPA-NaCl 
solutions (Figure 2.16) and 52% less on average for the two NaPA-MgSO4 solutions 
(Figure 2.17). However when considering the NaPA-deionised water controls in 
comparison with the NaPA-salt solutions it is interesting to note that the percentage 
difference in conductivity decreased with increasing salt concentration. This can be 
explained since the higher the concentration of salt present in the feed the more salt is 
likely to be available to permeate through the membrane and therefore the smaller the 
difference between the conductivities of the feed and permeate solutions. Given that 
the polyacrylate concentration remains constant whilst the salt concentration is varied 
and as there are a finite number of carboxylate groups that can interact with counter-
ions available in solution any excess of these counter-ions will be free in solution and 
in theory available to permeate through the membrane.  
 
It is also worth noting that in the NaPA-deionised water controls, the conductivity of the 
permeate is significantly higher than that of deionised water alone (from the ‘salt only’ 
control studies with deionised water) which has an average conductivity of 0.037 mS 
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cm-1, with the permeate from the two NaPA-DI studies being 2.96 mS cm-1 and 2.16 
mS cm-1. If we assume the polyacrylate anions are generally too large to traverse the 
membrane the source of the higher conductivity readings in these experiments 
suggests that some of the original sodium counter-ions are permeating though. 
However, if the cations alone were permeating the membrane with no 
counterbalancing anions a charge imbalance would be created preventing further 
transport. It is proposed the permeating sodium cations are counterbalanced by 
hydroxide anions also in solution. The latter are produced by the weakly basic 
carboxylate groups of the dissolved polyacrylate molecules, abstracting protons from 
water molecules.  
         
Figure 2.16: Conductivities of 1) NaCl and 2) NaPA-NaCl solutions before and after filtration at 1 bar 
pressure through a 100K MWCO PES membrane.  
 
Figure 2.17: Conductivities of 1) MgSO4 and 2) NaPA-MgSO4 solutions before and after filtration at 1 bar 
pressure through a 100K MWCO PES membrane.  
From the difference in conductivities between the feed and permeate solution the 
percentage retention could be calculated i.e. the amount of salt that was retained by 
the membrane. It was found that increasing the concentration of both the monovalent 
sodium chloride and divalent salt resulted in a reduced percentage rejection (Figure 
2.18). However, despite the proposed difference in interactions between the mono and 
di-valent salts, both types gave similar percentage retentions at each concentration. 
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The percentage rejection for the 10mM NaPA-NaCl solution was 58% whereas the 
percentage rejection for the 10mM NaPA MgSO4 solution was 63%. For the 100mM 
solutions the percentage rejection for the NaPA-NaCl solution was 43% and for the 
NaPA-MgSO4 was 41%. With the difference between the NaCl and MgSO4 
polyelectrolyte solutions being so small; 5% and 2% for the 10 and 100mM 
respectively, it seems the differing interactions between the mono and divalent salts 
with the polyelectrolyte may not significantly affect the number of ions ‘free in solution’ 
although the general trend is as expected; higher rejections for the divalent salt 
solutions. 
 
Figure 2.18: Percentage rejection vs. salt concentration of NaPA-salt solutions filtered at 1bar pressure 
through a 100K MWCO PES membrane. 
Upon further consideration of the results from the above experiments it was concluded 
that the system is more complex than suggested.  A proportion of the conductivity 
measurement for the polyacrylate feed solutions arises from the NaPA itself, which 
due to its high MW is retained within the stirred cell, this portion will not contribute to 
the conductivity of the permeate. Thus separating the contribution from the 
polyacrylate to examine the conductivity contributed by the free ions may clarify the 
situation. Using a standard curve and plotting conductivity vs. concentration (Figure 
2.19) it is possible to determine the concentration of unknown salt solutions by 
measuring their conductivity and if it is assumed that the conductivity of the salt free 
sodium polyacrylate solutions is equivalent to the contribution from the polyelectrolyte 
then this can be subtracted from the conductivity of the polyacrylate-salt solutions to 
isolate the conductivity of the ‘free salt’. This can then be used to determine a 
‘theoretical free salt concentration’. 
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Figure 2.19: Standard curve showing concentration (mM) vs. conductivity (mS cm
-1
) of different 
concentration sodium chloride and magnesium sulfate salt solutions.  
The theoretical free salt concentration of the feed solution can be calculated to check 
the accuracy of this method. It was found that the free salt concentration for higher 
concentration solutions was more accurately calculated that that of the lower 
concentration solutions (Table 2.3).  
Table 2.3: Theoretical free salt concentrations of feed solutions. 
NaPA-Salt solution Concentration (mM) Theoretical free salt 
concentration (mM) 
NaPA-NaCl 10 18.7 
NaPA-NaCl 100  100.5 
NaPA-MgSO4 10 16.49 
NaPA-MgSO4 100 95.1 
Following this the theoretical free salt concentration of the permeate can be compared 
with that of the feed to determine whether there is in fact a difference in the salt 
permeation when comparing the mono and divalent species. Figure 2.20 shows that 
with this comparison there is more of a difference between the two salts; for both the 
10mM and 100mM solutions the theoretical free NaCl present in the feed solution was 
equivalent to approximately 79% of the feed solution. However, for the MgSO4 
solutions a difference was observed between the two solutions, with the amount of 
MgSO4 present in the permeate of the 10mM study being equivalent to 53% of the feed 
solution and the MgSO4 present in the feed of the 100mM study being significantly 
higher at 94%. The difference observed for the divalent salt could be attributed to a 
complexation effect which in the 100mM study is saturated resulting in a higher 
percentage of salt permeating through the membrane. 
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Figure 2.20: Percentage conductivity of permeate concentration relative to feed concentration for both 
10mM and 100mM salt-NaPA solutions following subtraction of NaPA contribution. 
In order to further probe the effects of counter-ion valency on the structure of the 
sodium polyacrylate a viscosity study was performed. The absolute viscosity (ηabs) of 
the solutions of the sodium polyacrylate diluted with the same volume but different 
concentrations of both monovalent sodium chloride and divalent magnesium sulphate 
solutions was measured (Figure 2.21). In each sample the polyacrylate concentration 
would be the same but the salt concentration was different. Both NaPA-Salt solutions 
demonstrated a reduction in absolute viscosity with increasing salt concentration. This 
can be explained by considering the counter-ion effects discussed previously; as the 
counter-ion concentration increases counter-ion condensation/association with the 
polyelectrolyte shields the carboxylate group negative charges allowing the polymer to 
attain a more coiled structure thus reducing the viscosity of the solution. For each 
different concentration the NaPA-MgSO4 solutions demonstrated a lower viscosity with 
respect to the NaPA-NaCl solutions which may be attributed to the better screening 
ability of divalent ions compared to monovalent ions. If the difference between the two 
series of solutions is plotted the divide between the mono and divalent solution 
viscosities decreases with increasing salt concentration. 
 
Figure 2.21: a) Absolute viscosities of different solutions of sodium polyacrylate diluted with the same 
volume of sodium chloride and magnesium sulphate solutions of different concentrations; b) difference 
between absolute viscosities of NaPA-NaCl and NaPA-MgSO4 solutions at different salt concentrations.  
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Overall it is clear that the types of salts present in Krebs solution and therefore present 
in physiological solutions that would be interacting with the proposed medical device 
are capable of interacting with the sodium polyacrylate. The different valencies of the 
counter-ions present in such fluids (Table 2.4) may result in different interactions with 
the polyacrylate and further work is required to investigate possible effects on 
membrane fouling through possible formation of insoluble complexes – which may be 
overcome if low MW counter-ions are present i.e. CO3
2- for Ca2+.21 Polymer uncoiling 
effects along with the change in salt concentration produced by an influx of ions will 
also affect the osmotic pressure of the system. Furthermore it will be necessary to 
probe the interaction between the sodium polyacrylate and the proteins which will be 
removed along with the physiological fluid. 
Table 2.4: Cations present in Krebs physiological salt solutions 
Monovalent Divalent 
Na
+
 
K
+
 
Ca
2+
 
Mg
2+ 
 
2.3.5 Polyacrylate Draw Solution Optimisation 
The following studies were carried out to determine whether variations in the 
polyacrylate molecular weight, solution concentration and counter-ion could improve 
the average forward osmosis flux. The flux is influenced by the osmotic pressure of the 
draw solution so modifications to the draw solution that will change the osmotic 
pressure properties should have a direct influence on the flux. Osmotic pressure is a 
colligative property and therefore is dependent on the concentration of solutes and not 
on their identity.  
2.3.5.1 Molecular Weight Variation  
From the initial studies it was determined that very high molecular weight polyacrylate 
solutions (i.e. 6 million MW) despite their high flux generating properties were 
unsuitable for use in draw solution applications due to their high viscosity. A lower MW 
sodium polyacrylate 225K was found to produce similarly high fluxes without the 
limitations imposed by the high viscosity of the higher molecular weight analogues. It 
has been stated that the osmotic pressure of polyelectrolytes increases linearly with 
the polyelectrolyte concentration whilst being independent of the chain molecular 
weight.9,10 However, without directly measuring the osmotic pressure it was evident 
that these different MW solutions produced different fluxes. In addition to the standard 
225K NaPA draw solution two other MW draw solutions were investigated in FO 
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experiments; a 250K NaPA and a 345K NaPA with a deionised water feed and a 50K 
PES UF membrane. Two experiments were run in tandem to ensure reproducibility. 
Figure 2.22 shows that although the three polymers began with similar fluxes, with the 
feed solution volume decreasing by similar amounts each hour, as the experiment 
continued the difference between the three draw solutions flux ability increased with 
the feed volumes diverging more and more as each hour passed. This resulted in the 
lowest MW 225K NaPA draw ultimately removing the most feed solution – over half at 
26.6mL after 6 hours on average. In comparison the 250K NaPA removed 17.5mL on 
average and the 345K NaPA removed a mere 11.5mL.  
 
Figure 2.22: Polyacrylate optimisation study, changing molecular weight; 5% 225K NaPA, 250K NaPA 
and 345K NaPA draw solutions with deionised water feed, 50K PES UF membrane showing feed volume 
decrease per hour.  
Calculating the average flux (mL/h) for each experiment further reveals the difference 
between the draw solutions. The flux decreases with increasing polyelectrolyte MW; 
for the 225K NaPA the rate is 4.36 mL/h on average, for the 250K NaPA the rate is 
2.92 mL/h and for the 345K NaPA the rate is 1.92mL/h. Although we might expect the 
three polymers to have similar osmotic pressures this is not the only factor affecting 
the rate of flux across the membrane. It is possible that the different polyacrylates may 
have different interactions with the membrane surface resulting in some polymers 
exhibiting increased fouling behaviour which would affect the flux.10 
 
2.3.5.2  Variation of Draw Solution Concentration   
Changing the draw solution concentration will affect the osmotic pressure as a 
difference in concentration will create a difference in the number of solute particles in 
the draw solution. It might therefore be expected that as the concentration increases 
the flux should also increase, but this is not in fact observed. When comparing 4 
different 225K NaPA draw solutions of the following concentrations; 2%, 5%, 7% and 
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10% with a 50K PES UF membrane and a deionised water feed solution we observe a 
peak flux when the 5% draw solution is used (Figure 2.23). 
When increasing the draw solution concentration from a 2% to 5% an increase in flux 
is observed in both series of experiments.  For Series A the average flux increases 
from 3.57 mL/h to 3.86 mL/h whereas for Series B the increase is even higher starting 
at 1.71 mL/h and increasing to 4.86 mL/h. When the draw solution concentration is 
increased again from 5% to 7% a decrease in flux is observed for both series with the 
average flux dropping to 2.86 mL/h and 3 mL/h. Interestingly when increasing the draw 
solution concentration further to 10% the average flux is similar to that achieved with a 
7% draw solution in both series (2.8 mL/h). Again this may be attributed to membrane 
fouling or potentially to issues arising from the increasing viscosity of the draw 
solutions which can decrease stirring efficiency and therefore reduce membrane 
wetting resulting in a less efficient interface between the draw solution and membrane 
surface. 
 
Figure 2.23: Polyacrylate optimisation studies – effect of changing polyacrylate concentration on flux 
through a 50K PES UF Membrane with a deionised water feed solution, plot shows average flux mL/h for 
two series of experiments run in tandem (error derived from standard deviation of measured change in 
fluid volume per hour). 
2.3.5.3 Changing Counter-ion Identity  
The effect of changing counter-ion identity was examined by comparing both 250K and 
345K polyacrylate solutions with either Na+ or K+ counter-ions. In each case the 
average flux (mL/h) produced by each solution in a forward osmosis experiment with a 
50K MWCO PES UF membrane and a deionised water feed solution was compared. 
Two series of experiments were run for each of the four possible draw solutions; 250K 
NaPA, 250K KPa, 345K NaPA and 345K KPa leading to two sets of data. In both 
series and for both molecular weights (250K and 345K) the potassium polyacrylate 
generated far higher fluxes than the sodium polyacrylate solutions (Figure 2.24). This 
may be due to difference in the ionic radii of the metals; at 142 pm the ionic radius of 
the potassium cation is significantly larger than that of the sodium cation 116 pm.26 
This difference may result in K+ remaining in free solution due its larger size whereas 
3.57 
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Na+ is more readily condensed onto the polyelectrolyte making it less available to 
contribute to the osmotic pressure and therefore resulting in reduced membrane flux.  
   
Figure 2.24: Polyacrylate optimisation studies – effect of changing polyacrylate counter-ion on flux 
through a 50K PES with a deionised water feed solution, plot shows average flux mL/h a) Series 1 and b) 
Series 2. 
2.3.6 Ultrafiltration Membrane Osmotic Pressure Studies 
The initial device-design envisaged the use of dense osmosis-type membranes which 
would be compatible with a wide range of draw solutions including well-studied salt-
based ones, but the changing of the design to incorporate UF membranes with their 
relatively large pores resulted in some limitations for the draw solution. Clearly a larger 
pore size means simple salts can no longer be effectively contained by the membrane. 
In order to attain a sufficient molecular weight to prevent back flow of the draw solution 
into the feed solution, polymeric draw solutions would be required.  
A primary concern with polymeric draw solutions is that they may not be able to 
generate the high osmotic pressure required to drive the forward osmosis process 
when compared with traditional salt based draw solutions. To investigate this a simple 
stirred cell-forward osmosis experiment was set up with a saturated salt draw solution 
on one side of the UF membrane and the optimised polyelectrolyte draw solution (5% 
225K NaPA) on the other, allowing observation of the direction of water flow in this 
system.  Interestingly the water moved in the opposite direction to what would 
conventionally be expected; rather than the water being drawn into the salt solution, 
which has far higher osmotic pressure, the water moved into the polyelectrolyte draw 
solution seemingly against the osmotic pressure gradient even for a saturated sodium 
chloride solution (26%). To investigate this further a series of salt solutions of different 
concentrations (2%, 5% and 10%) were also tested with the same 50K MWCO PES 
UF membrane and 225K NaPA draw solution (Figure 2.25). 
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Figure 2.25: Osmotic Pressure study: 50K PES membrane, 5% 225K NaPA draw, average of two repeats 
run at same time. 
In all osmotic pressure experiments using brine vs. 5% sodium polyacrylate with a 50K 
MWCO PES UF membrane, the water was drawn into the polyelectrolyte draw solution 
against the osmotic pressure gradient. As the brine concentration (and therefore its 
osmotic pressure) increased the brine flow rate decreased. It is proposed that the 
unprecedented movement of water against the osmotic pressure gradient is a result of 
membrane pore-size effects. Since forward osmosis with salt draw solutions is usually 
performed with non-porous membranes, the presence of pores in the membrane must 
be affecting the osmosis process. This was investigated by a simple series of forward 
osmosis experiments involving the same brine solutions but comparing the 50K PES 
UF membrane with a non-porous reverse osmosis membrane obtained from a 
domestic point-of-use reverse osmosis module – See Section 2.3.7. 
Additionally, studies were carried out to investigate the osmotic pressure properties of 
brine draw solutions for comparison with the novel polyelectrolyte-UF membrane 
forward osmosis system. For simple dilute ionic solutions such as sodium chloride 
solutions it is possible to calculate the theoretical osmotic pressure (π) using the 
(Morse) Equation (1) which is derived from the van’t Hoff equation.27 
                                                             𝜋 = 𝑖𝑀𝑅𝑇                                                         (1) 
Where i is the van’t Hoff Factor which in the case of sodium chloride will be 2 as NaCl 
will dissociate into two particles (Na+ and Cl-) in solution. M is the molarity, R is the gas 
constant in units of L atm K-1 mol-1 and T is the temperature in Kelvin.   
The molarity is calculated from the % solution using Equation (2).  
                                               𝑀 =
(
𝑔𝑟𝑎𝑚𝑠 𝑟𝑒𝑎𝑔𝑒𝑛𝑡
100𝑚𝐿
)∗10
𝑓𝑜𝑟𝑚𝑢𝑙𝑎 𝑤𝑒𝑖𝑔ℎ𝑡
                                                       (2) 
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which can also be simplified to Equation (3): 
                                                       𝑀 = 𝑛/𝑉                                                                (3) 
Where n is the number of moles and V is the volume in litres. Using equations 1-3 the 
theoretical osmotic pressure of the brine draw solutions of different concentrations 
(used in the series of FO osmotic pressure study experiments) can be calculated (See 
Table 2.5 and Figure 2.26).  
Table 2.5: Theoretical osmotic pressures of different % concentration sodium chloride solutions 
Percentage NaCl Solution Molarity (mol/L) Osmotic Pressure (atm) 
2% 0.324 16.7 
5% 0.856 41.9 
10% 1.711 83.7 
26% 4.449 217.0 
 
Figure 2.26: Theoretical osmotic pressures (atm) of different percentage concentration sodium chloride 
solutions (2%, 5%, 10% and 26%). 
Following this treatment, from the solution osmotic pressure it is possible to calculate 
the theoretical Δh or change in fluid height these solutions would produce if placed in 
one half of a U-tube where the other half contains pure deionised water and both 
halves are separated by a semi-permeable membrane. If the fluids starting heights are 
equal, over time the osmotic gradient across the membrane will result in the movement 
of fluid from the deionised water side into the salt solution side of the U-tube until 
equilibrium is reached.  
Equation (4) relates the osmotic pressure to the solution height (see Table 2.6)28 as 
requires the solution density (ρ in Kg.m-3) and required knowledge of the density of the 
solution (ρ in Kg.m-3) as well as a constant g which is the acceleration due to gravity 
(9.8 m.s-2).  
𝜋 = 𝜌𝑔ℎ                                                             (4) 
y = 834.26x + 0.1421 
R² = 1 
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Table 2.6: Theoretical solution height in m of different concentration salt solutions.  
Percentage 
NaCl Solution 
Osmotic 
Pressure (Pa) 
Density 
 (Kg.m-3) 
Height 
(m) 
2% 1692128 1012 171 
5% 4245518 1034 419 
10% 8480903 1070 809 
26% 21990000 1197 1875 
 
A custom built U-tube was designed and used to examine the effects of differing salt 
draw solution concentration on a deionised water feed solution when separated by an 
RO membrane with the facing/active side towards the feed solution. Since the 
calculated solution heights are obviously out of range of the U-Tube system the 
average flux is calculated by hourly measurements of the change in height i.e. the 
increase in height of the draw combined with the corresponding decrease in height of 
the feed to give the overall ΔH (cm/h). Additionally a measurement was obtained after 
24 hours.  
 
Figure 2.27: Schematic showing average hourly Δh determination using U-tube, orange arrow shows fluid 
movement.  
These initial experiments showed that, as the salt draw solution concentration 
increased, the flux (cm/h) also increased. From just over 1 cm/h with a 2% salt draw to 
just over 2 cm/h cm/h with a 26% draw (Figure 2.28). Measurements at 24 hours 
could not be obtained as the solution height was beyond range of the U-tube 
dimensions. These experiments were repeated with a Krebs solution feed replacing 
the deionised water to examine the effects of the salts in the Krebs solution on the 
system. The presence of such solutes in the feed solution would affect the osmotic 
pressure gradient across the membrane, reducing the difference in osmotic pressures 
of the feed and draw solutions and consequently it was proposed the flux would 
decrease in the studies on the Krebs solutions. This was observed in the reduction of 
the flux relative to the deionised water studies. Interestingly the change in hourly flux 
FEED DRAW 
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(cm/h) between deionised water and Krebs solution was almost the same for all four 
draw solutions with each experiment showing a decrease in flux of approximately 1 
cm/h when the deionised water was replaced by the Krebs solution.  
    
Figure 2.28: a) U-tube schematic demonstrating solution configuration and fluid flow direction b) Average 
deionised water flux and Krebs solution flux (cm/h) created by sodium chloride draw solutions of different 
concentrations, determined by U-tube using an RO membrane.  
For the studies on Krebs solution, measurements after 24 hours were able to be 
obtained as the change in fluid height remained in range of the U-tube (Figure 2.29). 
As would be expected, the height increased with increasing saline draw concentration 
from 3.4 cm using a 2% saline draw solution to 19 cm using a 26% saline draw 
solution. 
 
Figure 2.29: Total change in fluid height (Δh, cm) between 0-24 hours Krebs solution feed vs. saline draw 
solutions of different concentrations. 
Table 2.7 compares the measured change in fluid height with the theoretical change in 
height calculated from the average flux values (Figure 2.28). It is interesting to note 
that, for the majority of the experiments, the measured total change in fluid height after 
24hrs values is significantly less than would be expected if the average flux measured 
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at the start of the experiment was maintained. Exceptions being the lowest 
concentration draw solution (2% saline) which produced a higher total change in fluid 
height than predicted by the theoretical calculation. A reduction in flux is often 
observed as an experiment progresses due to membrane fouling and concentration 
polarization effects.   
Table 2.7:  Theoretical vs. actual values for total change in fluid height (Δh, cm) after 24 hours. 
 
Saline Draw 
Concentration 
 
Average flux (cm/h) 
Δh 0-24 hours 
Theoretical  Actual  
2 0.08 2 3.4 
5 0.57 13.6 9 
10 0.80 19.2 13 
26 0.97 23.3 19 
 
Whilst salt-based draw solutions have been traditionally used for FO there have been 
no previous studies of forward osmosis using ultrafiltration membranes in combination 
with high molecular weight draw solutions which have more complex solution 
behaviours. The osmotic properties of sodium polyacrylate and the influence of the 
membrane type are explored in Section 2.3.7. 
2.3.7 Reverse Osmosis vs. Ultrafiltration Membranes 
In the present study it was proposed that the porous nature of the UF membranes 
would nullify the osmotic pressure of the brine solutions as the pores allow the salt to 
freely permeate through in both directions, thus preventing the development of an 
osmotic pressure gradient across the membrane. Only the larger polyelectrolyte 
molecules are held by the membrane and therefore can exert an osmotic pressure 
effect, introducing a gradient across the membrane and hence resulting in fluid flow 
from the saline solution into the polyacrylate solution. However, if a dense ‘non-porous’ 
RO membrane were to be used, the osmotic pressure of the brine solution would be 
able to create a pressure gradient across the membrane resulting in conventional fluid 
movement into the brine. To test this proposal, forward osmosis experiments were 
carried out using the modified stirred cell, comparing an RO membrane with a 50K 
PES UF membrane using the standard 5% 225K NaPA draw solution, against a 
variety of brine solutions ranging from 2%-26% (saturated) brine solution. These 
experiments were also repeated with a 100K PES UF membrane.  In each case the 
membrane face was orientated to be facing the designated feed solution i.e. the UF 
membrane was placed to be facing the brine solution and the RO membrane was 
placed to face the polyelectrolyte solution.  
87 
 
 
Figure 2.30: Proposed movement of fluid in FO processes using a) porous UF vs. b) non-porous RO 
membrane with a polyelectrolyte vs. saline draw solution. 
For both series of experiments employing either the 50K PES UF membrane or the 
100K PES UF  membrane the general trend found was that in the UF-FO experiments 
the fluid moved from the brine into the polyacrylate and for the RO-FO experiments the 
fluid moved in the opposite direction – from the polyacrylate into the brine.  The overall 
change in feed and draw volume was largest in the UF experiments signifying higher 
flux rates compared to the RO membrane experiments where little fluid exchange was 
observed. A final observation was that as the brine concentration increased the flux 
decreased. This was most clearly seen in the UF-FO experiments for both 
membranes. 
 
Results from the 50K PES UF membrane experiments are shown in Figure 2.31.  In 
the left hand plot the 5% 225K NaPA draw solution volume is increasing with time as it 
draws fluid from the 5% brine feed solution which consequently decreases in volume 
with time. A similar result is observed in the right hand side plot where the experiment 
is repeated with a feed solution of 10% brine. Increasing the concentration of the brine 
feed solution decreases the flux with average flux for the 5% brine experiment 
determined to be 1.3 mL/hour whilst doubling the brine concentration to 10% reduces 
the flux almost by half to 0.8mL/hour.  
  
Figure 2.31: Feed and draw solution volume change with time in FO study using a 50K PES UF 
membrane  comparing a) 5% brine vs. 5% 225K NaPA, with b) 10% brine vs. 5% 225K NaPA. 
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For the UF-FO experiments using a 100K PES UF membrane a similar result was 
observed; increasing the brine feed concentration reduced the flux as demonstrated in 
Figure 2.32 shown below. Increasing the brine feed from 2% to 26% reduced the flux 
from 2 mL/hour to 0.4 mL/hour. 
 
 
Figure 2.32: Comparison of feed and draw volume change with time in FO study using a 100K PES UF 
membrane comparing a) 2% brine vs. 5% 225K NaPA, with b) 26% brine vs. 5% 225K NaPA. 
Repeating a selection of these studies with a U-tube system allowed for more accurate 
determination of hourly flux measurements. A series of experiments was performed 
again comparing a UF membrane (100K PES) with an RO membrane. For each 
membrane type a U-tube experiment was carried out with one half of the U-tube 
containing 5% 225K NaPA and the other half containing deionised water or 2%, 5% or 
26% saline solution (Figure 2.33). Hourly measurements were made to determine the 
flux (using units of cm/hour) and also the direction of fluid movement. In both series of 
experiments (UF vs. RO) when the deionised water control was tested against the 5% 
225K NaPA the fluid moved from the deionised water into the polyacrylate as would be 
expected due to the osmotic pressure gradient produced by the sodium polyacrylate. 
This experiment also produced the highest fluxes for both series of experiments, at 
0.88 cm/hour and 2.08 cm/hour for the UF and RO membranes respectively.  
For the UF membrane studies, when 26% brine was tested against the polyacrylate no 
fluid movement in either direction was observed although conductivity measurements 
discussed below demonstrated that exchange was still occurring across the 
membrane. For both the 5% and 2% saline experiments the fluid moved in the 
proposed direction; from the brine into the polyacrylate. For the three experiments in 
which fluid movement was detected average (DI, 2% and 5%) hourly flux values were 
calculated and, as would be expected, the flux decreased when deionised water was 
exchanged for saline from 0.88 cm/hour to 0.2 cm/hour for the 2% brine and 0.46 
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cm/hour for the 5% brine. It is worth noting that a 5% sodium polyacrylate solution is 
capable of moving fluid from a brine solution of the same percentage concentration 
despite its significantly higher osmotic pressure (discussed above) when an 
ultrafiltration membrane is used to separate the solutions. 
For the RO membrane in all three experiments fluid movement was observed. For the 
three saline experiments (2%, 5% and 26%) fluid movement was from the polyacrylate 
into the saline solution and the rate increased as the saline concentration was 
increased – a reversal of the behaviour observed with the UF membrane. The flux 
increased from 0.2 cm/hour for the 2% solution to 0.36 cm/hour for the 5% solution 
and 1.32 cm/hour for the 26% solution.  
The most significant results are those obtained in the experiments with 5% saline vs. 
5% 225K NaPA which support the theory that the membrane type can influence flux 
direction in forward osmosis processes. In these experiments solutions of the same 
percentage concentration will behave as either a draw or feed depending on the 
membrane separating them. The RO membrane enables the saline solution to act as a 
draw solution whereas the UF membrane enables the polyacrylate solution to act as a 
draw solution (Figure 2.33).  
 
Figure 2.33: a) U-tube schematic demonstrating solution and membrane configuration and proposed fluid 
flow direction b) Average flux (cm/h) for deionised water, 2% saline, 5% saline and 26% saline vs. 5% 
225K NaPA comparing a 100K PES UF membrane with an RO membrane. 
As demonstrated in Figure 2.33, for the UF membrane when 26% saline was used 
there was no fluid movement i.e. zero flux, even after 24 hours. This could suggest 
that the fluids were not exchanging although further investigations demonstrated that 
this is not the case. Conductivity measurements of the 5% 225K NaPA draw solutions 
before and after the FO experiments show that there are changes to the fluid 
compositions. Indeed comparing the conductivity before and after 24 hours of forward 
osmosis experiments with the different water and salt solutions gives further insight 
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into the fluid exchange across the membrane. Figure 2.34 below shows the 
polyacrylate conductivity before and after the forward osmosis experiments, with the 
difference between the two readings shown in red when a decrease in conductivity is 
observed and green when an increase in conductivity is observed.  
For the both the UF and the RO membrane FO studies with deionised water result in a 
decrease in polyacrylate conductivity as would be expected due to the dilution of the 
polyelectrolyte solution with pure water, reducing the overall concentration. In contrast 
when saline solutions were used the polyacrylate conductivity increased for both the 
UF and RO membranes. This observation clearly indicates that there is movement of 
the sodium chloride ions from the saline solution into the polyacrylate. This is 
particularly interesting for the UF, 26% saline study which demonstrated no overall 
fluid movement but exhibited a significant change in conductivity from 10mS cm-1 to 
over 20 mS cm-1 (the upper limit of the conductivity meter). The 5% saline UF 
experiment also increased the polyacrylate conductivity to a point out of range of the 
conductivity meter (above 20 mS cm-1). 
   
  
Figure 2.34:  Conductivity (mS cm
-1
) of 5% 225k NaPA before and after U-tube FO experiment with 
deionised water or 2, 5 or 26% saline solutions comparing a) 100K PES UF membrane and b) RO 
membrane, red bar shows a decrease in conductivity after the experiment, green bar shows an increase 
in conductivity. 
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Additionally, although overall fluid flow in the RO saline studies was from the 
polyacrylate into the saline there is an increase in conductivity of the polyacrylate. This 
may be attributed to solution concentration as water is removed whilst the 
polyelectrolyte is retained. The increase in conductivity in the RO-saline experiments is 
less than that in the equivalent UF-saline experiments where bulk fluid flow is from the 
saline into the polyelectrolyte bringing additional ions and therefore increasing the 
sodium polyacrylate solution conductivity. As would be expected for both the RO and 
UF studies, as the saline concentration increased the change in conductivity also 
increased i.e. 5.8 mS cm-1 to >10 mS cm-1 for the UF membrane and 1 mS cm-1 to 5.4 
mS cm-1 for the RO membrane.   
For both series, measurements after 24 hours were able to be obtained as the change 
in fluid height remained in range of the U-tube (with an exception being for the RO-
deionised water experiment which produced a change in fluid height out of range of 
the U-tube).  
 
Figure 2.35: Total change in fluid height (Δh, cm) between 0-24 hours for deionised water, 2% saline and 
26% saline vs. 5% 225K NaPA comparing a 100K PES UF membrane with an RO membrane *OOR = 
Out of range. 
These values are compared to the theoretical change in height after 24 hours as 
calculated from the initial average flux (see Table 2.8). Again it is interesting to note 
that the values are less than would be expected if the average flux measured at the 
start of the experiment was maintained except for the 2% saline in the RO series which 
in fact has a higher fluid height than predicted by the average flux. A reduction in flux 
is often observed as an experiment progresses due to membrane fouling and 
concentration polarization effects.29  
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Table 2.8: Calculated and measured values for total change in fluid height (Δh, cm) after 24 hours 
comparing RO and UF membranes with deionised water or 2%, 5% and 26% saline solutions vs. 5% 
225K NaPA solution. 
 
Membrane Type 
 
Salt solution 
 
Average flux 
(cm/h) 
Δh 0-24 hours 
Theoretical  Actual  
 
UF 
0 0.88 21.12 18.4 
2 0.42 10.08 4.5 
5 0.46 11.04 1.7 
26 0 0 0 
 
RO 
0 2.08 49.92 22 
2 0.2 4.8 5.5 
5 0.36 8.64 5.9 
26 1.32 31.68 24.2 
 
Finally, the absolute viscosity of the sodium polyacrylate solutions was measured both 
before and after the U-tube-FO study to examine the impact of solution 
dilution/concentration. Changes in viscosity are associated with changes in the 
polymer conformation which can be affected by changing concentration and the 
presence of cations both of which will also affect the osmotic pressure of the system. 
The structure of polyelectrolytes in solution is determined by the interplay between the 
strong Coulombic repulsive forces between nearby charged moieties on the chain 
(favouring chain un-coiling) and the screening of this charge through rearrangement of 
counter-ions in the surrounding solution (favouring polymer coiling).11 Additionally 
there are entropy considerations arising from loss of entropy through ion localisation 
during counter-ion condensation.30 Polyelectrolytes have lower viscosities than neutral 
polymers at high concentrations as a result of dipolar attraction of condensed counter-
ions: this reduces the coil size and therefore lowers the viscosity.31,32  Therefore 
changes in the solution environment which favour counter-ion condensation (i.e. 
increased salt concentration) should decrease the polyelectrolyte viscosity whilst 
changes which favour counter-ion diffusion (solution dilution) should increase the 
polyelectrolyte viscosity. Of course in this study both factors are intertwined since the 
salt is added in solution form therefore diluting the overall polyelectrolyte 
concentration. However, simplifying the effects to 1) dilution with water or 2) addition of 
salt for the purposes of this study allows for the study of processes which are relevant 
to the future application of the system (the oedema treatment device) whereby the 
polyacrylate draw solution will be diluted by salt containing physiological fluids. 
  
Figure 2.36 demonstrates the viscosities of the polyelectrolyte solutions before and 
after 24 hours of forward osmosis in the U-tube experiments comparing the RO and 
UF membranes using 5% NaPA vs. deionised water, 2% saline, 5% saline and 26% 
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saline. When considering the experiments using deionised water (0%) the bulk 
movement of the fluid was from the water into the polyacrylate solution for both the UF 
and RO membrane. While it might be expected that the impact on the viscosity to be 
similar in both cases we instead observe an increase in viscosity in the UF experiment 
and a decrease in viscosity in the RO experiment. In both cases the sodium 
polyacrylate was diluted but to different extents; for the UF membrane the overall fluid 
height difference after 24 hours was 18.3 cm whereas for the RO membrane the fluid 
height difference was out of range of the U-tube (Figure 2.35). For the UF experiment 
this is equivalent to the movement of 21.6 mL (calculated from the dimensions of the 
tube) of fluid from the deionised water into the polyacrylate diluting it by a fifth of its 
original volume which results in a small increase in viscosity which could be attributed 
to the dilution increasing the osmotic pressure favouring counter-ion diffusion resulting 
in polymer uncoiling. Conversely for the RO membrane this viscosity is reduced in the 
FO study despite this solution being further diluted which in itself is unexpected since 
the more porous UF membrane should produce higher fluxes when compared to the 
non-porous RO membrane when using the same draw solution as in this case. 
 
For the 2% saline solution opposite effects on viscosity were observed for the two 
different membranes. The UF study showed an increase in polyacrylate viscosity 
whereas the RO study showed a decrease in viscosity. Although similar fluid height 
changes were obtained after 24 hours for both the UF and the RO experiment (4.5 cm 
and 5.5 cm, Figure 2.35) the fluid flux direction must be considered. In the UF study 
fluid moved from the saline into the polyacrylate whilst in the RO study bulk fluid flux 
was in the reverse direction. In the UF study the polyacrylate is not only diluted but is 
also flooded with excess cations, a volume of 4.72 mL of the 2% saline solution moved 
into the sodium polyacrylate. The two factors, dilution and cation concentration 
increase, will have opposing effects; counter-ions in excess can condense on the 
polyacrylate favouring polymer coiling whereas dilution favours counter-ion 
displacement through osmotic effects favouring polymer uncoiling. For the RO 
membrane a volume of 6.61 mL moved from the polyelectrolyte into the saline 
solution, concentrating the polyelectrolyte by approximately a twentieth of its original 
volume. 
 
For the 5% saline solution opposite effects on polyacrylate viscosity were observed 
for the two different membranes. In these experiments the bulk fluid movement was in 
the same direction as observed in the 2% saline experiments (in the UF membrane 
experiment the fluid moved from the saline solution into the polyacrylate whilst for the 
94 
 
RO membrane the bulk fluid movement was from the polyacrylate into the saline 
solution) however the effects on the polyacrylate viscosity were reversed. For the RO 
experiment the polyacrylate viscosity increased slightly which is attributed to 
concentration of the polyelectrolyte as fluid moves into the saline solution. For the UF 
experiment a decrease in polyacrylate viscosity was observed. To understand this 
reversal in trends it is important to consider the changes in fluid volume in comparison 
to the 2% saline experiment. In the 5% experiment the fluid height changes after 24 
hours were significantly different with the UF membrane producing a 1.7 cm change in 
height (equivalent to 3 mL in volume) whilst the RO membrane produced a 5.9 cm 
change (equivalent to 10.43 mL in volume). In going from a 2% to 5% saline solution, 
the saline concentration has more than doubled which, in the UF experiment, results in 
a smaller volume has moving from the saline into the polyelectrolyte. As discussed 
above the movement of fluid from the saline into the polyelectrolyte has two opposing 
effects; 1) increasing counterion concentration favouring polyelectrolyte coiling and 
therefore decreasing the viscosity and 2) dilution which favours polyelectrolyte 
uncoiling, increasing the viscosity. Since, compared to the 2% saline experiment, a 
smaller volume with a higher salt concentration is entering the polyelectrolyte perhaps 
the counterion condensation effect is stronger than the dilution effect hence the 
decrease in polyelectrolyte viscosity. For the RO experiment the polyelectrolyte is 
further concentrated compared to the 2% saline experiment hence an increase in 
viscosity.  
 
For the 26% saline solution opposite effects on viscosity were observed for the 
different membranes however in this case the changes in viscosity are the reverse of 
what was observed in the 2% saline study (Figure 2.36). In this case the UF study 
showed a decrease in polyacrylate viscosity whereas the RO study showed an 
increase in viscosity. On this occasion however for the UF membrane zero flux was 
observed. Nevertheless, from conductivity measurements before and after the UF 
study it is clear that salt exchange across the membrane has occurred and this is also 
reflected in the change in viscosity which is hugely reduced in this case. For the RO 
study fluid (28.59 mL) moved from the polyacrylate into the saline solution (as for the 
RO study with 2% saline) therefore concentrating the polyacrylate which results in an 
increased viscosity. 
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Figure 2.36:  Absolute viscosity (mm
2 
s
-1 
, measured at 25⁰C) of 5% 225k NaPA before and after U-tube 
FO experiment with deionised water or 2/26% saline solutions comparing a) 100K PES UF membrane 
and b) RO membrane, red bar shows a decrease in viscosity after the experiment, green bar shows an 
increase in viscosity. 
This section has focused on examining the osmotic properties of a sodium polyacrylate 
draw solution in comparison to traditional salt-based draw solutions and the effects of 
the membrane type used. It has been found that by using porous membranes the 
osmotic effects of the polyacrylate can dominate over the high osmotic pressures of 
salt-based draw solutions. Since the membrane is permeable to the salt solution but 
not the polymer, fluid can be transported from a brine solution into a polyelectrolyte 
solution when using porous membranes. When using non-porous membranes the fluid 
flows in the reverse direction as would be expected due to the high osmotic pressures 
of saline solutions. This means that fluid flow direction can be controlled by the choice 
of membrane. Additionally conductivity measurements before and after 24 hours of 
forward osmosis have demonstrated that in some experiments where no fluid height 
change is detected, suggesting zero flux, there are in fact changes in conductivity 
which signify that salt exchange across the membrane is still occurring. This is further 
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corroborated by viscosity measurements before and after 24 hours of forward osmosis 
which also show a change in solution properties even if the volume has remained the 
same implying no fluid exchange. Additionally these viscosity measurements allow the 
effects of polymer solution dilution and changing salt concentration to be quantified. 
Combining all three elements of data; the fluid height and volume changes, the 
conductivity changes and the viscosity changes enables the effect of changing solution 
environment on polyelectrolyte structure and therefore its solution behaviour to be 
identified.  
2.3.8 Protein Studies  
Due to the complexation and membrane fouling issues which arose from using PEGs 
to model the proteins it was decided to explore using real proteins to model the 
oedema fluid in forward osmosis studies. This strategy would also provide information 
on how the proteins will interact with the membranes and the draw solutions. The first 
protein investigated was bovine serum albumin (BSA) which has a molecular weight of 
69 kDa. The BSA would be expected to have limited permeability through the 50K 
MWCO PES membrane, so a 100K MWCO PES membrane was used for this initial 
study. A 2% w/v BSA protein solution in phosphate buffered saline (PBS) was used as 
a feed solution and the draw was 5% 225K NaPA. Every hour 500 µL aliquots were 
taken from the draw solution and the sample volume was replaced by an equivalent 
volume of the original draw solution. Furthermore a sample was taken the following 
morning after stirring overnight.  
Following this a bicinchoninic acid (BCA) assay was performed in order to determine 
the protein concentration in the samples. This biochemical assay relies on combining 
the samples and a series of standards of known concentration with a ‘working reagent’ 
(consisting of a combination of two solutions; copper sulfate and BCA) which will 
undergo a colour change that is dependent on the protein concentration. Specific 
amino acid residues in the protein (cysteine/Cys, tyrosine/Tyr and tryptophan/Trp) will 
reduce the copper(II) to copper(I) allowing it to be chelated by two molecules of the 
acid forming a brightly coloured water soluble complex with a strong linear absorbance 
at 562nm (Figure 2.37).33 This results in a colour change from green to purple which 
can be measured by colorimetric techniques using UV-Vis spectroscopy or a 
microplate photometer. The absorbance of the samples can be used to determine their 
protein concentration relative to a standard plot of known concentrations.  The 
absorbance of the draw solution was also measured to ensure no interference with the 
results.  
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Figure 2.37: BCA Assay schematic; Step 1. Cu
2+ 
reduced to Cu
+
 by protein (specifically amino acid 
residues Cys, Tyr or Trp). Step 2. Cu
+ 
chelated by two BCA molecules to form a complex with an 
absorbance evident at 562 nm. 
Following an initial FO experiment using a 5% 225K NaPA draw solution with a 2% 
BSA in PBS feed separated by a 100K MWCO PES UF membrane and a UV-Vis 
spectrometer to measure sample and standard absorbance from the subsequent BCA 
assay, it was observed that the BSA was able to permeate through the membrane. 
The samples showed that the protein concentration increased with time (Figure 2.38). 
A calculated concentration of less than zero indicates the sample produced zero 
absorbance therefore signifying zero protein present. This was the case in the first 
hour where the calculated concentration is less than zero µg/mL i.e. no protein. In the 
following hours the calculated protein present increases with time from 18.25 µg/mL to 
147.74 µg/mL for hours 2 and 3, respectively. After 24 hours the protein concentration 
increased to 661.60 µg/mL. 
 
Figure 2.38: Initial FO-Protein experiment using a 100K MWCO PES UF membrane with a 5% 225K 
NaPA draw solution and 2% BSA in PBS feed solution a) calculated protein concentration (µg/mL)  in 500 
µL samples taken hourly and after 24 hours from the 5% 225K NaPA draw solution b) standard curve 
used for protein concentration calculation. 
Additionally monitoring the feed volume to determine the average hourly flux (2 mL/h) 
demonstrated the protein did not appear to be noticeably fouling the membrane as 
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there was no significant decline in flux with time as associated with fouling events 
(Figure 2.39). 
 
Figure 2.39: Initial FO-Protein study - 2% BSA solution feed volume vs. time.  
Following these results the study was repeated using a microplate reader for sample 
analysis following the BCA Assay to provide more accurate results. The experiment 
was also performed with a 50K MWCO PES UF membrane to determine whether a 
lower membrane MWCO, associated with a smaller membrane pore size, would result 
in a reduction in protein permeation. 
As expected the 50K MWCO membrane did result in a lower protein concentration 
detected in the draw solution (Figure 2.40). After 3 hours of forward osmosis the 
protein concentration in the draw solution of the 100K experiment was 250 µg/mL 
whereas for the 50K experiment the protein concentration was only 61 µg/mL.  In both 
studies the protein concentration increased with time. As with the previous experiment, 
the proteins did not appear to foul the membrane or affect the flux with a similar rate of 
decline in feed volume measured for both membrane studies.  
  
Figure 2.40: Data from protein-FO studies comparing protein permeation through a 50K and 100K 
MWCO PES UF membrane  using a  5% 225K NaPA draw and a  2% BSA in PBS feed solution a) 
Calculated protein concentration (µg/mL)  in 500 µL samples taken hourly from the 5% 225K NaPA draw 
solution b) feed solution volume (mL) vs. time. 
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An alternative protein was also studied – fibrinogen with molecular weight of 340 kDa 
was expected to be too large to permeate through either the 50K or the 100K PES 
MWCO UF membranes. As shown in Figure 2.41 in neither case was any protein was 
detected in the draw solution after 3 hours (i.e. absorbance at 562 nm >0 as observed 
for the zero protein concentration control). As explained above, calculated negative 
concentrations from absorbance values which are less than zero signifies zero protein 
present. As for the albumin studies, the 50K membrane flux did not appear to be 
affected by the presence of the proteins in the feed solution with the feed solution 
volume decreasing at a steady rate, however, for the 100K membrane the flux 
appeared to begin plateauing between hours 2 and 3 (flux = 0 mL/h). This suggests in 
this particular experiment the high molecular weight protein was in fact beginning to 
foul the membrane. 
 
Figure 2.41: Data from protein-FO studies comparing protein permeation through a 50K and 100K 
MWCO PES UF membrane  using a  5% 225K NaPA draw and a  2% fibrinogen in PBS feed solution a) 
calculated protein concentration (µg/mL)  in 500 µL samples taken hourly from the 5% 225K NaPA draw 
solution b) feed solution volume (mL) vs. time. 
Additionally, the membranes used in all four experiments were analysed for protein 
adhesion. The membranes were rinsed to remove any non-bound proteins and then 
were heated in a solution of hydroxylated sodium dodecyl sulfate to desorb the 
attached proteins and release them into solution. Samples of the protein solutions 
were subsequently analysed using the BCA assay to determine the concentration of 
adhered protein. Control membranes unexposed to proteins show an absorbance 
equating to zero protein present. For both membranes adhered fibrinogen was present 
in higher concentrations than BSA (Figure 2.42) which is attributed to differences in 
absorption mechanisms with fibrinogen having a higher affinity for hydrophobic 
surfaces34,35. A larger protein surface area increases the risk of adhesion to the 
membrane surface. Additionally, fibrinogen is much larger than the membrane pores 
and cannot permeate through further increasing the risk of fouling. Interestingly the 
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difference between BSA and fibrinogen adhesion is not large, which suggests the 
fibrinogen does not foul as much as might be expected. This result is supported by the 
flux data which shows the fibrinogen did not appear to foul the membrane in the first 
few hours of the experiment. It is also surprising that for both BSA and fibrinogen the 
100K membrane appeared to have slightly less protein adhered than the 50K 
membrane. Again this may be related to the membrane pore size, the larger pores in 
the 100K membrane may prevent membrane adherence or potentially the larger 
MWCO may have a lower porosity as discussed above providing a surface which is 
less compatible with protein adhesion. 
   
   
Figure 2.42: Calculated protein concentration (µg/mm
2
) adhered to membranes used in FO-protein 
experiments (membrane sample area 31.67 mm
2
). 
A third protein was also examined; myoglobin with a MW of 16,951 kDa which was 
expected to easily permeate through both the 50K and 100K MWCO membrane. As 
before, an FO experiment was set up with a 2 mg/mL myoglobin in PBS feed solution, 
a 5% 225K NaPA draw and either a 50K or 100K PES UF membrane (face down in 
the stirred cell). Hourly samples of the draw solution were taken. Following this the 
samples were analysed to determine the protein content. Since myoglobin is already 
deeply coloured (red, wavelength 409 nm) a specific assay was not required to 
determine the protein concentration in samples taken hourly during the FO 
experiment. Instead a standard curve was prepared using a stock solution of 1 mg/mL 
myoglobin in PBS which was diluted to provide a selection of standards of known 
concentration.  
As with the BSA studies the protein concentration in the draw solution increased with 
time and there was little difference in amount of protein detected for the two different 
MWCO of membranes which is consistent with the theory that the myoglobin is small 
enough to easily permeate through both membranes (Figure 2.43). 
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Figure 2.43: : Data from protein-FO studies comparing protein permeation through a 50K and 100K 
MWCO PES UF membrane  using a  5% 225K NaPA draw and a  2% myoglobin in PBS feed solution a) 
calculated protein concentration (mg/mL)  in 500 µL samples taken hourly from the 5% 225K NaPA draw 
solution b) feed solution volume (mL) vs. time. 
Overall the experiments using real proteins have provided key results to support the 
fundamental device concept outlined in Chapter 1 and Section 2.2. It has been shown 
that it is possible to move proteins through a semipermeable porous membrane of an 
appropriate MWCO using forward osmosis employing high molecular weight 
polyelectrolyte draw solutions. Additionally these experiments have also shown this 
process can be carried out for several hours without membrane fouling affecting the 
flux properties of the system.  
2.4 Conclusions 
In conclusion, forward osmosis processes with ultrafiltration membranes and high 
molecular weight polyelectrolyte draw solutions have been investigated, for the first 
time, as a means of transporting not only water and salts but also macromolecules 
such as polymers/proteins. It has been shown that this system is capable of 
transporting proteins of an appropriate size through a UF membrane of corresponding 
MWCO and that this can occur over several hours without membrane fouling.  
Additionally, various different factors involved in this process have been studied to 
probe their effects on flux and on fouling.  In Section 2.3.1 it has been shown that 
polyelectrolyte draw solutions outperform neutral polymers when used as draw 
solutions with UF membranes generating higher fluxes. It was also found that the 
molecular weight of the draw solution is important due to viscosity effects: higher 
molecular weight polymers, although capable of generating higher fluxes, are too 
viscous to work with in practice. When investigating different membrane materials and 
MWCO it was found that PES performed better (experienced less fouling) than 
regenerated cellulose in FO experiments and lower MWCO membranes were found 
give higher fluxes. 
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In Section 2.3.2 whilst trying to model physiological proteins using PEG/PEO it was 
found that the higher molecular weight PEO fouled the membranes but lower 
molecular weight PEGs did not create the same drop in membrane flux. Investigations 
into PEG behaviour in solution (Section 2.3.3) showed they were not affected by the 
salts of the Krebs solution used to simulate physiological interstitial fluid.  
When investigating sodium polyacrylate behaviour in solution (Section 2.3.4) it was 
found that cations present in physiological salt solutions interact with the polyacrylate 
affecting the polymer structure which could potentially influence membrane fouling. 
Additionally the change in structure and salt concentration would alter the osmotic 
pressure of the system. These complex effects would require further research in the 
context of the medical device system to fully understand their implications.  
Related to polyacrylate behaviour in solution; in Section 2.3.5 studies were carried out 
to optimise the polyacrylate draw by investigation the effect on flux when molecular 
weight, polymer concentration and counter-ion identity were varied found that these 
three factors could influence the flux of the system. It was found that:  
1) the average flux  decreases with increasing polyelectrolyte molecular weight; 
 
2)  when comparing four different 225K NaPA draw solutions of the following 
concentration; 2%, 5%, 7% and 10% with a 50K PES UF membrane and a 
deionised water feed solution we observe a peak flux when the 5% draw 
solution is used; 
 
3) exchanging sodium for potassium in the polyacrylate salts can also increase 
the flux by a factor of up to five, presumably as a result of weaker ion-pairing 
with the polyelectrolyte chain. 
 
When investigating the osmotic properties of the system (Section 2.3.6) it was found 
that polyacrylate draw solutions could generate large enough osmotic pressure 
gradients to transport fluid from brine solutions (traditionally used as draw solutions in 
FO with non-porous membranes) into polyacrylate draw solutions. It was proposed this 
phenomenon may result from the porosity of the membrane preventing the saline from 
exerting any osmotic effects since it can freely permeate through the membrane whilst 
the polyelectrolyte is retained on one side. This theory was further examined in 
Section 2.3.7 where the osmotic properties of sodium polyacrylic acid was probed 
using both porous and non-porous membranes. It was confirmed that by using porous 
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membranes the osmotic effects of the polyacrylate can dominate over the high osmotic 
pressures of salt based draw solutions since the membrane is permeable to the salt 
solution but not the polymer. This means that fluid can be transported from a brine 
solution into a polyelectrolyte solution when using porous membranes whereas when 
using non-porous membranes the fluid flows in the reverse direction allowing control of 
fluid flow direction by the choice of membrane used. Additionally further information 
about the system obtained from conductivity and viscosity measurements before and 
after 24 hours of forward osmosis demonstrated that in some experiments where no 
fluid height change is detected, suggesting zero flux, there are in fact changes in 
conductivity and viscosity which confirm that salt exchange across the membrane is 
still occurring. Additionally these viscosity and conductivity measurements allow the 
effects of polymer solution dilution and changing salt concentration to be quantified.  
The final experiments in this Chapter, Section 2.3.8 explored the behaviour of the 
optimised forward osmosis system (determined in Sections 2.3.1 and 2.3.2) with real 
proteins. It has been found that it is possible to move proteins through a 
semipermeable porous membrane of an appropriate MWCO using forward osmosis 
employing high molecular weight polyelectrolyte draw solutions. Additionally these 
experiments have shown this process can be carried out for several hours without 
membrane fouling affecting the flux properties of the system 
Overall this Chapter provided some fundamental results which were then used to 
design, develop and fabricate a prototype, membrane-based medical device which 
was then tested both in an in vitro system and in an ex-vivo mammalian limb model 
specifically designed for the project – see Chapter 5. 
2.5 Future Work 
In order to continue the work into forward osmosis processes with ultrafiltration 
membranes investigated in this chapter, several aspects of this process could be 
further studied. For example initial work using PEGs to model proteins resulted in 
membrane fouling causing zero flux. To verify this preliminary work was carried out 
investigating tagging PEG molecules with a fluorophore in order to identify whether 
different MW PEGs were able to permeate through the membranes. This approach 
could also potentially quantify the amount of PEG traversing the membrane. In 
addition using fluorescently tagged proteins would allow for real-time monitoring and 
quantification of proteins being transported via forward osmosis, allowing for a clearer 
understanding of this process. This would also remove the need for the complex assay 
step simplifying the procedure. 
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The work carried out in this chapter also identified that, in the context of this project, a 
better understanding of polyelectrolyte behaviour in solution, particularly with solutions 
containing mixtures of salts, is required. For example, whilst interactions with NaCl and 
MgSO4 were investigated it would also be beneficial to study the interactions between 
the polyacrylate and mono- and divalent salts from the fourth period such as KCl and 
CaCl2 for comparison. Particularly since K
+ and Ca2+ cations are also present in the 
Krebs solution, which was used as a feed solution to simulate oedema fluid. 
Additionally, the present work discovered that exchanging potassium ions for sodium 
ions in the polyelectrolyte salt draw solution significantly altered the flux generated 
(resulting in a fivefold increase) suggesting such a change may have a major effect on 
the polyelectrolyte properties. This discovery was only made towards the end of the 
present project and clearly warrants more extensive investigation. 
2.6 Experimental 
2.6.1 Materials 
All materials were used as supplied unless otherwise stated. The following materials 
were purchased from Fisher Scientific UK Ltd (Leicestershire, UK); Pierce™ BCA 
Protein assay kit (containing; Reagent A - bicinchoninic acid, Reagent B - 4% (w/v) 
copper sulfate, 2 mg/mL albumin standard ampules), 96-well flat-bottomed 
microplates, and micrometre feeler gauges. All membrane disks were obtained from 
Merk Millipore (Massachusetts, USA). These included; 10 KDa regenerated cellulose 
UF discs, 30 KDa/50 KDa/100 KDa polyethersulfone UF discs and Ultracel® 100 KDa 
UF discs. The following polymers were acquired from Poysciences, Inc; 225,000 MW 
Poly(acrylic acid) sodium salt (20% aqueous solution), 345,000 MW Poly(acrylic acid) 
(25% aqueous solution) 1,000,000 MW poly(acrylic acid, 1,000,000 MW poly(styrene 
sulfonic acid) sodium salt. The commercial RO membrane was sourced from a 
Vontron® Residential Membrane Element (Vontron®, China). All other materials 
including; bovine serum albumin, calcium chloride, diglyme, dimethylformamide, 
fibrinogen,  glucose, magnesium sulphate, myoglobin from equine skeletal muscle 
poly(ethylene glycol) - Mn 600, 6,000 and 35,000 , poly(ethylene oxide)- Mv 100,000 
and 1,000,000, polysulfone (average Mw 35K by LS, average Mn 16K), 250,000 MW 
poly(acrylic acid) (35% aqueous solution), 45% 160K Mr poly(vinylpyrrolidone) solution, 
6,000K MW poly(acrylic acid) sodium salt, phosphate buffered saline, potassium 
chloride, potassium phosphate monobasic, sodium azide, sodium chloride, sodium 
hydrocarbonate and sodium hydroxide were purchased from Sigma Aldrich (Dorset, 
UK). 
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2.6.2 Equipment  
The following equipment was sourced from Fisher Scientific (Leicestershire, UK); 
portable conductivity meter, disposable glass test tubes, Eppendorf tubes (0.5, 1.5 and 
2 mL), micropipettes (1000µL and 200µL) and tips. The Amicon® 200 mL and 10 mL 
stirred cells were obtained from Merck Millipore (Massachusetts, USA). The U-tube 
was custom built U-Tube using membrane flange and seal from Adams & Chittenden 
Scientific Glass (CA, USA).  
All conductivity measurements were made using a calibrated conductivity meter.  
Solution viscosity measurements were carried out using a Schott-Geräte CT-52 auto-
viscometer with capillary No.I for the 0.1% (w/v) PEG solutions (stirred overnight to 
ensure complete dissolution) and capillary No. II (53102, H2SO4) for the polyelectrolyte 
solutions which were 5% (w/v) prior to forward osmosis experiments and of an 
unknown concentration following FO (see Section 2.3.7). In the case of the PEG 
solutions, the inherent viscosities of the solvents (Krebs solution and deionised water) 
were also measured. The viscometer was used to measure the absolute viscosity of 
the samples (mm2 s-1) which was then used to calculate the inherent viscosity using 
Equation 5 and the absolute viscosity of the appropriate solvent.  
 
Where ηinh is the inherent viscosity (dL g
-1), t1 and t2 are the average absolute 
viscosities (mm2 s-1) of the solvent and polymer solution(s) respectively and c is the 
concentration of the polymer solution (g dL-1). The t values are an average of 5 
measurements per sample. In the case of the polyelectrolyte solutions, the absolute 
viscosities were used as measured. 
Absorbance data was collected using either Varian Cary 300 UV-Visible spectrometer 
or a FLUOstar Omega Microplate Reader. When employing the UV-Vis spectrometer, 
samples and standards were analysed in quartz cuvettes with a 5.0 mm path length 
and were baseline corrected with respect to a blank cell with the appropriate solvent. 
When using the microplate reader, samples and standards were transferred to a clear 
flat-bottomed 96-well microplate before the absorbance was read at 562 nm. In both 
cases the samples and standards underwent an assay before the absorbance was   
read (described in Section 2.6.3.6). 
(5) 
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2.6.3 Methods 
 
2.6.3.1 Stirred Cell Forward Osmosis Experiments 
All stirred cell forward osmosis experiments were carried out using an Amicon® 
200  mL stirred cell in which the membrane was placed in the membrane holder facing 
the feed solution (i.e. active skin layer face down). The cell was then filled with 
deionised water and pressurised to fill the inlet tube which was then placed in a beaker 
containing the relevant feed (50 mL) solution (Figure 2.44). The deionised water in the 
stirred cell was then replaced by the draw solution (50 mL) and the draw solution was 
left to stir for an entire day (6-7 hours).The decrease in volume of the feed solution 
was measured every hour and in some cases the increase in volume of the draw 
solution was also monitored. Deionised water was used as a control feed and a model 
oedema fluid was developed to use in test conditions. To determine the average flux 
(mL/h) the average of the change in feed volume every hour was calculated. 
 
Figure 2.44: a) Schematic showing stirred cell modified for forward osmosis studies and b) experimental 
set up: stirred cell on stirrer-hotplate connected via silicone tubing to beaker containing feed solution.  
Model Oedema Fluid 
The model oedema solution was derived from a physiological salt solution (Krebs 
solution, see below) containing high molecular weight polymers poly(ethylene 
glycol)/poly(ethylene oxide) (PEG/PEO) to model high molecular weight protein 
components (i.e. plasma proteins such as serum albumin - MW 67K). For the standard 
model oedema fluid 100K PEO (2 g/dL) was used although other molecular weight 
PEGs (6K and 35K) were also used to investigate the effects of MW on membrane 
a) b) 
107 
 
fouling. In later studies the PEO was replaced by proteins; myoglobin at 16,951 KDa, 
bovine serum albumin (BSA) at 69 KDa and fibrinogen at 340 KDa.  
Table 2.9: Krebs Solution composition.
36
 
Component Concentration  (mM) Mass (g) in 1L 
NaCl 118 6.9 
KCl 3.4 0.25 
CaCl2 2.5 1.3 mL 
KH2PO4 1.2 0.16 
MgSO4 1.2 0.14 
NaHCO3 2.5 2.10 
Glucose 11.1 2.00 
 
2.6.3.2 Ultrafiltration Membrane Forward Osmosis Studies 
Initial studies into forward osmosis processes with ultrafiltration membranes were 
carried out to investigate potential draw solutions and membrane effects. Seven draw 
solutions were investigated; four uncharged polymers and three polyelectrolytes (see 
Table 2.10). A control feed solution of deionised water was used during these 
experiments. 
Table 2.10: Draw solutions investigated in preliminary forward osmosis experiments.  
  Draw solution 
P
o
ly
m
e
r 
1 5% 35K MW PEG 
2 5% 100K MW PEO 
3 1% 1 million MW PEO 
4 5% 160K MW PVP 
   
P
o
ly
-
e
le
c
tr
o
ly
te
 5 5% 1 million MW PSSA 
6 5% 225K NaPA 
7 1% 6 million MW NaPA 
 
The membrane was also varied to investigate the effect of the membrane material and 
molecular weight cut off (MWCO) - a property related to pore size. Five commercially 
available ultrafiltration membranes with different MWCO were investigated, two 
regenerated cellulose (10K, 100K) and three polyethersulfone (PES) membranes 
(30K, 50K and 100K). 
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2.6.3.3 Ultrafiltration Membrane FO Fouling Studies 
Fouling studies involved forward osmosis experiments with feed solutions consisting of 
Krebs solutions with varying molecular weight PEGs/PEO’s all at 2 g/dL to investigate 
the effects of PEG/PEO MW on fouling. The draw was a 50 mL 5% 225K NaPA 
solution and the PES membrane MWCO was varied. 
2.6.3.4 Ultrafiltration Membrane FO Osmotic Pressure Studies 
Osmotic pressure studies involved running forward osmosis experiments with ‘feed’ 
solutions of sodium chloride at varying percentages (2%, 5%, 10% and fully saturated 
– 26%). Again, in combination with a stirred cell, a draw of 50 mL 5% 225K NaPA 
solution was used and the PES membrane MWCO was varied. For U-tube 
experiments the draw and feed solution volumes were 100 mL. The change in fluid 
height was recorded hourly and an additional measurement was made after 24 hours 
where possible, providing the fluid height did not exceed that of the U-Tube. 
2.6.3.5 Reverse Osmosis vs. Ultrafiltration Membranes 
Forward osmosis experiments were carried out comparing reverse osmosis 
membranes with ultrafiltration membranes to investigate the effects of membrane 
structure on the forward osmosis process. As above for stirred cell experiments, a 
draw solution 50 mL 5% 225K NaPA was used. The membranes used were a RO 
membrane obtained from a domestic RO module and a 50K PES UF membrane. For 
U-Tube experiments the draw and feed solution volumes were 100 mL. The 
membrane was clamped in the membrane holder and the feed solution was placed in 
the U-Tube chamber in contact with the membrane surface whilst the draw solution 
was placed in the remaining U-tube chamber. Both fluid heights were made level and 
the change in fluid height was recorded hourly and an additional measurement was 
made after 24 hours where possible (i.e. where fluid height did not surpass U-tube). 
                        
Figure 2.45: a) schematic of U-tube and b) membrane holder and fluid chambers in custom-
built U-tube. 
a) b) 
109 
 
2.6.3.6 Protein Studies 
Forward osmosis experiments were performed using the modified stirred cell as 
described previously with 5% 225K NaPA draw solution and either a 50K or 100K 
membrane face down in the stirred cell with a 2% protein (BSA or fibrinogen) in PBS 
solution feed (or plasma). Every hour 500 µL aliquots were taken and the sample 
volume was replaced by an equivalent volume of the draw solution. Furthermore a 
sample was taken the following morning after stirring overnight.  
Following this a bicinchoninic (BCA) Assay was performed in order to determine the 
protein concentration in the samples. The absorbance of the draw solution was also 
measured to ensure no interference with the results.  
Bicinchoninic Acid Assay  
The resulting supernatant was analysed using the BCA assay (bicinchoninic acid 
assay) to determine the protein concentration present in each sample with respect to a 
standard curve of BSA solutions of known concentrations. The calculated 
concentration of the unknown samples was then extrapolated to estimate the protein 
concentration per unit membrane area.  
 
A standard curve was prepared using a 2 mg/mL stock solution of BSA with dilutions 
ranging from 2000-25 µg/mL (Table 2.11). The diluent was PBS. 
Table 2.11: Preparation of standard BSA solutions for standard curve 
Solution No. Final BSA 
Concentration 
(µg/mL) 
Volume of 
Diluent  
(µL) 
Volume and 
source of BSA  
(µL) 
Final 
Volume 
(µL) 
 
A 2000 0 300 (stock) 300 
B 1500 125 375 (stock) 325 
C 1000 325 325 (stock) 325 
D 750 175 175 (vial B dilution) 350 
E 500 325 325 (vial C dilution) 325 
F 250 325 325 (vial E dilution) 325 
G 125 325 325 (vial F dilution) 550 
H 25 400 100 (vial G dilution) 500 
I 0 400 0 400 
 
The BCA standard working reagent was prepared by combining the BCA reagent 
(component A) with 4% (w/v) CuSO4 (component B) in a ratio of 50:1. 
Standards and samples were vortexed before 25 µL of each added to a clear, flat-
bottomed 96-well microplate in triplicate. Following this 200 µL of the BCA standard 
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working reagent was added in a randomised pattern to each well containing a sample 
or standard. The microplate was incubated for 37 ⁰C for 30 minutes before measuring 
the absorbance at 562nm in a FLUOstar Omega Microplate Reader 
For the myoglobin studies due to the proteins inherent colour no assay was required to 
provide a measurable colour change. Instead a standard curve was prepared using 
solutions of myoglobin of known concentrations (Table 2.12). Standards and samples 
were vortexed before 25 µL of each added to a clear, flat-bottomed 96-well microplate 
in triplicate following which; the absorbance was measured at 409 nm in a FLUOstar 
Omega Microplate Reader. 
Table 2.12: Preparation of standard myoglobin solutions for standard curve 
Solution No. Final 
Myoglobin 
Concentration 
(mg/mL) 
Volume of 
Diluent  
(µL) 
Volume and 
source of 
Myoglobin 
(µL) 
Final 
Volume 
(µL) 
 
A 1 0 500 (stock) 300 
B 0.5 250 250 (vial A dilution) 500 
C 0.2 400 100 (vial A dilution) 500 
D 0.1 450 50 (vial A dilution) 500 
E 0.05 475 25 (vial A dilution) 500 
F 0 300 300 300 
 
2.6.3.7 Commercial Ultrafiltration Membranes 
Commercial ultrafiltration membranes were obtained from Merck Millipore. The 
membranes were used as standards to investigate potential draw solutions. The PES-
50K membrane was also used as a solid support for composite nanofiltration 
membranes through in-situ interfacial polymerisation on the surface (see Chapter 3). 
Table 2.13: Commercial Membrane Materials and MWCO, deionised water (mL/h) at 1 bar. 
Composition MWCO Deionised water flux 
(mL/h)  at 1 bar pressure 
Regenerated Cellulose 10K 180 
Polyethersulfone 30K 236 
Polyethersulfone 50K 336 
Polyethersulfone 100K 2088 
Regenerated Cellulose 100K 456 
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Chapter 3 – Poly-ylid Membranes by Interfacial Polycondensation 
3.1 Abstract 
Novel hydrophilic poly-ylids derived from interfacial polycondensation of the 
1,1’-diamino-4,4’-bipyridinium ion with aromatic di-sulfonyl chlorides and di-isocyanates 
were synthesised, characterised and their thin film composite membrane-forming 
properties analysed. A number of previously reported acid chloride based poly-ylids 
were also synthesised characterised and used to create thin film composite 
nanofiltration membranes for comparison. Studies of membrane performance, pH 
effects and biocompatibility of the new membranes were carried out, as well as more 
conventional membrane characterisation studies of pure water flux, salt rejection and 
surface morphology. 
3.2 Introduction 
Interfacial polycondensation is the most widely used technique to fabricate thin-film 
composite (TFC) membranes.1 A highly successful system was developed by Cadotte 
et al.2 in 1978 and was based on the interfacial reaction between m-phenylenediamine 
(MPD) and trimesoyl chloride (TMC) and this system is still the most commonly used.3 
However, other aromatic diamines have also been explored such as 
p-phenylenediamine as well as some non-aromatic diamines as reviewed by Lau et 
al.4,5   
In 1995 a novel heterocyclic diamine was proposed: the 1,1’-diamino-4,4’-bipyridinium 
cation which was found to produce bright yellow polymers on reaction with aromatic tri 
and di-substituted acid chlorides.6 These hydrophilic polymers had unusual N+-N- ylid 
linkages adjacent to the N-C bonds formed between the amine and the acid chloride 
(Scheme 3.1). Several different diacid chloride monomers were investigated including 
species with one aromatic ring such as: trimesoyl chloride (1,3,5-benzenetricarbonyl 
trichloride), isophthaloyl chloride (1,3-benzenedicarbonyl dichloride) and terephthaloyl 
chloride (1,4-benzenedicarbonyl dichloride) and systems with two aromatic rings: 
4,4’-oxydibenzoyl chloride and naphthalene-2,3-dicarbonyl dichloride.  
                                  
Scheme 3.1: 1,1’-diamino-4,4’-bipyridinium  di-iodide salt and poly-ylid formed after polycondensation with 
tri/di-acid chloride. 
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Figure 3.1 shows the formation of the poly-ylid shown in Scheme 3.1 via a stirred 
interfacial polycondensation reaction between the 1,1’-diamino-4,4’-bipyridinium  
di-iodide (in aqueous solution) and the trimesoyl chloride (in hexane). The yellow 
polymer forms at the interface between the two solutions. This acyl poly-ylid was then 
used to make thin film composite nanofiltration membranes via in situ 
polycondensation on the surface of a polyethersulfone (PES) ultrafiltration membrane. 
These membranes were found to have reasonable flux and salt rejection properties. 
Morphological analysis using scanning electron microscopy (SEM) revealed a highly 
nodular structure.  
 
Figure 3.1: Stirred interfacial polycondensation of TMC in hexane with 1,1’-diamino-4,4’-bipyridinium  
di-iodide in aqueous solution. 
The diamine salt is synthesised following a method reported by Downes where 
O-hydroxylamine sulfonic acid salt reacts with 4,4’-bipyridine followed by acidification 
with hydriodic acid (Scheme 3.2).7 Downes also reported the conversion of the 
di-iodide salt to an ylid by reaction with benzoyl chloride under Schotten-Baumann 
conditions.  
 
Scheme 3.2: Synthesis of 1,1’-diamino-4,4’-bipyridinium  di-iodide salt and subsequent ylid formation on 
reaction with benzoyl chloride.  
In the present thesis, it was proposed that other monomers could be investigated as 
alternatives to acid chlorides to create new classes of poly-ylids based on sulfonyl 
chlorides and isocyanates. Additionally several of the previously reported acid chloride 
poly-ylids were synthesised for comparative studies (Figure 3.2). These include the 
poly-ylids based on the trimesoyl chloride (3.1), isophthaloyl chloride (3.2) and 
terephthaloyl chloride (3.3). The membrane forming properties and membrane 
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characteristics of these poly-ylids were also investigated. Membranes made using 
poly-ylids from acyl chlorides 3.2 and 3.3 were not previously reported.  
 
Figure 3.2: Generic structure of acid chloride based poly-ylids (acyl poly-ylids) and investigated 
monomers 3.1, 3.2 and 3.3. 
Figure 3.3 shows the novel monomers which included three sulfonyl chlorides: 
benzene-1,3-disulfonyl dichloride (3.4), biphenyl-4,4’-disulfonyl chloride (3.5) and 
4,4’-oxybis(benzenesulfonyl chloride) (3.6) and two isocyanates; methylene diphenyl 
diisocyanate (3.7) and 1,1’-oxybis(4-isocyanatobenzene) (3.8).  
 
 
Figure 3.3: Generic structure of a) sulfonyl poly-ylids with co-reactant monomer structures: 3.4, 3.5 and 
3.6 and b) carbamoyl poly-ylids with co-reactant monomer structures:  3.7 and 3.8. 
3.3 Results and Discussion 
3.3.1 Synthesis of 1,1’-Diamino-4,4’-bipyridinium di-iodide  
The synthesis of 1,1’-diamino-4,4’-bipyridinium di-iodide monomer was carried out 
using the method reported by Downes (see Section 3.6.3.1).7 Analysis of the product 
by IR spectroscopy confirmed the formation of the diamine di-iodide salt product when 
compared to the spectrum of the starting material, 4,4’-bipyridine (Figure 3.4). 
Comparing the starting material and product spectra the latter contains a broad NH2 
absorbance at 3300 cm-1 with two bands signifying the presence of a primary amine 
consistent with the two amine groups present in the diamino-bipyridinium salt product. 
a) 
b) 
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Figure 3.4: IR spectra of 4, 4’-bipyridine starting material and 1, 1’-diamino-4,4’-bipyridinium  di-iodide.  
Additionally NMR spectroscopy confirmed the formation of the product by providing 
evidence for the addition of the amine groups to the pyridine nitrogen in the form of a 
singlet resonance at 8.81 ppm equivalent to the four amino protons which was not 
evident in the spectrum of 4, 4’-bipyridine. Figure 3.5 below shows the 1H NMR 
spectra of both the starting material and product. 
 
 
Figure 3.5: 
1
H NMR spectra of 4,4’-bipyridine starting material and 1,1’-diamino-4,4’-bipyridinium  di-
iodide (DMSO-d6).  
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3.3.2 Poly-ylid Synthesis  
The synthesis of the  1,1’-diamino-4,4’-bipyridinium  di-iodide monomer was carried out 
using the method reported by Downes (see Section 3.6.3.1).7 The acid chloride, 
sulfonyl chloride and isocyanate monomers were used as purchased. The poly-ylids 
were synthesised by a stirred interfacial polymerisation reaction in which the diamine 
(1% w/v) in 0.08 M aqueous sodium hydroxide solution was mixed with a 0.1% w/v 
solution of the acid chloride/sulfonyl chloride/isocyanate in hexane. Exceptions were 
sulfonyl chlorides 3.5 and 3.6 and isocyanate 3.8, which proved insoluble in hexane 
and were instead dissolved in chloroform. The reactant solutions were mixed and 
stirred rapidly resulting in a polycondensation reaction to produce the polymer product 
which was then filtered, washed and dried before characterisation. The three different 
classes of starting material produced polymers of different colours with the acid 
chlorides producing bright yellow polymers, the sulfonyl chlorides affording yellow-
brown polymers and the isocyanates generating red-brown polymers (see Figure 3.6). 
 
Figure 3.6: Poly-ylid samples demonstrating the different colours associated with the three different 
classes of poly-ylid. Acid chloride based polymers 3.1, 3.2 and 3.3 are yellow while sulfonyl chloride based 
polymers 3.4, 3.5 and 3.6 are brown and isocyanate based polymers 3.7 and 3.8 are red. 
Table 3.1 shows the structures of the acid chloride/sulfonyl chloride/isocyanate 
monomers and the poly-ylids produced following stirred interfacial polycondensation 
with the 1,1’-diamino-4,4’-bipyridinium  di-iodide. 
 
 
 
 
 
 
 
3.1  3.2 3.3  3.4  3.5  3.6  3.7 3.8  
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Table 3.1: Acid chloride, sulfonyl chloride and isocyanate monomers and their corresponding poly-ylids. 
 Monomer Poly-ylid 
3.1  
 
Trimesoyl chloride 
 
3.2 
 
 
Isophthaloyl chloride 
 
3.3 
 
 
Terephthaloyl chloride 
 
3.4 
 
 
Benzene-1,3-disulfonyl chloride 
 
3.5 
 
 
biphenyl-4,4’-disulfonyl chloride 
 
3.6 
 
 
4,4’-oxybis(benzene sulfonyl 
chloride)  
 
3.7 
 
 4,4’-
methylenebis(phenylisocyanate) 
 
3.8  
4,4’-oxybis(phenyl isocyanate) 
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3.3.3 Poly-ylid Characterisation 
The poly-ylids were characterised using the following analytical techniques; IR, 1H 
NMR and 13C NMR spectroscopy, solution viscosity measurements and thermal 
analysis (TGA and DSC). The results are discussed below. 
 
3.3.3.1 Infrared Spectroscopy  
The IR spectra provided evidence for successful formation of the polymers. For 
example, when investigating the acyl poly-ylids 3.1, 3.2 and 3.3 the polymer IR spectra 
(Figure 3.7) did not show any evidence of absorbances at 1815-1785 cm-1 which are 
associated with an acid chloride (C=O) stretch. Instead all three acyl poly-ylids 
showed a (C=O) absorbance at a lower wavenumber closer to the expected range for 
a secondary amide carbonyl stretching absorbances (i.e. 1680-1640cm-1).  
 
Figure 3.7: IR spectra of the three acyl poly-ylids 3.1, 3.1 and 3.3. 
Using poly-ylid 3.1 as an example, the (C=O) absorbance appears at 1602 cm-1, 
significantly lower than both the acid chloride carbonyl starting material and the 
expected secondary amide carbonyl absorbance. The shift to a lower wavenumber 
relative to the starting material acid chloride carbonyl is due to delocalisation of 
electron density from the adjacent anionic nitrogen (Figure 3.8) which lengthens and 
weakens the C=O bond unlike the chloride substituent which is a poor lone pair 
electron donor due to poor p-orbital overlap (i.e. the 3p orbital in chlorine atom is larger 
than 2p orbital in carbon). The acid chloride carbonyl stretching frequencies are 
instead dominated by inductive effects due to the strongly electron withdrawing 
electronegative chlorine which results in carbonyl bond shortening and strengthening 
(i.e. higher wavenumber value).8 Additionally, the ylid carbonyl stretching frequencies 
are even lower than expected because the “amide” nitrogen is deprotonated and 
therefore negatively charged. Although this negative charge is stabilised by the 
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adjacent positively charged nitrogen in the aromatic ring the negative charge can also 
delocalise onto the more electronegative oxygen of the carbonyl bond. Since this 
second resonance form is more favoured the C=O bond is further weakened when 
compared to a neutral amide.  
 
Figure 3.8: Resonance effects on C=O bond arising from conjugation with adjacent amide nitrogen, 
lengthening and weakening C=O bond resulting in absorbance at a lower frequency. 
Furthermore the acyl poly-ylid IR spectra exhibited strong (N-N) stretching 
absorbances at ca. 1280 cm-1. The remaining acyl poly-ylids absorbances are 
summarised in Table 3.2. 
Table 3.2: Acyl poly-ylid IR absorbances 
Poly-ylid (C=O)/cm-1 (N-N)/cm-1 
3.1 1602 1279 
3.2 1594 1293 
3.3 1559 1280 
 
The sulfonyl poly-ylids (3.4, 3.5 and 3.6) showed no evidence of the strong sulfonyl 
chloride (S=O) stretching absorbances, expected at 1410-1370 cm-1 and 1204-1177 
cm-1, in their IR spectra (Figure 3.9).  
 
Figure 3.9: IR spectra of the three sulfonyl poly-ylids 3.4, 3.5 and 3.6. 
Instead the (S=O) absorbance had shifted to a lower wavenumber which is 
associated with the formation of a sulfonamide bond. Again this shift to a lower 
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wavenumber is a result of resonance which lengthens and weakens the S=O bond 
causing it to absorb at a lower frequency (Figure 3.10).  
 
Figure 3.10: Resonance effects on S=O bond arising from conjugation with adjacent nitrogen, lengthening 
and weakening S=O bond resulting in absorption at a lower frequency.  
Sulfonamides typically exhibit multiple S=O stretching frequencies which generally fall 
between 1225-980 cm-1 and often appear as two bands: one for asymmetric S=O 
stretching between 1420-1300 cm-1 and the other corresponding to the symmetric S=O 
stretch between 1200-1000 cm-1. Using poly-ylid 3.4 as an example, the spectrum of 
the benzene-1,3-disulfonyl dichloride monomer exhibited characteristic (S=O) sulfonyl 
chloride absorbances at 1370 cm-1 and 1159 cm-1 which have shifted to lower 
wavenumbers in the poly-ylid product spectrum. Poly-ylid 3.4 instead has S=O 
stretching absorbances at 1131 cm-1 and 932 cm-1 which are both within the expected 
range of the sulfonamide (S=O) stretches. The values obtained fall at the lower end of 
the range due to the negative charge on the sulfonamide nitrogen favouring resonance 
forms where the charge is delocalised to the more electronegative oxygen. Additionally 
all three sulfonyl poly-ylids exhibited an (N-N) stretch between 1200-1300 cm-1 and an 
S-N stretch which appears at ca.700 cm-1. These absorbances along with those for the 
remaining sulfonyl poly-ylids (3.5 and 3.6) are summarised in Table 3.3. 
Table 3.3: Sulfonyl poly-ylid IR absorbances 
Poly-ylid (N-N)/cm-1 Asymmetric 
(S=O)/cm-1 
Symmetric 
(S=O)/cm-1 
(S-N)/cm-1 
3.4 1285 1131 932 690 
3.5 1284 1140 932 720 
3.6 1243 1133 925 701 
 
In the IR spectra of the carbamoyl poly-ylids (Figure 3.11), there is no evidence of the 
isocyanate bonds present in the starting materials, i.e. there is no (N=C=O) 
absorbance at 2275-2250 cm-1. Instead, evidence for a urea type bond can be seen 
with a (N-H) absorbance present at around 3400 cm-1for both poly-ylids and (C=O) 
absorbance, within the expected range for a urea carbonyl which is between 1675-
1590 cm-1, also present for both poly-ylids (Table 3.4). 
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Figure 3.11: IR spectra of the two carbamoyl poly-ylids 3.7 and 3.8 
For both carbamoyl poly-ylids the urea carbonyl absorbance values are slightly lower 
than might be expected for a neutral urea carbonyl. This is due to delocalisation of the 
negative charge this time across both the carbonyl oxygen and the second nitrogen 
again weakening the carbonyl bond (Figure 3.12).  
 
Figure 3.12: Resonance effects on the C=O bond arising from conjugation with adjacent nitrogen atoms, 
lengthening and weakening the C=O bond, resulting in IR adsorption at a lower frequency.  
Additionally both poly-ylids demonstrated the presence of (N-N) stretch at 1159 cm-1 
and 1162 cm-1 for poly-ylids 3.7 and 3.8, respectively. The remainder of the carbamoyl 
poly-ylid resonances are summarised in Table 3.4. 
Table 3.4: Carbamoyl poly-ylid IR absorbances 
Poly-ylids (N-H) /cm-1 (C=O) /cm-1 (N-N)/cm-1 
3.7 3390 1596 1159 
3.8 3303 1604 1162 
 
In several of the poly-ylid IR spectra broad ν(OH) absorptions were observed at 
ca.  3400cm-1 which suggests the presence of solvating water molecules. These broad 
absorbances may also arise from the additional N-H present in the urea type bond 
formed in the isocyanate based poly-ylid. 
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3.3.3.2 1H Nuclear Magnetic Resonance Spectroscopy  
 
1H NMR spectroscopic analysis confirmed formation of the poly-ylids. As each polymer 
contained the same bipyridinium diamine residue resonances derived from this 
structure were present in each sample (Ha and Hb, Figure 3.13) with additional 
resonances arising from the acyl, sulfonyl or carbamoyl unit.  
 
 
Figure 3.13: Generic structures of poly-ylids containing bipyridine-diamine residue 
Comparing the bipyridinium proton resonances in each of the poly-ylids demonstrates 
some trends as illustrated in Table 3.5. The lowest-field resonances were produced by 
acid chloride based poly-ylid 3.2 at 10.74 ppm for Ha and 9.52 ppm for Hb whilst the 
other acyl poly-ylid (3.3) had bipyridinium proton resonances with a more similar shift 
to those present in the poly-ylids. The carbamoyl poly-ylids produced slightly higher Ha 
chemical shifts compared to the sulfonyl poly-ylids whilst the carbamoyl Hb shifts were 
closer in ppm to the sulfonyl Hb shifts. 
 
Table 3.5: Bipyridinium proton resonances (ppm)  
 
 
 
 
 
 
Poly-ylid  Ha Hb 
3.2 10.74 9.52 
3.3 9.98 9.44 
   
3.4 9.66 9.21 
3.5 9.63 9.27 
3.6 9.64 9.25 
   
3.7 9.77 9.17 
3.8 9.88 9.29 
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Assigning acyl poly-ylid 3.2 (Figure 3.14); alongside the two 4H resonances 
associated with the bipyridinium  moiety, labelled Ha and Hb (10.07 ppm and 9.63 ppm, 
respectively), are the three proton resonances associated with the isophthaloyl chloride 
residue. The most de-shielded proton resonance on the acid chloride derived ring 
corresponds to the single proton ortho to both carbonyl substituents labelled Hc which 
is assigned as the 1H singlet at 9.63 ppm. The other single proton resonance at 8.66 
ppm therefore must correspond to proton He which would be expected to be a triplet, 
but poor resolution makes this impossible to observe. The remaining two proton 
resonance at 9.21 ppm therefore corresponds to the Hd protons. 
 
 
 
 
 
Figure 3.14: 
1
H NMR spectra of acyl poly-ylid 3.2 in d-TFA. 
Assigning the 1H NMR spectrum of sulfonyl poly-ylid 3.4 (Figure 3.15); the two 
bipyridinium 4H proton resonances are the most deshielded and therefore the furthest 
down field at 9.66 ppm (Ha) and 9.21 ppm (Hb). Of the remaining three proton 
resonances, the most deshielded is Hc ortho to both sulfonamide substituents 
(expected to be a singlet), however, this resonance is overlapping with the resonance 
for the pair of Hd protons (expected to be a doublet) producing a 3H multiplet at ca. 
8.94 ppm. The remaining resonance is assigned to He the furthest upfield at 8.63 ppm.  
 
 
 
 
 
Figure 3.15: 
1
H NMR spectra of sulfonyl poly-ylid 3.4 in d-TFA. 
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Assigning the 1H NMR spectrum of carbamoyl poly-ylid 3.8 (Figure 3.16): alongside 
the bipyridylium resonances at 9.88 ppm and 9.29 ppm there are resonances at 8.07 
ppm and 7.76 ppm assigned to the aromatic protons on the oxybis(phenyl isocyanate) 
moiety (Hc and Hd). The urea amide proton (He) is not observed due as a result of 
proton-deuterium exchange with the deuterated TFA solvent. This occurs because d-
TFA is a strong acid (pKa 0.23) favouring dissociation therefore facilitating proton 
exchange with the urea (pKa is ca. 26.9). This effect also occurs for poly-ylid 3.7 with 
no amide proton observed in the 1H NMR spectrum. 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: 
1
H NMR spectra of isocyanate based poly-ylid 3.8 in d-TFA 
 
3.3.3.3 Inherent Viscosity  
 
The poly-ylid inherent viscosities were determined by measuring the relative viscosity 
(ηinh) of a 0.1% w/v solution in formic acid alongside a formic acid solvent blank at 
25 ⁰C and calculating the ηinh using Equation 1.  
                       
Where ηinh is the inherent viscosity (dL g
-1), t1 and t2 are the average absolute 
viscosities (mm2 s-1) of the solvent and polymer solution(s) respectively and c is the 
concentration of the polymer solution (g dL-1). The inherent viscosity provides 
information on the relative molecular weights of polymers of similar types, though not 
absolute molecular weights. As a general rule the higher the molecular weight of the 
polymer the higher the viscosity. Whilst none of the poly-ylids have exceptionally high 
inherent viscosities the highest values obtained were for the two acid chloride based 
poly-ylids 3.2 and 3.3 at 1.53 and 1.68 dL/g respectively (Table 3.6).  All other poly-
ylids had an inherent viscosity of less than 1 dL/g, indicating these polymers are of 
significantly lower molecular weight. 
 
c d a b 
d-TFA 
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Table 3.6: Inherent viscosity characterisation data for the poly-ylids. 
 
Monomer Polymer 
inherent 
viscositya  
(dL/g) 
3.1 
 
Cross-linked 
3.2 
 
1.53 
3.3 
 
1.68 
3.4 
 
0.42 
3.5 
 
0.15 
3.6 
 
0.74 
3.7 
 
0.69 
3.8 
 
insoluble 
a
 Inherent viscosity measured for a 0.1% solution in formic acid at 25⁰C 
 
3.3.3.4 Thermogravimetric analysis 
 
Thermogravimetric analysis (TGA) was used to determine poly-ylid degradation 
temperatures (Tdeg). Samples were heated at 15⁰C/min in an inert atmosphere and the 
thermogram was analysed to determine the Tdeg. This was defined as the temperature 
at which 10% weight loss was observed after weight equilibration to allow for 
evaporation of any residual solvent.  
 
For each class of poly-ylid, similarities between the thermogram profiles could be 
observed. For example, in the acyl poly-ylids, both 3.2 and 3.3 exhibit similar 
degradation temperatures of 261 ⁰C and 265 ⁰C, respectively (Figure 3.17). This may 
be attributed to the similarity in their structures with the only difference being meta or 
para substitution of the second arene-dicarbonyl residue. Acyl poly-ylid 3.1 however 
had an unexpectedly low Tdeg of 233 ⁰C particularly considering its cross-linked 
structure. 
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Figure 3.17: TGA thermograms of the acyl poly-ylids 3.1, 3.2 and 3.3.  
Figure 3.18 a) shows the TGA thermograms of the three sulfonyl poly-ylids. Whilst two 
of the poly-ylids have a very similar Tdeg at 312 ⁰C for poly-ylid 3.4 and 317 ⁰C for poly-
ylid 3.5, the third sulfonyl poly-ylid (3.6) exhibited a significantly lower Tdeg of 261 ⁰C. 
The low Tdeg for poly-ylid 3.6 is unexpected since the sulfonyl chloride monomer 
exhibits a structural similarity to monomer 3.5 differing only in the presence of an ether 
linker between the aromatic rings rather than a methylene group. Figure 3.18 b) 
demonstrates that both of the carbamoyl poly-ylids had similar degradation 
temperatures; 252 ⁰C for poly-ylid 3.6 and 255 ⁰C for poly-ylid 3.7.  
 
Figure 3.18: a) TGA thermograms of the sulfonyl poly-ylids 3.4, 3.5 and 3.6 and b) TGA thermograms of 
the carbamoyl poly-ylids 3.7 and 3.8. 
 
The sulfonyl poly-ylids demonstrated the highest degradation temperatures which may 
be attributed to extensive delocalisation of the negative charge on the ylid nitrogen 
onto the very strongly electron-withdrawing sulfone group. The acyl and carbamoyl 
poly-ylids had more similar degradation temperatures about 60-80 ⁰C less than the 
sulfonyl chlorides, averaging at 253 ⁰C.  
a) b) 
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3.3.3.5 Differential Scanning Calorimetry  
Differential Scanning Calorimetry (DSC) was used to analyse the thermal properties of 
the poly-ylids. The poly-ylid samples were heated to 200 ⁰C at a ramp rate of 
10 ⁰C/min for one cycle before undergoing a second cycle heating to 350 ⁰C, again at 
a ramp rate of 10⁰C/min. The first cycle ensured all solvent was removed as the 
hydrophilicity of the poly-ylids resulted in water adsorption and therefore it was the 
second cycle that was analysed. The second cycle heated the polymers beyond their 
degradation points as determined by TGA analysis (see Section 3.3.3.4).  
 
Typically three types of thermal transitions can be observed using DSC: the glass 
transition temperature (Tg), the crystallisation temperature (Tc) and the melt 
temperature (Tm). None of the poly-ylids demonstrated any characteristic crystallisation 
or melt thermal transitions within this temperature range at this ramp rate (see Figures 
3.19, 3.20 and 3.21). The lack of a crystallisation peak is consistent with materials 
which are already highly crystalline and therefore cannot easily undergo further 
crystallisation during heating, although 100% crystallinity is unusual and most 
crystalline polymers will contain amorphous regions.9 Crystallinity is determined by 
polymer structure and intermolecular forces.10 All of the poly-ylids (apart from poly-ylid 
3.1 which is cross-linked) are linear polymers with no possibility of branching due to the 
substitution of the monomers. Additionally the high degree of aromaticity within the 
poly-ylids increases polymer rigidity both of which suggest a highly ordered structure. 
The high aromatic character of the poly-ylids also contributes to potential 
intermolecular bonding arising from π-π stacking. Additionally for some of the poly-
ylids there is also the potential for hydrogen bonding. Within the carbamoyl poly-ylids 
the urea bond contains both a hydrogen-bond donor (urea nitrogen atom) and a 
hydrogen-bond acceptor (urea carbonyl oxygen atom) facilitating intermolecular 
hydrogen bonding. In the case of the the acyl poly-ylids the amide nitrogen is assumed 
to be deprotonated since it is also part of the adjoining N-N ylid bond. Thus the bond 
only provides the hydrogen-bond accepting portion of a hydrogen bond although if the 
ylid nitrogen was protonated both components of a hydrogen bond would be present. 
This additional intermolecular bonding contributes to increased polymer ordering and 
therefore potentially to polymer crystallinity. Crystalline materials show a melting peak 
when the melt temperature is achieved due to a phase transition from solid to liquid 
involving a structural reordering of crystalline regions from ordered solid to disordered 
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liquid.11 The lack of a melting peak in the poly-ylid DSC thermograms was attributed to 
the poly-ylids undergoing degradation before melt temperature can be attained. 
The third thermal transition which can usually be observed in DSC analysis is the glass 
transition (Tg) which is associated with thermal transitions within amorphous polymers 
or amorphous regions within semi-crystalline polymers and involves the reversible 
transition from a glassy state to a rubbery state due to changes in polymer chain 
mobility as the sample is heated.12 As previously stated it is uncommon for polymers to 
exist in a purely crystalline state, and so some amorphous regions will exist which are 
capable of undergoing a glass transition upon heating to appropriate temperature. 
However the Tg was undetectable in all of the poly-ylids studied in the present work.  
Figure 3.19 shows the second cycle thermograms of the three acid chloride poly-ylids 
and highlights the lack of a characteristic crystallisation exotherm (positive peak) or 
melting endotherm (negative peak). Additionally a Tg transition was not observed 
although each acyl poly-ylid undergoes degradation demonstrated by the degradation 
exotherm peaks above 200 ⁰C. The degradation peaks are fairly broad and in the case 
of 3.1 and 3.2 occur between 200-300 ⁰C additionally these degradation peaks have 
two maxima suggesting a two stage degradation process. Poly-ylid 3.3 has a sharper 
degradation peak between 250-300 ⁰C.  
 
Figure 3.19: DSC thermograms of poly-ylids 3.1, 3.2 and 3.3.  
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Figure 3.20 shows the second cycle thermograms of the three sulfonyl poly-ylids 3.4, 
3.5 and 3.6. As for the acyl poly-ylids no characteristic crystallisation or melt peaks 
were detectable and the Tg transition is similarly indiscernible. However, degradation is 
observed this time occurring over a higher temperature range 275-325 ⁰C. The 
degradation peaks are also much narrower suggesting the degradation occurs over a 
smaller temperature range. For example poly-ylid 3.4 begins to degrade at 275 ⁰C and 
by 300 ⁰C, an increase of only 25 ⁰C the polymer is degraded.  
 
Figure 3.20: DSC thermograms of sulfonyl poly-ylids 3.4, 3.5 and 3.6.  
Figure 3.21 shows the second cycle thermogram of the carbamoyl poly-ylids 3.7 and 
3.8. The degradation peaks are broader than the sulfonyl poly-ylid degradation peaks 
and occur over a lower temperature range of 200-250 ⁰C. 
 
Figure 3.21: DSC thermograms of carbamoyl poly-ylids 3.7 and 3.8.  
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3.3.4 Membrane Fabrication 
The UF support-membrane was soaked in a 0.1% (w/v) solution of the bipyridinium salt 
in aqueous 0.08M sodium hydroxide for 15 minutes. The membrane was then removed 
from the aqueous solution and allowed to stand briefly to drain excess diamine solution 
before the surface was contacted for 30 seconds with a 0.01% solution of the relevant 
monomer in hexane (Figure 3.22). Monomers 3.5, 3.6 and 3.8 could not be used to 
produce interfacial PES based membranes as they were insoluble in hexane. The 
composite membrane was then rinsed with, and stored in, deionised water before 
being characterised. Both commercially available and laboratory-fabricated PES UF 
membranes were evaluated as support-membranes. 
To fabricate support-membranes, membrane casting solutions were first prepared by 
adding PES polymer granules to a mixture of dimethylformamide (DMF) and diglyme 
and stirring in a sealed vessel until fully dissolved. To cast the support-membranes, 
Awa 10 non-woven polyester backing paper was taped to a glass plate which was then 
clipped onto a casting block. The membrane casting solution was pipetted onto the 
backing paper and a casting blade set to the desired membrane thickness (typically 
300µm) was used to create a thin film of polymer solution which was then immersed in 
tap water. The resulting membrane was rinsed for one hour under running water before 
cutting into disks and storing in deionised water. 
   
Figure 3.22: In-situ interfacial polymerisation of diamino-bipyridinium salt with trimesoyl chloride on a PES 
ultrafiltration membrane solid support a) membrane soaking in diamine, b) membrane clamped and 
surface contacted with acid chloride c) membrane surface following interfacial polymerisation. 
3.3.5 Membrane Characterisation 
Thin film composite membranes for nanofiltration and reverse osmosis are typically 
analysed for their pure water flux and salt rejection properties. Both these parameters 
a) b) c) 
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can be determined by crossflow-filtration of an appropriate feed solution under high 
pressure and monitoring the permeate volume and in the case of salt rejection, 
conductivity, over time. In the present work, this was achieved using a custom built 
crossflow rig capable of pumping fluid across a membrane surface (membrane area = 
52.27 cm2) at 5 bar pressure (Figure 3.23). 
Additionally, due to the ylid linkage present in all of the poly-ylids, which can potentially 
undergo reversible protonation and deprotonation of the nitrogen depending on the 
conditions, studies into the effect of pH on membrane filtration were also carried out.  
Membrane surface morphology was analysed using electron microscopy. Initial 
biocompatibility tests were performed to investigate whether the hydrophilicity of the 
poly-ylid coatings affected protein adhesion in comparison to uncoated PES support 
membranes.  
 
 
 
 
 
 
 
 
 
    
Figure 3.23: Schematic and images of custom built cross-flow rig and membrane holder.  
3.3.5.1 Membrane Permeability 
In a cross-flow filtration rig running at 5 bar transmembrane pressure, with a 
membrane area of 52.27 cm2 and a deionised water feed, the volume of aqueous 
permeate was measured every hour to determine the average water flux as a volume 
(mL) per hour (Figure 3.24) which can be converted to the standard units of 
membrane flux, L m-2 h. 
Pump 
Pressure gauges 
Feed 
solution 
Permeate 
Flow rate 
gauge  
Solution out  Solution in  
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Figure 3.24: Average deionised water flux (mL/hour) for composite membranes 3.1-3.4 & 3.7 at 5 bar 
pressure (* Membranes 3.2 & 3.3 made using lab-fabricated PES UF membranes as microporous 
supports). 
 
The trimesoyl composite acyl ylid membrane 3.1 had the highest water permeability 
with an average flow rate of 45.75 mL/hour. The carbamoyl ylid membrane 3.7 had a 
very low flow rate of only 1.88 mL/hour despite a reduced interfacial polymerisation 
time (15 seconds contact time for isocyanate solution) to reduce the poly-ylid coating 
thickness. The other membranes had similar average flow rates of approximately 
10 mL/hour the exception being the sulfonyl ylid 3.4 coated membrane which had an 
average flux of 19.4 mL/hour. 
Converting these results to standard membrane flux units (L m-2 h-1) gives the results 
shown in Table 3.7 below. The active membrane area within the cross flow rig was 
5.03x10-3 m2. The average flux for an RO membrane in a domestic module, using the 
example of the membrane used in Chapter 2 (RO membrane information taken from 
accompanying data sheet, experiments performed at 4.13 bar), is 0.38 m3/d with a 
membrane area of 0.46 m2. This is equivalent to 15.83 L/h or taking into consideration 
the membrane area; 34.4 L m-2 h-1. Membrane 3.1 has the highest flux at 9.12 L m-2 h-1 
which is still significantly less than the commercial membrane flux at approximately a 
third of the value.  
Table 3.7: Average deionised water flux (L h
-1
 and L m
-2 
h
-1
) for composite membranes 3.1-3.4 & 3.7 at 5 
bar pressure (* Membranes 3.2 & 3.3 made using lab-fabricated PES UF membranes as microporous 
supports). 
Membrane 
Deionised water 
Flux (L/h) 
Deiniosed water 
Flux (L m
-2 
h
-1
) 
3.1 
0.04575 9.10 
3.2 
0.01066 2.12 
3.3 
0.0091 1.81 
3.4 
0.0194 3.86 
3.7 
0.0019 0.32 
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3.3.5.2 Salt Rejection  
Salt rejection properties of the membranes for both monovalent and divalent salts were 
measured (Figure 3.25). All membranes exhibited a higher percentage rejection for the 
divalent salt MgSO4 than for the monovalent NaCl, which is attributed to the larger radii 
of hydration for divalent anions and cations making these species less able to 
permeate through a membrane. The sulfonyl ylid coated membrane 3.4 however, 
showed an unusually high rejection for the monovalent salt (70%), very close to the 
rejection value for the divalent species (73%).  
 
Figure 3.25: Percentage salt rejection of NaCl and MgSO4 solutions (both 500 ppm) for composite 
membranes 3.1-3.4 and 3.7 at 5 bar pressure. (* Membranes 3.2 and 3.3 were made using lab-fabricated 
PES UF membranes as microporous supports). 
In Figure 3.26 the percentage salt rejection, of both NaCl and MgSO4, is plotted 
against flux for the PES TFC poly-ylid membranes. For magnesium sulfate,  the higher 
the flux the higher the rejection with the highest flux and rejection coinciding at 19.6 
mL/hour, 87% rejection – a trend that is not typically observed since generally the 
reverse is observed: high flux = low rejection. For sodium chloride it would appear the 
higher rejections are generally associated with a lower flux with the highest rejection 
70% associated with a more modest flux of 10 mL/hour.  
 
Figure 3.26: Flux vs. rejection for NaCl and MgSO4 of the PES-bipyridinium -acyl/sulfonyl /carbamoyl TFC 
membranes (500ppm salt solutions, 5 bar pressure). 
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3.3.5.3 pH Effects on permeability  
Each of the poly-ylids contains an unusual N-N ylid bond adjacent to the bond formed 
during the polymerisation step (an amide, sulfonamide or urea depending on the 
monomer) see Figure 3.27. 
 
Figure 3.27: Ylid bond adjacent to bond formed in polymerisation reaction between 1,1’-diamino-4,4’-
bipyridinium  di-iodide and either an acid chloride, sulfonyl chloride or isocyanate.  
In neutral conditions the ylid is relatively stable as a result of delocalisation of the 
positive charge around the aromatic ring system whilst the negative charge is 
stabilised by resonance with the amide carbonyl or sulfonamide sulfur-oxygen bonds or 
urea carbonyl group. The negatively charged ylid nitrogen is, however, still susceptible 
to protonation. This results in a colour change which can be clearly observed when a 
membrane sample is placed in acidic and basic solutions. Using membranes coated 
with poly-ylid 3.1, 3.4 and 3.7 as examples, which are yellow in neutral conditions, 
when placed in acid, the bright yellow colour is diminished to a very much paler version 
whilst subsequently in base the yellow colour re-intensifies (Figure 3.28).  
  
Figure 3.28: a) Acyl poly-ylid 3.1, b) Sulfonyl poly-ylid 3.4 and c) Carbamoyl poly-ylid 3.7 composite 
membranes in acidic conditions (A) and basic conditions (B). 
In acidic conditions, the ylid nitrogen is protonated, which decreases the polarity of the 
N-N bond and therefore decreasing the hydrophilicity of this linkage. Comparing fluxes 
obtained with feed solutions of differing pH shows that this phenomenon significantly 
affects the membrane filtration properties. Three different membranes were 
a) b) c) 
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investigated, with an example from each type of poly-ylid i.e. membrane 3.1 (acyl poly-
ylid), 3.4 (sulfonyl poly-ylid) and 3.7 (carbamoyl poly-ylid).  
Figure 3.29 shows that when these membranes are used to process feed solutions at 
two different pH’s; pH 4 and pH 10, there is a pH dependent change in flux. Generally 
lower fluxes are observed under the acidic conditions. This is thought to be caused by 
the reduced hydrophilicity caused by ylid protonation producing a polymer which can 
form strong hydrogen bonds between the chains rather than with approaching water 
molecules reducing the membrane permeability to water. In basic conditions, the ylid 
nitrogen is deprotonated resulting in a more hydrophilic bond and therefore a more 
permeable membrane: hence then the increased fluxes in basic conditions. When 
compared to pure deionised water generally both the acidic and basic feed solutions 
have a lower flux relative to pure water, an exception being membrane 3.4 which gave 
higher flux at pH 10.  
 
Figure 3.29: Average flux (mL/hour) for buffered solutions at pH 4, 7 and 10 at 5 bar pressure.  
3.3.5.4 Surface Morphology 
Environmental scanning electron microscopy (ESEM) was used to image the 
membrane surfaces to investigate their morphology. The majority of the membranes 
had a smooth featureless surface, with no evidence of any fine structure (see Figure 
3.30). 
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Figure 3.30: Environmental scanning electron micrographs of gold coated poly-ylid membranes a) 3.2 
magnification x14,000, b) 3.3 magnification x 54,000, c) 3.4 magnification x 29,000 and d) 3.7 
magnification x 20,000. 
The coating obtained from the polymer based on monomer 3.1 has an unusual nodular 
structure creating an increased surface area (Figure 3.31). These features are absent 
in the other composite membranes suggesting that this structure could be related to 
the cross-linked nature of the polymer resulting from the tri-substituted monomer. For 
comparison the surface of a membrane coated with the standard polyamide used in 
commercial RO membranes is shown. This polyamide is made via a polycondensation 
reaction between m-phenylenediamine and trimesoyl chloride and also results in a 
polyamide with a highly structured surface morphology.  
  
Figure 3.31: Environmental scanning electron micrographs of gold-coated TFM membranes a) m-
phenylenediamine-trimesoyl chloride, magnification x 10,000 b) trimesoyl- 1,1’-diamino-4,4’-bipyridinium , 
magnification x 12,000. 
 
a) b) 
c) d) 
a) b) 
5.0 µm 1.0 µm 
2.0 µm 2.0 µm 
5.0 µm 5.0 µm 
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Blends of monomers 3.1 and 3.4 gave rise to an intermediate structure with nodules 
present surrounded by flat featureless surfaces suggesting that perhaps combinations 
of monomers could be used to fine tune membrane surface properties as required. 
 
  
Figure 3.32: Environmental scanning electron micrograph of gold-coated blend composite membrane 
(from monomers 3.1 and 3.4, a) 1:1, magnification x 20,000 and b) 2:1, magnification x 6,600. 
 
3.3.5.5 Biocompatibility testing  
In order to evaluate the biocompatibility of the poly-ylid coatings, protein adhesion 
studies were carried out. Two different plasma proteins were investigated; bovine 
serum albumin (BSA) and fibrinogen (FIB). Serum albumin usually makes up 
approximately 55% of the blood plasma protein content in humans whilst fibrinogen 
represents around 7%.15 
 
To perform the study, coated and uncoated membrane samples were incubated at 
37 ⁰C in a 10 mg/mL protein (BSA or fibrinogen) in phosphate buffered (PBS) solution 
for 24 hours. Following this the membranes were rinsed to remove any non-adhering 
protein and the samples were then heated in sodium dodecyl sulfate (SDS)-hydroxide 
to desorb the attached proteins. The resulting supernatant was analysed using the 
BCA assay (bicinchoninic acid assay, described in Chapter 2) to determine the protein 
concentration present in each sample which was then extrapolated to estimate the 
protein concentration per unit membrane area. Control samples in protein-free 
solutions (PBS only) were also incubated and assayed. Calculated concentrations 
resulting in a ‘negative concentration’ signify zero absorption and therefore zero protein 
present. 
 
Figure 3.33 shows the calculated protein concentration (mg/mL) present in 25 µL of 
supernatant from the protein denaturation step following 24hrs incubation in a 10 
mg/mL BSA solution (69 kDa). The uncoated PES support membrane gave an average 
a) 
b) 
2.0 µm 10.0 µm 
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concentration of 2.01 mg/mL. Membranes coated with poly-ylids 3.1 and 3.4 gave 
similar protein concentrations suggesting that the increased hydrophilicity of the poly-
ylid coating did little to prevent protein adhesion (1.96 mg/mL and 2.19 mg/mL). 
However, the sample coated with poly-ylid 3.7 did show a 31% reduction in protein 
concentration from 2.01 mg/mL in the uncoated sample to 1.39 mg/mL in the coated 
sample. 
 
Figure 3.33: Calculated average BSA protein concentration mg/mL in 25 µL samples from SDS-OH 
supernatant. 
The data collected from the assay were used to estimate the protein concentration per 
membrane area see Table 3.8 below. All four membranes were found to have 
reasonably similar protein concentrations. Membrane 3.1 had a protein concentration 
of 0.40 mg/cm2 which was more or less the same as the uncoated membrane 
(0.41 mg/cm2) and membrane 3.4 had slightly more protein than the uncoated 
membrane (0.45 mg/cm2). However, membrane 3.7 had significantly less adsorbed 
protein than the uncoated membrane, at only 0.28 mg/cm2. This suggests that the 
increased hydrophilicity of the membrane surface provided by poly-ylid G may increase 
the biocompatibility of hydrophobic PES membranes and so reduce levels of protein 
adhesion.  
Table 3.8: Calculated BSA protein concentration per unit membrane area. 
 
 
Membrane Protein concentration per unit 
membrane area (mg/cm2) 
Uncoated  0.41 
3.1 0.40 
3.4 0.45 
3.7 0.28 
 
The study was repeated using fibrinogen – a larger protein at 340 kDa but results 
suggested that the uncoated membrane performed better than the TFC poly-ylid 
membranes, with zero adhered protein detected (Figure 3.34).  
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Figure 3.34: Calculated average fibrinogen protein concentration mg/mL in 25 µL samples from SDS-OH 
supernatant.  
The amount of protein adhering to the coated membranes however was significantly 
smaller (by a factor of 10) than for the BSA studies with an average protein 
concentration of 0.056 mg/cm2 present on the coated membranes in the fibrinogen 
study compared with an average of 0.5133 mg/cm2 for the BSA study (Tables 3.8 and 
3.9).  
Table 3.9: Calculated fibrinogen protein concentration per unit membrane area. 
Membrane Protein concentration per unit 
membrane area (mg/cm2) 
Uncoated  0 
3.1 0.0581 
3.4 0.0687 
3.7 0.0249 
 
A final study involved the use of porcine plasma which contains a number of different 
plasma proteins (Figure 3.35). The same protocol was used exchanging 10 mg/mL 
protein incubation for the plasma both neat and diluted tenfold with PBS. Again a 
protein free control was also incubated and assayed. Only one type of poly-ylid 
membrane was analysed; poly-ylid 3.1 coated compared with an uncoated control. 
When incubated in neat plasma little difference was observed between the uncoated 
and coated membranes which gave concentrations of 1.36 mg/mL and 1.28 mg/mL, 
respectively, equivalent to a 6% decrease. When the plasma was diluted the coated 
membrane showed again a decrease in protein concentration this time by 
approximately 26%.  
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Figure 3.35: Calculated average protein concentration mg/mL in 25µL samples from SDS-OH 
supernatant. 
 
Overall it appears that the increased hydrophilicity provided by the poly-ylid coatings 
does not generally reduce the amount of protein that adheres relative to an uncoated 
membrane with an exception being poly-ylid 3.7 which was able to reduce BSA protein 
adhesion significantly relative to an uncoated membrane. 
 
3.4 Conclusions 
Five novel poly-ylids based on sulfonyl chloride and isocyanate monomers (and three 
previously reported acid chloride poly-ylids) were successfully synthesised and fully 
characterised using a variety of techniques including; infrared and proton NMR 
spectroscopy, inherent viscosity measurements and thermal analysis 
(Thermogravimetric Analysis and Differential Scanning Calorimetry). 
Two of the novel poly-ylids along with three previously reported acid chloride-derived 
poly-ylids were then used to fabricate thin-film composite nanofiltration membranes via 
in situ polycondensation reactions on the surface of a polyethersulfone ultrafiltration 
support membrane. Both commercially available and lab-fabricated PES UF 
membranes were investigated. The resulting thin film composite membranes were then 
characterised by analysing their pure water flux and salt rejection properties (for both 
mono- and di-valent salts). It was found that the highest pure water fluxes were 
achieved with the membrane coated with the previously reported acyl poly-ylid 3.1. 
This is attributed to the tri-substituted monomer producing an unusual nodular surface 
(see Section 3.3.5.4) therefore increasing the membrane surface area and hence 
increasing the water flux. Despite this the average flux could not compete with a 
commercial RO membrane which had a flux of 34.4 L m-2 h-1 compared to membrane 
3.1 which had an average flux of 9.10 L m-2 h-1. 
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As for the salt rejection studies, when comparing mono and divalent salt rejection, in all 
cases the divalent salt showed a higher percentage rejection although membranes 
coated with poly-ylid 3.4 showed an unusually high monovalent salt rejection of 70% 
relative to the divalent salt rejection at 73%. The highest overall rejection was again 
achieved with the poly-ylid 3.1 coating; 88% rejection of the divalent magnesium 
sulfate. Novel poly-ylid 3.7 achieved comparable sodium chloride rejection (52%) to 
poly-ylids 3.2 (56%) and 3.3 (55%).  
Additionally, due to the presence of a novel ylid linker which contains a negatively 
charged nitrogen atom susceptible to reversible protonation and deprotonation, further 
flux studies under different pH’s were performed to examine the effect of pH on 
membrane permeation. It was found that changing the pH of the feed did affect the flux 
with all three membranes examined (3.1, 3.4 and 3.7) achieving higher fluxes in basic 
conditions than under acidic conditions. It is proposed that this is a result of the 
reduced hydrophilicity caused by ylid protonation in acid conditions which produces a 
polymer which can form strong hydrogen bonds between the chains rather than 
forming hydrogen bonds with approaching water molecules. This then reduces the 
membrane permeability to water. In basic and neutral conditions, the ylid nitrogen is 
deprotonated resulting in a more hydrophilic bond and therefore a more permeable 
membrane, hence then increased fluxes in basic conditions. 
Scanning electron microscopy was used to analyse the membrane surface 
morphology. It was found that only the tri-substituted crosslinking monomer trimesoyl 
chloride was able to produce any morphological effects creating a characteristic 
nodular surface. All other poly-ylids produced flat featureless membrane surfaces 
although bends of the trimesoyl chloride monomer an a di-substituted sulfonyl chloride 
monomer (benzene-1,3-disulfonyl chloride) were able to produce an intermediate 
surface structure with both flat and nodular regions. 
Initial biocompatibility studies were carried out to examine the effect of the increased 
hydrophilicity of the TFC membranes as a result of coating with the highly polar poly-
ylids. Protein adhesion was studied with two different proteins (BSA and fibrinogen) 
and porcine plasma containing a mixture of plasma proteins. It was found that the 
increased hydrophilicity of the membrane surfaces did not generally decrease the 
protein adhesion relative to uncoated control membranes except in one study: poly-ylid 
3.7 with BSA.  
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3.5 Future Work 
A continuation of the work presented in this chapter should include investigation into 
the structure of the novel sulfonyl and carbamoyl poly-ylids by synthesising model 
oligomer compounds for single-crystal X-ray diffraction analysis. Additionally 
alternative sulfonyl chloride and isocyanate monomers could be synthesised to expand 
the library of 1,1’-diamino-4,4’-bipyridylium poly-ylids. Following characterisation of any 
novel poly-ylids their membrane forming abilities’ should be assessed.    
The existing TFC membranes should be further analysed by investigating their 
rejection of different salts or mixtures of salt solutions. Furthermore the effect of 
changing pH on flux suggests that the pH of the feed could also affect salt rejection 
properties, so analysing the membrane salt rejection at different pH values would also 
be worthy of investigation. Additional SEM analysis could be performed to image the 
membrane cross-sections for further information on the membrane morphology. The 
blended coatings incorporating both trimesoyl chloride and a di-substituted sulfonyl 
chloride in different ratios could be analysed in terms of their flux and salt rejection 
properties and to quantify the impact of the changing ratio of monomers. Finally, other 
biocompatibility experiments could be performed i.e. investigating bacterial adhesion 
onto coated vs. uncoated membranes. 
3.6 Experimental 
3.6.1 Materials 
The following materials were sourced from Fisher Scientific UK Ltd (Leicestershire, 
UK); Pierce™ BCA Protein assay kit (containing; Reagent A - bicinchoninic acid, 
Reagent B - 4% (w/v) copper sulfate, 2mg/mL albumin standard ampules), 96-well flat-
bottomed micro-plates and the micrometre feeler gauge. The 50K MWCO 
polyethersulfone UF disks were purchased from Merck Millipore (Massachusetts, 
USA). The "Awa 10" backing paper used to fabricate UF membranes was obtained 
from Awa Paper Ltd (Japan) and the membrane casting blade was sourced from 
Mitutoyo (Japan). The Victrex® 5200 High MW aromatic polyethersulfone also used in 
UF membrane fabrication was ex ICI plc. All remaining materials including; acetic acid, 
acetone, benzene-1,3-disulfonyl chloride, bovine serum albumin, biphenyl-4,4’-
disulfonyl chloride, 4,4’-bipyridyl dihydrate, deuterated dimethyl sulfonic acid, 
deuterated trifluoroacetic acid, diglyme, dimethylformamide, fibrinogen, hexane, 
hydriodic acid, hydrochloric acid, hydroxylamine-O-sulfonic acid, isophthaloyl chloride, 
magnesium sulphate, methanol, 4,4’-methylenebis(phenylisocyanate), oxybis(benzene 
144 
 
sulfonyl chloride), oxybis(phenyl isocyanate), phosphate buffered saline, potassium 
carbonate, potassium hydroxide, sodium chloride, sodium dodeceyl sulfate, sodium 
hydrogen carbonate, sodium hydroxide, terephthaloyl chloride, trimesoyl chloride were 
purchased from Sigma Aldrich  (Dorset, UK)  
3.6.2 Equipment  
The following items of equipment were sourced from Fisher Scientific UK Ltd 
(Leicestershire, UK); conductivity meter, disposable glass test tubes, Eppendorf tubes 
(0.5, 1.5 and 2mL), micropipettes (1000µL and 200µL) and tips and NMR vials with 
polyethylene lids.  
IR spectra were recorded using a Perkin Elmer Spectrum FT-IR spectrometer 
equipped with a universal attenuated total reflectance accessory. Both monomer and 
polymer samples were analysed in powder form. 
 1H and 13C NMR spectra were obtained on a Bruker Nanobay 400 or 100 MHz 
spectrometer and were referenced to residual solvent resonances. Samples were 
dissolved in appropriate solvents at room temperature. When assigning 1H and 13C 
NMR spectra all values representing chemical shifts (δ) are in units of parts per million 
(ppm). 
The absolute viscosities of the poly-ylids were measured at 25 ⁰C for 0.1% (w/v) 
polymer solutions in ≥96% formic acid with a Schott-Geräte CT-52 auto-viscometer 
using glass capillary No. II. Samples were stirred overnight to ensure complete 
dissolution. Following this inherent viscosity was calculated using Equation 1 relative 
to the flow time of the solvent.  
 
Where ηinh is the inherent viscosity (dL g
-1), t1 and t2 are the average absolute 
viscosities (mm2 s-1) of the solvent and polymer solution(s) respectively and c is the 
concentration of the polymer solution (g dL-1). The t values are an average of 5 
measurements per sample. In some cases the absolute viscosities were used for 
comparison rather than calculating the inherent viscosity.  
 
Thermogravimetric Analysis employed a TA Instruments TGA Q50 attached to a TGA 
heat exchanger, platinum crucible and an aluminium TA-Tzero pan (ramp rate of 
15 ⁰C/min up to 500 ⁰C).  
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Differential scanning calorimetry analysis employed a TA DSC Q2000 with TA 
Refrigerated Cooling System 90 (aluminium TA-Tzero pans and lids) with a ramp rate 
of 10 ⁰C/ min: first cycle to 200 ⁰C and second cycle to 350 ⁰C). 
Nanofiltration experiments were carried out using a custom built cross-flow rig. 
Conductivity measurements were made using a calibrated conductivity meter  
Electron micrographs were obtained using an FEI Quanta FEG 600 Environmental 
Scanning Electron Microscope (ESEM). Samples were sputter coated with gold before 
imaging with high vacuum ESEM. 
Absorbance data was collected using a FLUOstar Omega Microplate Reader. Samples 
and standards were transferred to a clear flat-bottomed 96-well microplate before the 
absorbance was read at 562 nm. In both cases the samples and standards underwent 
an assay before the absorbance was read (described in Section 3.6.3.7). 
3.6.3 Methods 
3.6.3.1 Synthesis of 1,1’-diamino-4,4’-bipyridinium  di-iodide7 
 
Hydroxylamine-O-sulfonic acid (11.3 g, 100mmol) in water (20 mL) was cooled to -5 ⁰C 
and neutralised with potassium hydroxide (5M, 20 mL). The solution was added to a 
suspension of 4,4’-bipyridyl dihydrate (9.6 g, 62mmol) in water (30 mL) at 30 ⁰C. The 
suspension was stirred on a steam-bath until the solid dissolved, and then stirred for a 
further 2 hours. The cooled solution was treated with a saturated aqueous solution of 
potassium carbonate (6.9 g, 50mmol in 60mL). The resulting yellow solution was 
diluted with methanol until no further solid separated, and the potassium sulfate filtered 
off. The filtrate was made acid with concentrated hydriodic acid and cooled to 0 ⁰C. 
The solid which separated was filtered off, washed with acetone and recrystallised 
from water, affording the diamino-bipyridinium  di-iodide salt as yellow/orange crystals, 
(7.9 g, 42mmol, 68%), IR (ATR)/cm-1 3440, 3251, 3033, 1641, 1495, 1373, 1198, 1H 
NMR (400 MHz, DMSO-d6) 8.95 (appt. d, 4H, Ha), 8.81 (s,4H, Hc), 8.51 (appt. d, 4H, 
Hb) ppm, 
13C NMR (100 MHz, DMSO-d6) 143.1, 137.9, 126.4 ppm. Tdeg  203 ⁰C. 
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3.6.3.2 Stirred Interfacial Polycondensation 
The synthesis of the 1,1’-diamino-4,4’-bipyridinium  di-iodide monomer (above) was 
carried out using the method reported by Downes.7 Acid chloride, sulfonyl chloride and 
isocyanate monomers were used as purchased. The poly-ylids were synthesised in 
bulk by a stirred interfacial polymerisation reaction in which the diamine (0.9% w/v) in 
0.08 M aqueous sodium hydroxide solution was mixed with a 0.6% w/v solution of the 
acid chloride/sulfonyl chloride/isocyanate in hexane. Exceptions were sulfonyl 
chlorides 3.5 and 3.6 and isocyanate 3.8, which proved insoluble in hexane and were 
instead dissolved in chloroform. The reactant solutions were mixed and stirred rapidly, 
with the poly-ylid forming instantly at the interface of the two solutions.  The solid was 
filtered off, washed and then dried in a vacuum oven (80 ⁰C, 4 hours) before 
characterisation.  
Acyl Poly-ylid 3.1; 
 
as yellow flakes, (0.2891g, 73%), IR (ATR)/cm-1 3500, 3029, 1602, 1534 1472, 1422, 
1279, 1091, 954, 828, 772, 739; (cross-linked, insoluble); Tdeg 232 ⁰C.  
Acyl Poly-ylid 3.2; 
 
as yellow  flakes, (0.2237g, 55%), IR (ATR)/cm-1 3370, 3108, 1595, 1535, 1471, 1423, 
1293, 1261, 1159, 1079, 1026, 939, 899, 819, 774, 726, 703; 1H NMR (100 MHz, d-
TFA) 10.07 (m, 4H, Ha) 9.63 (s, 1H, Hc), 9.52 (m, 4H, Hb) 9.21 (m, 2H, Hd), 8.66 (m, 
1H, He); Inherent viscosity (25 ⁰C, formic acid) 1.53 dL/g; Tdeg 260 ⁰C. 
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Acyl Poly-ylid 3.3; 
 
as yellow flakes, (0.1876, 47%), IR (ATR)/cm-1 3500, 3111, 1560, 1467, 1421, 1281, 
1162, 1015, 893, 817, 786, 727, 700; 1H NMR (100 MHz, d-TFA) 9.98 (m, 4H, Ha), 
9.44 (m, 4H, Hb) 8.96 (m, 4H, Hc); Inherent viscosity (25 ⁰C, formic acid) 1.68 dL/g; Tdeg 
265 ⁰C. 
Sulfonyl Poly-ylid 3.4; 
 
as brown powder, (0.2495g, 56%), IR (ATR)/cm-1  3531, 3115, 1621, 1476, 1425, 
1285, 1154, 1129, 1103, 929, 840, 689, 636, 568; 1H NMR (100 MHz, d-TFA) 9.66 (m, 
4H, Ha), 9.21 (m, 4H, Hb), 8.96 (t, 1H, Hc), 8.92 (m, 2H, Hd), 8.63 (s, 1H, He); Inherent 
viscosity (25 ⁰C, formic acid) 0.42 dL/g; Tdeg 312 ⁰C. 
Sulfonyl Poly-ylid 3.5; 
 
as a brown powder, (0.2007g, 47%), IR (ATR)/cm-1  3540, 3118, 1624, 1477, 1284, 
1136, 1088, 927, 822, 714, 587; 1H NMR (100 MHz, d-TFA) 9.63 (m, 4H, Ha), 9.27 (m, 
4H, Hb), 8.57 (m, 4H, Hd), 8.57 (m, 4H, Hc); Inherent viscosity (25 ⁰C, formic acid) 0.15 
dL/g; Tdeg  317 ⁰C.
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Sulfonyl Poly-ylid 3.6; 
 
as a brown powder, (0.04007g, 11%), IR (ATR)/cm-1 3124, 1581, 1484, 1243, 1133, 
1124, 925, 838, 701; 1H NMR (100 MHz, d-TFA) 9.64 (m, 4H, Ha), 9.25 (m, 4H, Hb), 
8.58 (m, 4H, Hd), 7.94 (m, 4H, Hc); Inherent viscosity (25 ⁰C, formic acid) 0.74 dL/g; 
Tdeg 261 ⁰C. 
Carbamoyl Poly-ylid 3.7; 
 
as red-brown flakes, (0.0878, 18%), IR (ATR)/cm-1 3390, 3255, 3112, 2036, 2963, 
2923, 1596, 1509, 1467, 1403, 1346, 1265, 1203, 1160, 1007, 814, 743; 1H NMR 
(100 MHz, d-TFA) 9.79 (m, 4H, Ha), 9.19 (m, 4H, Hb), 7.96 (m,4H, Hd) 7.84 (m, 4H, Hc), 
4.60 (s, 2H, He); Inherent viscosity (25 ⁰C, formic acid) 0.69 dL/g; Tdeg 251 ⁰C. 
Carbamoyl Poly-ylid 3.8; 
 
as red-brown flakes, (0.3407g, 73%), IR(ATR)/cm-1 3303, 3000, 1604, 1496, 1268, 
1162, 831; 1H NMR (100 MHz, d-TFA) 9.88(m, 4H, Ha), 9.29 (m, 4H, Hb), 8.07 (m, 4H, 
Hd), 7.76 (m, 1H, Hc); Tdeg 255 ⁰C. 
3.6.3.3 Thin-film Composite Membrane Fabrication 
The UF support-membrane was soaked in a 1% (w/v) solution of the bipyridinium salt 
in aqueous 0.08M sodium hydroxide for 15 minutes. The membrane was then removed 
from the aqueous solution and was drained in the vertical position and then allowed to 
stand horizontally before the surface was contacted for 30 seconds with a 0.1% 
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solution of the relevant monomer in hexane. Monomers 3.5, 3.6 and 3.8 could not be 
used to produce interfacial membranes as they were insoluble in hexane. The 
composite membrane was then rinsed with, and stored in, deionised water before 
being characterised. Both commercially available and laboratory-fabricated PES UF 
membranes were used as support-membranes. 
To fabricate PES support-membranes in the laboratory, membrane casting solutions 
were first prepared.  PES polymer granules (20.2 wt%) were gradually added to the 
solvent [DMF (73.3 wt%) + diglyme (6.5 wt%)] and were then stirred in a sealed vessel 
until fully dissolved. To cast the support-membranes, Awa 10 non-woven polyester 
backing paper was taped to a glass plate which was then clipped onto a casting block. 
Approximately 25mL of membrane casting solution was poured onto the backing paper 
and a casting blade set to the desired membrane thickness (typically 300µm) was used 
to create a thin film of polymer solution, and the glass plate with the backing paper and 
polymer film was then immersed in water. The resulting membrane was rinsed for one 
hour under running water before cutting into disks and storing in deionised water. 
 
Figure 3.36: Schematic demonstrating membrane casting process 1) casting solution prepared, 2) 
solution cast into thin film on backing paper taped to casting block, 3) casting block, backing paper and 
film submerged in non-solvent precipitation bath. 
3.6.3.4 Membrane Flux Determination  
Nanofiltration membrane water flux was determined using the cross-flow rig with 500 
mL of deionised water at a pressure of 5 bar and a cross-flow velocity across the 
membrane surface of 1 m s-1.  The volume of water which permeated through the 
membrane every hour was recorded. This was used to calculate the average permeate 
volume per hour (mL/h) which was then converted to units of flux (L m-2 h).  
3.6.3.5 Membrane Salt Rejection Determination  
Nanofiltration membrane salt rejection was carried out using the cross-flow rig with 
500 mL solutions of 500 ppm sodium chloride and magnesium sulfate at a pressure of 
5 bar and a cross-flow velocity across the membrane surface of 1 m s-1. The 
conductivity of the feed solution was compared with the conductivity of the permeate to 
determine the percentage salt rejection, R, using Equation 2: 
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                                           𝑅 = (1 −
𝐶𝑝
𝐶𝑓
) ⨯  100%                                                      (2) 
Where Cp is the conductivity of the permeate and Cf is the conductivity of the feed. 
3.6.3.6 pH Effects on Permeability  
Buffer solutions of differing pH values were prepared and filtered through the 
membrane at a pressure of 5 bar using the cross-flow rig. The volume of the permeate 
was measured every hour. 
Table 3.10: Buffer solution compositions  
pH 4 pH 10 
423.5 mL 0.1 M acetic acid  500 mL 0.05 M sodium hydrogen 
carbonate  
76.5 mL 0.1 M sodium acetate 21.4 mL 0.1 M sodium hydroxide  
 
3.6.3.7 Biocompatibility Testing 
The membrane-protein adhesion studies involved three steps;  
1) A ‘protein challenge’ where samples and controls were incubated in protein 
solution 
2) A sample preparation step to isolate adhered proteins in solution for analysis  
3) An assay to determine protein concentration in samples relative to a standard 
curve of standards of known concentration 
 
Protein Challenge 
Membrane samples were incubated for 24 hours at 37 ⁰C in either PBS buffer alone 
(control) or in a 10 mg/mL protein solution in PBS (either BSA or fibrinogen). 
Sample Preparation  
Following the protein challenge the membranes were rinsed to remove any non-
adhering protein and the samples were then heated to 95 ⁰C for 20 minutes in a known 
volume of SDS-hydroxide (1% (w/v) SDS solution in 0.2M NaOH) to desorb the 
attached proteins.  
 
Bicinchoninic Acid Assay  
The resulting supernatant was analysed using the BCA assay (bicinchoninic acid 
assay) to determine the protein concentration present in each sample with respect to a 
151 
 
standard curve of BSA solutions of known concentrations. The calculated 
concentration of the unknown samples was then extrapolated to estimate the protein 
concentration per unit membrane area.  
 
A standard curve was prepared using a 2 mg/mL stock solution of BSA with dilutions 
ranging from 2000-25 µg/mL. The diluent was the SDS-NaOH solution.  
Table 3.11: Preparation of standard BSA solutions for standard curve 
Solution  Final BSA 
Concentration 
(µg/mL) 
Volume of 
Diluent  
(µL) 
Volume and 
source of BSA  
(µL) 
Final 
Volume 
(µL) 
 
A 2000 0 300 (stock) 300 
B 1500 125 375 (stock) 325 
C 1000 325 325 (stock) 325 
D 750 175 175 (vial B dilution) 350 
E 500 325 325 (vial C dilution) 325 
F 250 325 325 (vial E dilution) 325 
G 125 325 325 (vial F dilution) 550 
H 25 400 100 (vial G dilution) 500 
I 0 400 0 400 
 
The BCA standard working reagent was prepared by combining the BCA reagent 
(component A) with 4% (w/v) CuSO4 (component B) in a ratio of 50:1. 
Standards and samples were vortex-mixed before 25 µL of each was added to a clear, 
flat-bottomed 96-well microplate in triplicate. Following this, 200 µL of the BCA 
standard working reagent was added in a randomised pattern to each well containing a 
sample or standard. The microplate was incubated for 37 ⁰C for 30 minutes before 
measuring the absorbance at 562 nm in a FLUOstar Omega Microplate Reader. 
3.7 References 
1. K. C. Khulbe, C. Y. Feng, and T. Matsuura, in Synthetic Polymeric Membranes 
Characterisation by Atomic Force Microscopy, Springer-Verlag, Berlin, 2008, pp. 
5–14. 
2. J. E. Cadotte, US Patent 4,277,344 (1981), to FilmTec Corporation. 
152 
 
3. B. S. Lalia, V. Kochkodan, R. Hashaikeh, and N. Hilal, Desalination, 2013, 326, 
77–95. 
4. S. Veríssimo, K. V. Peinemann, and J. Bordado, J. Membr. Sci., 2006, 279, 
266–275. 
5. W. J. Lau, A. F. Ismail, N. Misdan, and M. A. Kassim, Desalination, 2012, 287, 
190–199. 
6. H. M. Colquhoun, A. L. Lewis, C. A. Mahoney, and D. J. Williams, Polymer , 
1995, 36, 443–446. 
7. J. E. Downes, J. Chem. Soc. (C), 1967, 1963–1964. 
8. J. Clayden, N. Greeves, S. Warren, and P. Wothers, in Organic Chemistry, 
Oxford University Press, Oxford, 2012, pp. 43–79. 
9. J. M. G. Cowie, in Polymers: Chemistry and Physics of Moderm Materials, 
Nelson Thornes Ltd, Cheltenham, 2002, pp. 247–271. 
10. J. D. Roberts and M. C. Caserio, Basic Principles of Organic Chemistry, 1977, 
pp. 1419–1459. 
11. J. He, W. Liu, and Y.-X. Huang, PLoS One, 2016, 11, 1–12. 
12. Mettler Toledo, Applications Note, Thermal Analysis of Polymers - Selected 
Applications, 2008, pp. 1–40. 
13. S. Sivakova, D. A. Bohnsack, M. E. Mackay, P. Suwanmala, and S. J. Rowan, J. 
Am. Chem. Soc., 2005, 127, 18202–18211. 
14. B. D. Kaushiva, S. R. McCartney, G. R. Rossmy, and G. L. Wilkes, Polymer , 
2000, 41, 285–310. 
15. N. L. Anderson, Mol. Cell. Proteomics, 2002, 1, 845–867. 
153 
 
Chapter 4 – Membranes based on Polyetherketone (PEK)  
4.1 Abstract 
Novel hydrophilic poly-ylids derived from interfacial polycondensation of the 1,1’-
diamino-4,4’-bipyridylium ion with aromatic di-sulfonyl chlorides and di-isocyanates as 
described in Chapter 3 were here synthesised on the surfaces of  lab-fabricated 
polyetherketone (PEK) support membranes to produce thin film composite 
nanofiltration membranes with the potential to carry out organic separations, owing to 
the crystalline, solvent resistant character of PEK. This strategy also allows the use of 
monomers that are not soluble in apolar solvents, such as hexane, which are the only 
type of solvents compatible with traditional polysulfone membranes. The latter are non-
crystalline and are therefore readily attacked by many solvents.  
4.2 Introduction 
Thin film composite (TFC) membranes are traditionally made by coating a polysulfone 
support (an ultrafiltration membrane) with a thin polyamide film via interfacial 
polycondensation. In the previous chapter (Chapter 3) a novel class of polymer 
coatings was explored as a route to new TFC membranes based on polycondensation 
between 1,1’-diamino-4,4’-bipyridylium di-iodide and a variety of di and tri-substituted 
aromatic monomers to create poly-ylids. Although five novel poly-ylids were 
synthesised and characterised (see Figure 4.1) only two of them were suitable for use 
in TFC membrane fabrication (3.4 and 3.7). This is due to limitations arising from the 
chemical stability of the polysulfone support membrane which is degraded by most 
organic solvents. Since the membrane coating process involves an in situ 
polycondensation on the membrane surface where the chosen monomer is in an 
organic solvent, the chosen solvent must be compatible with the support membrane. 
To overcome this limitation, it was decided that alternative support membranes could 
be investigated, not only widening the scope of potential monomers but also creating a 
completely novel solvent resistant TFC membrane which could have new applications 
in organic separations.  
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Figure 4.1: Generic structure of a) sulfonyl poly-ylids and sulfonyl chloride monomers 3.4, 3.5 and 3.6 and 
b) carbamoyl poly-ylids with isocyanate monomers 3.7 and 3.8. 
Polyaryletherketones (PAEK) are a type of high-performance industrial thermoplastic 
characterised by their stability at high temperatures. When compared with amorphous 
polyarylethersulfones (PAESs), see Figure 4.2, PAEKs are crystalline as a result of 
better chain packing which in PAESs is disrupted by conformational effects and steric 
hindrance arising from the bulky sulfone group.1 This increased crystallinity makes 
PAEKs resistant to all organic solvents at room temperature. In this study, it was 
proposed that this solvent resistance may allow access to previously unexplored 
monomers in TFC membrane fabrication via use of a PEK solid support. 
 
Figure 4.2: Polyethersulfone vs. polyetherketone  
Modifying the supporting polymer membrane had implications for other the 
components of the TFC membrane. Whilst polysulfones are soluble in solvents such as 
dimethylformamide or N-methylpyrrolidone, the high crystallinity of PEK means it will 
only dissolve in solvents which interact chemically with the carbonyl group. One such 
suitable solvent is concentrated sulfuric acid. However, it was suspected that this 
solvent would degrade the non-woven polyester AWA backing paper used for 
polysulfone membranes therefore requiring that an alternative substrate be found.  
Preliminary work into hollow-fibre and flat-sheet PEK membranes was reported in a 
patent by Colquhoun and co-workers who found the optimum PEK concentration to be 
between 7-15 wt%.2 The group also found that the films cast from concentrated sulfuric 
a) 
b) 
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acid produced membranes with low crystallinity (~15%) and therefore a post-treatment 
was developed to increase crystallinity. However, this process also reduces flux and 
molecular weight cut-off (MWCO) of the membranes corresponding to a reduction in 
pore size.3 Initial experiments into alternative support substrates found that 
polyphenylenesulfide (PPS) paper produced promising results. Gelation in strong acids 
is known to produce membranes with low porosity and additional work by the group 
found that adding polyvinylpyrrolidone (PVP) could improve membrane porosity, by 
acting as a pore forming agent.4 
In this study, the monomers chosen for exploration as components of novel PEK based 
TFC membranes were biphenyl-4,4’-disulfonyl chloride, 4,4’-oxybis(benzene sulfonyl 
chloride) and 4,4’-oxybis(phenyl isocyanate), shown in Figure 4.3. 
  
 
Figure 4.3: sulfonyl chloride (3.5, 3.6) and isocyanate (3.8) monomers. 
4.3 Results and Discussion 
4.3.1 PEK TFC Membrane Fabrication 
PEK support UF membranes were fabricated in the laboratory. A casting solution was 
prepared by dissolving 9% (w/v) PEK with a 2% (w/v) 44K polyvinylpyrrolidone additive 
in 98% sulfuric acid and stirring until fully dissolved. This solution was then cast as a 
thin film using a casting blade set to the desired membrane thickness (typically 300µm) 
onto a variety of substrates.  A novel potential substrate Tyvek® (a non-woven 
polyethene paper) was investigated (Section 4.3.3) although the best results were 
obtained when the solution was cast directly onto the glass plate. Following membrane 
casting the film was immersed in tap water and rinsed for one hour under running 
water before cutting into disks and storing in deionised water until use. 
To convert the PEK support membranes into TFC membranes an in situ interfacial 
polymerisation on the membrane surface was performed. The UF support-membrane 
was soaked in a 0.1% (w/v) solution of the bipyridylium salt in aqueous 0.08M sodium 
hydroxide for 15 minutes. The membrane was then removed from the aqueous solution 
and excess solution was drained from the surface before it was contacted for 30 
seconds with a 0.01% solution of the relevant monomer in chloroform. The composite 
3.5 3.6 3.8 
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membrane was then rinsed with, and stored in, deionised water before being 
characterised. 
Table 4.1: Sulfonyl chloride and isocyanate monomers and their corresponding poly-ylids 
 Monomer Poly-ylid 
3.5 
 
 
biphenyl-4,4’-disulfonyl chloride 
 
3.6 
 
 
4,4’-oxybis(benzene sulfonyl 
chloride)  
 
3.8  
4,4’-oxybis(phenyl isocyanate) 
 
 
4.3.2 Membrane Characterisation  
The novel PEK based TFC membranes* were analysed for their pure water flux and 
salt rejection properties in the same way as the PES based membranes described in 
Chapter 3. Both of these parameters can be determined by filtration of an appropriate 
feed solution under high pressure and monitoring the permeate volume and in the case 
of salt rejection, conductivity, over time. This was achieved using the previously 
described cross flow rig capable of pumping fluid at 1 m s-1 crossflow velocity across a 
membrane surface (membrane area = 52.27cm2) at a pressure of 5 bar. In addition, as 
a result of ylid linkage present in all of the poly-ylids (which can potentially undergo 
reversible protonation and deprotonation of the nitrogen depending on the conditions) 
studies into the effect of pH on membrane filtration were also performed. Furthermore 
membrane morphology was analysed using electron microscopy and initial 
biocompatibility tests were performed to investigate whether the hydrophilicity of the 
poly-ylid coatings affected protein adhesion in comparison to uncoated PEK support 
membranes.  
*All TFC PEK membranes discussed in Section 4.3.2 were made using laboratory-
fabricated PEK support membranes cast directly onto glass. 
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4.3.2.1 Membrane Permeability 
Figure 4.4 demonstrates the PEK membrane permeability which was determined by 
measuring the average deionised water flux. Using the cross-flow filtration rig (running 
at 5 bar transmembrane pressure, with a membrane area of 52.27cm2 and a deionised 
water feed) the volume of deionised water permeate was measured every hour to 
determine the average water flux as a volume (mL) per hour. This figure was then 
converted to the standard units of membrane flux: L m-2 h-1. 
 
Figure 4.4: Average DI water flux (mL/hour) for composite membranes 3.5, 3.6 and 3.8 at 5 bar pressure. 
Membranes 3.5 and 3.8 had low average flux rates, 33.6 mL/hour and 13 mL/hour 
respectively relative to membrane 3.6 which had a very high average flux rate of 96 
mL/hour. Although poly-ylids 3.5 and 3.8 differ only in the bond linking the monomers 
i.e. a sulfonamide bond for 3.5 and a urea bond for 3.8 there is a significant difference 
in the flux properties of membranes coated by these polymers. As discussed in the 
introduction, the difference between a carbonyl and sulfonyl group can affect the 
properties of the support membranes used in TFC when exchanging PEK for PES 
which is traditionally used. Therefore it is unsurprising that what would appear to be a 
small difference in structure can have large effects on the poly-ylid membrane 
properties. Whilst the carbon and sulfur atoms have similar Pauling electronegativities 
(2.55 and 2.58, respectively), in poly-ylids 3.5 and 3.8 these atoms are in different 
oxidation states. The sulfonyl sulfur is in an oxidation state of 6+ as a result of the 
presence of the two oxygen atoms bonded to it whereas the carbonyl carbon atom is in 
an oxidation state of 4+. This means the sulfur is much more strongly electron 
withdrawing than the carbon therefore resulting in a more polar and more hydrophilic 
bond increasing membrane hydrophilicity and therefore enhancing water flux. 
Converting these results to standard membrane flux units (L m-2 h-1) gives the results 
shown in Table 4.2 below. The active membrane area within the crossflow rig was 
5.03 x 10-3 m2. The average flux for an RO membrane in a domestic module, using the 
example of the RO membrane used in Chapter 2 (information taken from 
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accompanying data sheet, experiments performed at 4.13 bar), is 0.38m3/d with a 
membrane area of 0.46m2. This is equivalent to 15.83 L/hour or taking into 
consideration the membrane area: 34.4 L m-2 h-1. The flux data for Membrane 3.6 is 
comparable to the commercial membrane which has a flux value of 19.10 L m-2 h-1. 
Table 4.2: Average deionised water fluxes (L h
-1
 and L m
-2 
h
-1
) for composite membranes 3.5, 
3.6 and 3.8 at 5 bar pressure. 
Membrane 
Deionised water 
Flux (L/h) 
Deionised water 
Flux (L m-2 h-1) 
3.5 0.0336 0.40 
3.6 0.096 19.10 
3.8 0.013 2.59 
 
4.3.2.2 Salt Rejection  
The salt rejection properties of the membranes for both monovalent and divalent salts 
were measured using the protocols described for the PES membranes (see Section 
3.6.3.5). All of the membranes exhibited a higher percentage rejection for the divalent 
salt magnesium sulfate than for the monovalent sodium chloride, which again is 
attributed to the larger radii of hydration for divalent anions and cations making these 
species less able to permeate through a membrane. For all three membranes (3.5, 3.6 
and 3.8) the percentage rejection was low even for the divalent salt solutions. The 
average percentage rejection (for all three membranes) for sodium chloride was 24% 
whilst for magnesium sulfate it was 46%.  
 
Figure 4.5: Percentage salt rejection of 500ppm NaCl and MgSO4 solutions for composite 
membranes 3.5, 3.6 and 3.8 at 5 bar pressure. 
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Although the rejection for both salts was generally much lower than those recorded for 
the PES based membranes, the difference between mono and divalent salt rejection 
was much less than the difference observed with the PES based membranes. For the 
PES membranes, excluding membrane 3.4 which had an unusually high NaCl rejection 
the average difference between NaCl and MgSO4 rejection was 35% whereas for the 
PEK membranes this dropped to 12%.  
4.3.2.3 pH Effects on Permeability  
As previously discussed each of the poly-ylids contains an ylid bond adjacent to the 
bond formed during the polymerisation step (either sulfonamide or urea depending on 
the monomer) see Figure 4.6. 
 
Figure 4.6: Ylid bond adjacent to bond formed in polymerisation reaction between 1,1’-diamino-4,4’-
bipyridylium di-iodide and either a sulfonyl chloride or isocyanate  
In neutral conditions the ylid is quite stable as a result of delocalisation of the positive 
charge around the aromatic ring system whilst the negative charge is stabilised by 
resonance with the amide carbonyl or sulfonamide sulfur-oxygen bonds or urea 
carbonyl group. The negatively charged ylid nitrogen is, however, susceptible to 
protonation in the correct conditions. For example at an acidic pH, the ylid nitrogen 
would be protonated, decreasing the polarity of the N-N bond.  This, in turn, decreases 
the hydrophilicity of the ylid linkage which will reduce the membranes permeability to 
water. Comparison of the flux measurements performed with feed solutions of differing 
pH indicates that this phenomenon may affect the membrane filtration properties. All 
three of the PEK TFC membranes were investigated (3.5, 3.6 and 3.8) at different pH 
values. 
Figure 4.7 shows that when these membranes are used to process feed solutions at 
two different pH’s values (4 and 10, respectively), there is a pH dependent change in 
flux. For membranes 3.5 and 3.6 lower flux rates were observed in acidic conditions. 
This is attributed to the reduced hydrophilicity caused by protonation of the ylid as 
discussed in Chapter 3. In basic conditions, the ylid nitrogen is deprotonated resulting 
in a more hydrophilic bond and therefore a more permeable membrane, leading to 
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increased flux rates in basic conditions. Membrane 3.8 showed little difference 
between flux rates in acidic and basic conditions. For the majority of the PEK 
membranes, deionised water flux was higher than for the buffered solution with the 
exception of membrane 3.6 which produced a higher flux with pH 10 buffered solution.  
 
Figure 4.7: Average flux (mL/hour) for deionised water and buffered solutions at pH 4 and 10 at 5 bar 
pressure.  
4.3.2.4 Surface Morphology 
ESEM was used to image the membrane surfaces to investigate their morphology. 
Additionally the uncoated PEK membrane was imaged for comparison before and after 
coating. The uncoated surface (Figure 4.8) was flat and featureless and, as in the 
case of the other non-cross-linked poly-ylid membranes imaged in Chapter 3, the poly-
lid coated membranes were also  flat and featureless (Figure 4.9). 
 
Figure 4.8: Uncoated PEK lab fabricated UF membrane (magnification x 5,000) 
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Figure 4.9: Environmental scanning electron micrograph of gold coated poly-ylid TFC PEK membranes a) 
3.5 magnification x 10,000), b) 3.6 magnification x 5,000 and c) 3.8 magnification x 6,000. 
4.3.2.5 Biocompatibility Testing  
 
Initial biocompatibility studies were performed to analyse the effects of the increased 
hydrophilicity produced by the poly-ylid coatings relative to uncoated PEK. To analyse 
this, protein adhesion studies were carried out. One plasma protein was investigated: 
bovine serum albumin (BSA). Serum albumin is the most abundant plasma protein in 
humans and usually makes up approximately 55% of the plasma protein content.5 It is 
also present in oedema fluids in varying amounts depending on the mechanism of 
oedema formation (see Section 1.5.7 Fluid Composition).  
 
As previously described coated and uncoated membrane samples were incubated at 
37 ⁰C in a 10 mg/mL protein (BSA) in phosphate buffered (PBS) solution for 24 hours. 
The membranes were then rinsed to remove any non-adhering protein and the 
samples were then heated in SDS-hydroxide to desorb the attached proteins. The 
resulting supernatant was analysed using the BCA assay (see Chapter 2) to determine 
the protein concentration present in each sample which was then extrapolated to 
estimate the protein concentration per membrane area. Control samples in protein free 
solutions (PBS only) were also incubated and assayed. As stated previously, 
calculated negative concentration values are taken to be equivalent to zero 
absorbance which therefore signifies zero protein present. 
 
Figure 4.10 shows the calculated protein concentration (mg/mL) present in 25 µL of 
supernatant from the protein desorption step following 24 hours incubation in a 
10 mg/mL BSA solution. The uncoated PEK support membrane has an average 
concentration of 1.06 mg/mL. All three coated membranes showed a decrease in 
protein concentration relative to the uncoated membrane. Poly-ylid 3.5 gave the largest 
decrease in protein concentration with an average of 0.53 mg/mL which was equivalent 
to a 50% decrease relative to the uncoated PEK membrane. Poly-ylid 3.8 produced a 
decrease of 39% whilst poly-ylid 3.6 produced a decrease of 30%. 
a) b) c) 
5.0 µm 10.0 µm 10.0 µm 
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Figure 4.10: Calculated average BSA protein concentration mg/mL in 25 µL samples from SDS-OH 
supernatant.  
The data collected from the assay was used to estimate the protein concentration per 
membrane area (see Table 4.4). The uncoated membranes had the highest protein 
concentration per membrane area at 0.54 mg/cm2 so that all three PEK TFC poly-ylid 
membranes were able to reduce protein adhesion relative to an uncoated control. 
Membrane 3.5 reduced the protein adhesion the most with a reduction in concentration 
of 50%. Membranes 3.6 and 3.8 produced smaller reductions in protein concentration 
of 30% and 39%, respectively.  
 
Table 4.4: Calculated BSA protein concentration per membrane area 
 
 
Membrane Protein concentration per membrane 
area (mg/cm2) 
Uncoated  0.54 
3.5 0.27 
3.6 0.37 
3.8 0.32 
4.3.3 PEK Support Membrane Optimisation  
In addition to examining a novel backing paper support (Tyvek®) a post-membrane 
casting treatment known to increase membrane crystallinity was explored in an attempt 
to optimise PEK membrane performance. 
4.3.3.1 Backing Paper Exploration 
Whilst casting PEK directly onto glass created more reproducible membranes, a true 
thin-film composite nanofiltration membrane requires a solid support layer to enable it 
to withstand the high pressures of the nanofiltration process. The polyethene based 
material Tyvek® was explored as a potential backing paper as a result of its resistance 
to the concentrated sulfuric acid require to cast the PEK films. The Tyvek® backed 
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PEK membranes were coated with Poly-ylid 3.1 (Scheme 4.1, see Chapter 3) via an 
in situ polycondensation reaction between the bipyridylium salt and trimesoyl chloride 
to create thin film composite nanofiltration membranes.  
 
Scheme 4.1: In situ polycondensation between bipyridylium salt (in aqueous solution, soaked into 
membrane) and trimesoyl chloride (in organic solution, contacted with membrane surface for 30 seconds) 
to produce poly-ylid 3.1. 
As previously described these composite membranes were then analysed for water 
flux and salt rejection properties. The glass-cast TFC membrane had a higher average 
flux than the membrane cast onto Tyvek® - 82 mL/hour and 42.5 mL/hour, respectively 
(Figure 4.11). 
 
Figure 4.11: Deionised water flux (mL/min) for composite membranes using poly-ylid 3.1 on glass and 
Tyvek® at 5 bar pressure. 
In salt rejection studies the Tyvek® membranes performed slightly better than the 
glass-cast producing higher percentage rejections for both sodium chloride and 
magnesium sulphate (Figure 4.12) with a NaCl rejection of 33% and an MgSO4 
rejection of 46% when compared to 28% (NaCl) and 32% (MgSO4) for the glass-cast 
membrane. 
 
Figure 4.12: Percentage salt rejection of 500 ppm NaCl and MgSO4 solutions for composite membranes 
using poly-ylid 3.1 on glass and Tyvek® at 5 bar pressure. 
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4.3.3.2 PEK Crystallisation 
PEK membranes cast onto TYVEK® backing paper (see Section 4.3.1) were heated in 
deionised water for 1 hour at 60 °C to remove residual PVP. Following the procedure 
developed by Colquhoun3 the membrane was then heated in a mixture of  acetone, 
methanol and glycerol (70:20:10) and stirred under reflux at 56 °C for 30 minutes. 
Following this the membranes were removed and allowed to dry in air overnight, 
leaving the membrane pores coated with glycerol to promote subsequent re-wetting.  
Samples of both crystallised and non-crystallised PEK were removed from the backing 
paper, extracted with water to remove the glycerol, dried and analysed by differential 
scanning calorimetry (DSC, Figure 4.13). In the non-crystallised sample a 
crystallisation peak (exothermal) occurs at around 175 ⁰C, and additionally there is 
evidence of a glass transition (Tg) just before crystallisation at around 150 ⁰C. The Tg in 
the crystallised sample occurs at a slightly higher temperature of around 160 ⁰C. Both 
samples demonstrate a strong crystal melting peak (endothermal) at ca. 360 ⁰C.  
 
Figure 4.13: DSC thermograms of crystallised and non-crystallised PEK UF membrane. 
4.3.3.3 Characterisation of Crystallised PEK Membranes 
As for the PEK thin film composite membranes PEK support membrane, permeability 
was determined by measuring the average deionised water flux. Since the PEK 
support is essentially an ultrafiltration membrane, lower pressures are required than for 
the nanofiltration thin film composite membranes. Using the stirred cell (running at 1 
bar transmembrane pressure, with a membrane area of 31.66 cm2 and a deionised 
water feed) the volume of permeate was measured every hour to determine the 
average water flux as a volume (mL) per hour and this value was then converted to the 
standard units of membrane flux; L m-2 h-1. The crystallisation process reduced the flux 
by a half from 0.25 L/h to 0.12 L/h suggesting a reduction in pore size as observed in 
previous work.3 
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Table 4.5: Average deionised water flux (L h
-1
 and L m
-2 
h
-1
) for non-crystallised and crystallised PEK UF 
membranes at 1 bar pressure. 
Membrane 
Deionised water 
Flux (L/h) 
Deionised water 
Flux (L m-2 h-1) 
Non-crystallised 0.25 7.93 
Crystallised 0.12 3.89 
Additionally membrane molecular weight cut-off (MWCO) was investigated via filtration 
of polyethylene glycol (PEG) standards of known molecular weight. The permeate 
collected was analysed by GPC and the chromatogram produced was compared with 
that of the unfiltered PEG standard to determine whether the crystallisation process 
affected the pore size therefore affecting what permeates through.  MWCO is defined 
as the lowest molecular weight solute of which 90% is retained by the membrane 
(conventionally in units of Daltons).6 
For both a 6K and 35K PEG standard the amount of PEG present in the permeate 
following filtration with the crystallised membrane was significantly less than in the 
permeate obtained from filtration with the non-crystallised membrane (Figure 4.15) 
again suggesting a reduction in membrane pore size as a result of crystallisation.  
  
Figure 4.14: GPC chromatograms of a) unfiltered 6K PEG standard and filtrate from both non-crystallised 
and crystallised PEK membranes b) unfiltered 35K PEG standard and filtrate from both non-crystallised 
and crystallised PEK membranes. 
Calculating the percentage retention of both the non-crystallised and crystallised PEK 
membranes and comparing the percentage retention with a commercial membrane 
with a known MWCO gave an indication of the fabricated membranes approximate 
MWCO (Figure 4.15). The commercial membrane with a known MWCO of 10K 
retained 100% of the 100K PEG, as did both PEK membranes. The 10K membrane 
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also retained 89% of the 35K PEG and 46% of the 6K PEG. The lab fabricated PEK 
membranes, however, retained less of the lower MW PEG samples suggesting they 
have a higher MWCO than 10K and lower than 100K. Comparing the percentage 
retention for the 35K PEG, the crystallised membrane retains a higher percentage 
(38%) with respect to the non-crystallised membrane (31%) again suggesting the 
crystallisation process reduces the membrane pore-size. 
 
Figure 4.15: Percentage retention of different molecular weight PEG samples by a 10K commercial 
membrane and two lab fabricated PEK membranes (non-crystallised and crystallised). Note: % retention 
not calculated for crystallised PEK, 6K PEG as a result of negative peak interference (see Figure 4.14). 
4.3.3.4 Interfacial Polycondensation on a Crystallised PEK Membrane  
Both non-crystallised and crystallised PEK membranes were coated using the 
procedure described in Section 4.3.1. However the bipyridylium salt was replaced by 
m-phenylenediamine which is traditionally used in combination with trimesoyl chloride 
to form polyamide coated TFC nanofiltration and reverse osmosis membranes. 
Additionally a commercial 10K MWCO PES membrane was coated for comparison.  
Following the standard procedure the commercial UF membrane produced TFC 
membranes with low salt rejection (26% for sodium chloride) so the coating method 
was modified to increase the amine solution concentration to 2%. Additionally the 
membrane was pre-treated with a 10% ethanol solution to improve amine wetting and 
following coating the membrane was oven dried for 5 minutes at 50 ⁰C which improved 
the sodium chloride rejection to 95%. Attempts to repeat this modified procedure with 
the PEK membranes proved unsuccessful and the polyamide coatings produced were 
shown to be severely defected by SEM. An alternative pre-treatment to improved PEK 
membrane wetting was investigated; soaking the membranes in 10% aqueous acetone 
which when applied to a crystallised PEK membrane which then was coated following 
the modified procedure (involving an increased diamine concentration and oven drying 
step) produced a membrane with 26% sodium chloride rejection. 
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Initial attempts to optimise the PEK membranes have shown that small modifications to 
the membrane fabrication procedure can have significant effects on membrane 
performance and further work is required in order to develop solvent resistant 
membranes with properties which rival existing membrane systems.  
4.4 Conclusions 
Three novel poly-ylids synthesised in Chapter 3 were used to create solvent resistant 
thin film composite nanofiltration membranes based on a lab-fabricated 
polyetherketone support. The TFC membranes were characterised in terms of their 
deionised water flux and salt rejection properties and were found to perform 
reasonably well. Additionally the effect of feed solution pH was investigated and it was 
found that (as for the PES based TFC poly-ylid membranes in Chapter 3) the flux 
could be affected by pH, with generally lower fluxes in acidic conditions which is 
attributed to the reduced hydrophilicity or increased internal hydrogen-bonding as 
discussed earlier, caused by ylid protonation which in turn would reduce the membrane 
permeability to water. In basic conditions, the ylid nitrogen is deprotonated resulting in 
a more hydrophilic bond and therefore a more permeable membrane, hence then 
increased flux rates in basic conditions. Furthermore membrane surface morphology 
was investigated by scanning electron microscopy and it was found that the poly-ylid 
coating formed a flat and featureless film on the PEK surface. Initial biocompatibility 
testing found that all three PEK TFC poly-ylid membranes were able to reduce protein 
adhesion relative to an uncoated PEK support membrane. 
Initial studies into PEK membrane optimisation found that adding a support layer to the 
PEK membrane to strengthen it could also improve its salt rejection properties when 
compared with a PEK film cast directly onto glass. The additional layer does reduce 
the average flux.  
Some preliminary work into PEK crystallisation to improve solvent resistance 
properties demonstrated that the previously reported crystallisation process can be 
used to increase PEK membrane crystallinity and will also reduce the membrane pore 
size therefore reducing flux and lowering the MWCO as explored by PEG filtration 
coupled with GPC analysis. 
Attempts to coat the non-crystallised and crystallised PEK membranes with a 
polyamide layer to form thin film composite membranes have shown that a modified 
procedure is required when working with these novel PEK support membranes but it 
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has also been demonstrated that small modifications in the membrane fabrication 
procedure can have significant effects on membrane performance. 
4.5 Future Work 
Further research into the work carried out in this chapter could include further 
optimisation of the PEK support membranes including developing a protocol for 
reproducible membrane fabrication using the additional backing paper support which 
was omitted for the TFC membranes analysed in the first sections of the chapter. This 
would strengthen the membranes and allow them to better withstand the high 
pressures used in nanofiltration. Additionally the protocol for coating onto these 
supported PEK membranes requires optimisation again to ensure reproducible results. 
Finally, since these membranes have been designed to be solvent resistant; filtration 
studies examining flux and rejection in organic solvents could also be performed to test 
membrane performance in conditions which standard nanofiltration membranes would 
fail.  
4.6 Experimental 
4.6.1 Materials 
The following materials were sourced from Fisher Scientific UK Ltd (Leicestershire, 
UK); Pierce™ BCA Protein assay kit (containing; Reagent A - bicinchoninic acid, 
Reagent B - 4% (w/v) copper sulfate, 2mg/mL albumin standard ampules), 96-well flat-
bottomed microplates and  micrometre feeler gauges. The membrane casting blade 
was obtained from Mitutoyo (Japan). The PEK was grade 220P (ex ICI plc.). And the 
Tyvek® paper was purchased from Spenic Ltd (Gloucestershire, UK). The remaining 
materials; acetic acid, bovine serum albumin, chloroform, hydrochloric acid, 
magnesium sulphate, phosphate buffered saline, sodium chloride, sodium dodeceyl 
sulfate, sodium hydrogen carbonate, sodium hydroxide, and concentrated sulfuric acid 
were obtained from Sigma Aldrich (Dorset, UK) . 
 
4.6.2 Equipment 
The following equipment was sourced from Fisher Scientific UK Ltd (Leicestershire, 
UK); conductivity meter, disposable glass test tubes, Eppendorf tubes (0.5, 1.5 and 2 
mL), micropipettes (1000 µL and 200 µL) and tips, NMR vials with polyethylene lids.  
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Nanofiltration experiments were carried out using a custom built cross-flow rig. 
Conductivity measurements were made using a calibrated conductivity meter  
Electron micrographs were obtained using an FEI Quanta FEG 600 Environmental 
Scanning Electron Microscope (ESEM). Samples were sputter coated with gold before 
imaging with high vacuum ESEM. 
Absorbance data was collected using a FLUOstar Omega Microplate Reader. Samples 
and standards were transferred to a clear flat-bottomed 96-well microplate before the 
absorbance was read at 562 nm. In both cases the samples and standards underwent 
an assay before the absorbance was read (described in Section 3.6.3.7). 
4.6.3 Methods  
4.6.3.1 PEK Thin-film composite membrane fabrication 
Two steps were required to prepare PEK-TFC membranes; 1) To create PEK support 
membranes a casting solution was prepared by adding PEK polymer beads (9 wt%) to 
the solvent [conc. sulfuric acid (89 wt%) + 44K PVP (2 wt%)] which was then then 
stirred in a sealed vessel until fully dissolved. Following this, thin films were cast from 
the polymer solution either directly onto glass or onto the backing paper (Tyvek®) 
which was taped to the glass plate. Approximately 25 mL of membrane casting solution 
was poured onto the glass/backing paper and a casting blade set to the desired 
membrane thickness (300 µm as standard) was used to create a thin film of polymer 
solution, following this the glass plate (with the backing paper if being used) and 
polymer film was then immersed in water. The resulting membrane was rinsed for one 
hour under running water before cutting into disks and storing in DI water. 
2) The second step involved coating the PEK support membrane with a thin film of 
poly-ylid. The PEK support-membrane was soaked in a 1% (w/v) solution of m-
phenylenediamine in aqueous 0.08M sodium hydroxide for 15 min. The membrane 
was then removed from the aqueous solution, drained and allowed to stand briefly in 
air before the surface was contacted for 30 s with a 0.1% solution of the relevant 
monomer in chloroform. The composite membrane was then rinsed with, and stored in, 
DI water before being characterised. Modifications to this second step included 1) Pre-
treating the membranes by soaking in 10% aqueous acetone solution before interfacial 
polymerisation, 2) increasing the amine concentration to 2% and 3) oven drying the 
membranes for 5mins at 50⁰C following interfacial polymerisation. 
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4.6.3.2 Membrane Flux Determination  
See Chapter 3 
4.6.3.3 Membrane Salt Rejection Determination  
See Chapter 3 
4.6.3.4 pH Effects on Permeability  
See Chapter 3 
4.6.3.5 Biocompatibility Testing  
See Chapter 3 
4.6.3.6 PEK Crystallisation  
Lab-cast PEK membranes were heated in deionised water for 1 hour at 60 °C to 
remove any remaining PVP additive, after which they were crystallised using a 
procedure described by Colquhoun.3 The membranes were added to a mixture of 
acetone, methanol and glycerol (7:1:2) and this solution was heated under reflux at 
56 °C for 30 minutes, after which the membranes were removed from the solution and 
allowed to air dry overnight.  
4.6.3.7 PEK Crystallinity Investigation via DSC Analysis 
Samples of both crystallised and non-crystallised PEK were separated from the 
backing paper, compressed into pellets and placed into pre-weighed DSC pans. The 
pan lids were sealed and the samples were loaded into the DSC instrument. The 
samples were heated from 30-400 °C at a ramp rate of 10 °C per minute under a 
nitrogen atmosphere.  
4.6.3.8 MWCO Analysis  
Gel permeation chromatography (GPC) was used to estimate the MWCO of the PEK 
membranes before and after the crystallisation process. Stock standard solutions of 
known MW PEG’s (6K, 35K and 100K) were prepared using the GPC mobile phase 
(0.1% w/v) and stirred overnight to ensure complete dissolution. A fraction of each 
standard solution was retained for GPC analysis as a control whilst the remainder of 
each PEG solution was filtered through the membrane being analysed (i.e. non-
crystallised or crystallised PEK) using the stirred cell under 1 bar pressure. The first 
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few mL of permeate were discarded for each PEG solution and the membrane was 
rinsed with GPC mobile phase between PEG solutions. 
Following this a sample of each individual standard or sample solution was manually 
injected into the GPC and run through the column (a PL-Aquagel column fitted with a 
5µm guard column) at a rate of 1 mL/min after first being filtered through a 1.5µm nylon 
syringe filter. All runs were conducted at 40 ⁰C and the samples were detected by and 
refractive index detector. Data capture and subsequent analysis were carried out using 
Agilent GPC software.  
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Chapter 5 – Device Prototype Design, Fabrication and Testing  
5.1 Abstract 
Several prototypes were designed, fabricated and tested to obtain proof-of-concept for 
the medical device proposed, but not exemplified, by US Patent 8, 211, 053 B2 
(interosmolar fluid removal)1.  This was achieved with the assistance of fundamental 
research into draw solutions, membranes and using forward osmosis to transport both 
fluid and macromolecules carried out in Chapters 2-4. Following the design and 
fabrication of the prototypes they were tested in both an in vitro and ex vivo oedema 
model. For the latter, a porcine perfused-limb system was developed to simulate the 
condition of oedema. Additionally plans for future design optimisation and manufacture 
of a biomedical device based on the present work were developed, requiring 
consultation with a design house and manufacturer, both specialising in medical 
devices. 
5.2 Introduction 
The research motivation for this project was to develop an implantable medical device 
to treat oedema and lymphoedema. After researching membrane materials, draw 
solutions and the transport of fluid and proteins through membranes, as described in 
Chapters 2-4, device design and testing were investigated. Several prototypes were 
designed and fabricated for testing within a perfused limb oedema model developed 
specifically for this project.  
As outlined in Chapter 1, the device concept was based on a US patent licenced to 
BioInteractions Ltd for interosmolar fluid removal.1 This patent proposed, but did not 
exemplify, the idea of an implantable medical device based on a semipermeable 
membrane compartment containing trapped osmotic solutes which can act as a draw 
solution. The described device would function by removing abnormally accumulated 
fluid in the tissues surrounding the medical device, allowing them to be drained from 
the body via a tube in communication with an external reservoir (Figure 1.1). Current 
treatments for such oedemic conditions rely on complex manual therapies involving 
massage, bandaging and exercise in an attempt to direct accumulated fluid towards an 
area in the body where drainage is not comprised. In extreme cases, when the affected 
tissue is damage beyond repair, surgery is required. Additionally pharmaceutical 
interventions are often required such as the use of diuretics in an attempt to reduce 
fluid accumulation. The main advantage of the proposed osmotic approach is that the 
fluid is removed directly and does not require harsh suction or pumping which may 
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exacerbate the condition, thereby offering an alternative option for a currently unmet 
clinical need.  
 
In the present project, device design was investigated by the development of simple 
prototypes to obtain proof-of-concept through testing with in both in vitro and ex vivo 
models. Whilst the patent proposed possible device configuration and components, 
practical factors were not considered. These included: 
- The method of implantation and subsequent removal of the device as required. 
Ideally both processes being as minimally invasive as possible; 
- the necessity of replenishing the draw solution once saturated.  
The prototypes also had to be reproducible, both in fabrication and mode of action and 
simple to make whilst also providing as large a membrane surface as possible area for 
efficient fluid transport. Two generations of prototypes were made. The 1st generation 
prototype was based on a simple membrane pouch and the 2nd generation was based 
on a sealed membrane cylinder with a double lumen outlet/inlet tube (Figure 5.1). 
 
Figure 5.1: a) 1
st
 Generation prototype, b) 2
nd
 Generation prototype. 
Alongside designing and fabricating the prototypes, in vitro and ex vivo models were 
then developed. The in vitro model was based on an extremely simplified system. This 
involved suspending the prototype in a beaker containing the chosen feed solution and 
monitoring the feed and draw solution volumes. The ex vivo model was significantly 
more complex involving inducing oedema in a porcine hind limb, from a freshly-
slaughtered animal, via perfusion of a physiological salt solution through the femoral 
artery which creates fluid accumulation in the surrounding tissues. This occurs as a 
result of the oncotic pressure difference between the perfused salt solution within the 
circulatory system which, although isotonic, contains no proteins, and the surrounding 
tissues which contain proteins (Section 1.5.2). The oncotic pressure difference causes 
a) b) Tubing connector  
Membrane (RO or UF) 
End-piece  
Membrane seam 
and waterproof 
tape  
Membrane (RO or UF) 
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large volumes of fluid to move from the blood vessels into the surrounding tissues 
where it accumulates. Matheis et al. have shown that rat hind limb perfusion using a 
solution without colloid osmotic pressure (i.e. not containing macromolecules) 
produces severe limb oedema and that including macromolecules with a molecular 
weight similar to albumin should prevent oedema occuring.2 Similarly Fisher et al. have 
shown that perfusion of isolated ventilated rat lungs with a Krebs physiological salt 
solution results in alveolar oedema within 40-85 minutes, however the addition of 
bovine serum albumin can prevent oedema formation for up to 5 hours.3 Whilst, to the 
author’s knowledge, no ex vivo model exists to simulate oedema, however porcine 
perfused limbs have been used for transdermal adsorption studies4 and for 
pharmacokinetic studies.5 
 
In the ex vivo perfused limb model developed during the project a peristaltic pump was 
used to perfuse a porcine limb with a physiological salt solution (Krebs solution) to 
create the oedema (as a result of the oncotic pressure difference, described 
previously). Following which an incision was made to create a cavity to accommodate 
the device. After implantation the opening was sealed using a cyanoacrylate adhesive. 
Figure 5.2 shows schematics of both the in vitro and ex vivo models and demonstrates 
the movement of fluid into the prototype devices as a result of the encapsulated 
osmotic agents.  
 
Figure 5.2: a) In vitro model testing of 1
st
 Generation prototype, b) ex vivo model testing of 2
nd
 Generation 
prototype, dark blue arrows show direction of fluid flow.  
 
 
 
a) b) 
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5.3 Results and Discussion  
5.3.1 Prototype Design  
The basic design of the system encompasses two main parts, an implanted device and 
an external reservoir.  The implanted device consists of a semipermeable membrane 
containing trapped osmotic solutes which act as a draw solution for accumulated fluid 
in tissue surrounding the implant (see Figure 5.3). The implanted portion of the device 
is in communication with the external portion, a fluid reservoir, via a tube connected to 
a transdermal port allowing for fluid collected within the implanted device to be drained 
and removed.  
 
Figure 5.3: Schematic representation of the components of the proposed implantable membrane device 
(and external reservoir) for the treatment of oedema.  
Several different designs were proposed based around the general device concept 
depicted in Figure 5.3. A key consideration was the implantable pouch portion which 
was required to fulfil several design considerations including: 
- Material limitations - the majority of the pouch must be made from membrane 
and additionally must be made from biocompatible materials and suitable for 
sterilization; 
- Collapsible design - to aid minimally invasive implantation procedure without 
compromising large surface area required for rapid fluid exchange across the 
membrane; 
- Connected to exterior - through transdermal port; 
- Maximum possible membrane area - to ensure efficient exchange of fluids 
across the membrane surface. 
 
Figure 5.4 below illustrates some of the proposed designs which were used to discuss 
the prototype with a design house, Hunt Developments Ltd. 
INTERNAL EXTERNAL 
Membrane pouch 
containing trapped 
osmotic solutes 
Transdermal port 
Connecting tube 
Reservoir  
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Figure 5.4: Sketches showing potential device designs 1) Silicone/thermoplastic polyurethane solid 
support 2) Stainless steel mesh, rigid solid support 3) Membrane pouch within silicone/thermoplastic 
polyurethane rigid solid support 4) Membrane pouch without a solid support inserted in a spiral-wound 
form. 
5.3.2 Prototype Fabrication 
In order to explore the device capability first a simplified prototype was made based on 
the implanted pouch component of the device. Two different membrane materials were 
investigated and a number of different adhesive options were also explored. After in 
vitro tests with this system a more sophisticated second generation prototype was 
made with a connecting tube – suitable for implantation within the perfused limb model.  
5.3.2.1 1st Generation Prototype  
The 1st Generation prototypes were based on simple square pouches of membrane 
which were filled with a known volume of draw solution and suspended in a beaker of 
either deionised water (control) or Krebs physiological salt solution (Section 5.6.3.2). 
The membrane pouches were made by adhesive bonding of two rectangles of 
membrane along three sides, with the membrane active layer facing out (Figure 5.5). 
 
Figure 5.5: Schematic of Membrane pouch fabrication.  
Membrane outside Membrane inside 
1) 2) 3) 4) 
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A number of different membrane materials, adhesives and draw solutions were 
investigated in the fabrication of the 1st generation prototypes. Both ultrafiltration 
membranes (lab-cast polyethersulfone, PES) and a reverse osmosis membrane (thin 
film composite membrane consisting of polysulfone coated with ultrathin layer of 
polyaramid) were explored. The different materials used dictated the draw solutions 
which could be used and also affected what could be transported. For example, using 
a non-porous RO membrane would only allow transport of water across the membrane 
and could be used in combination with a traditional salt based draw solution whilst 
using a porous UF membrane enabled solutes within the feed solution to be 
transported along with the fluid as demonstrated in Chapter 2 where high molecular 
weight polyethylene glycols and proteins were transported by osmosis through porous 
UF membranes. As a consequence of the porosity of the membrane a salt based draw 
solution was no longer suitable due to backflow of the salt into the feed. An alternative 
approach explored in Chapter 2 was the use of high molecular weight polyelectrolyte 
draw solutions (5% 225K sodium polyacrylate). The final component in membrane 
pouch fabrication was the adhesive. A good seal was essential to allow the prototype 
to function effectively. Both hot-melt, epoxy and cyanoacrylate adhesives were 
explored. The hot-melt material was found to damage the membrane and the epoxy 
was difficult to work with therefore the cyanoacrylate adhesive was chosen for the 2nd 
generation prototypes. 
5.3.2.2 2nd Generation Prototype  
A more sophisticated prototype suitable for implantation within the perfused limb was 
developed consisting of a sealed ‘membrane tube’ connected to silicone tubing  with a 
double lumen, allowing for both draw solution injection (following device implantation) 
and fluid withdrawal by forward osmosis. The tube was created by cutting a sheet of 
membrane to size (either RO or UF) and placing it around a cylindrical former before 
sealing with waterproof tape. The tape seams were further reinforced through 
additional sealing using cyanoacrylate adhesive. After sealing and removing the former 
the membrane tube ends were closed; one with a plastic end-piece and the other with 
a plastic tubing connecter which were both also taped and glued into place. The 
prototypes were allowed to cure overnight before being tested for leaks by filling with 
DI water, after which a double lumen silicone tube (i.e. two tubes one inside the other) 
was connected to the device.  Figure 5.6 shows both a schematic and an image of the 
completed 2nd generation prototype. 
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Figure 5.6: a) 2
nd 
generation prototype device schematic b) 2
nd
 generation prototype device (RO, 
membrane) based on sealed membrane tube capped at each end with end-piece and connecter for 
double lumen tubing, active membrane area approximately 14 cm
2
. 
Fluid monitoring was achieved through over-filling the device so that the meniscus of 
the draw solution was visible in the tubing; this level was marked and was designated 
the starting point. Once the device was submerged into a reservoir containing the feed 
solution, any fluid moving into the device across the membrane increased the fluid 
level resulting in the meniscus rising (Figure 5.7). 
a) 
b) 
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Figure 5.7: 2
nd
 Generation prototype device (RO membrane, saline draw).  
Two versions of the second generation prototype were constructed: 1) using a 
commercial RO membrane (taken from a domestic RO module) and tested with a 
range of sodium chloride draw solutions of different concentrations and 2) using a 10K 
MWCO PES UF membrane with a 5% 225K sodium polyacrylate draw solution. 
5.3.3 Prototype Testing 
Two methods of prototype testing were developed. The first involved a simple ‘bench-
top’ in vitro system, as outlined above, and the second a significantly more complex 
perfused limb model designed to simulate the condition of oedema.  
5.3.3.1 In vitro testing 
For the basic bench-top tests a beaker was filled with the chosen feed solution: either 
deionised water as a control or the physiological Krebs solution. The prototype device 
was suspended within the beaker and filled with the chosen draw solution. The 
subsequent change in draw volume was measured every hour either by direct 
measurement for the 1st generation membrane pouches (i.e. pouring into a measuring 
cylinder) or by measuring the change in fluid height within the tubing for the second 
generation prototypes. 
1st Generation Prototype In vitro Testing  
The 1st generation prototypes were based on an extremely simplified design consisting 
of a square or rectangular pouch sealed on three sides, but left open along the top 
edge. A draw solution of a known concentration and volume was added through this 
opening and the pouch was suspended in the chosen feed solution (Figure 5.8). The 
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volumes of both the feed and draw solution were monitored over time. Many problems 
were encountered when testing these simple prototypes due to issues with obtaining a 
watertight seal and many experiments were terminated when the pouches were found 
to have failed. However, these preliminary studies provided important information when 
considering the design and fabrication of the 2nd Generation prototypes. Additionally it 
was clear that although the simple square design could provide the large surface area 
necessary for efficient membrane exchange the shape was wholly unsuited to testing 
in the perfused limb model and also was difficult to seal efficiently. Furthermore the 
shape produced other problems related to the internal volume of the pouch which was 
vastly reduced following the application of the adhesive due to the subsequent ‘seam’ 
formation. Attempts to create this necessary internal volume capable of 
accommodating both draw and permeating feed by adhering membrane sheets around 
a shaped ‘former’ also failed due to the inflexibility of the membrane material which 
could not be shaped without creasing damaging the membrane surface and creating 
folds which were then difficult to seal.    
 
Studies focused on testing the optimal polyelectrolyte draw solution 5% 225K NaPA 
determined by experiments discussed in Chapter 2. Two membrane materials were 
compared; commercial RO membrane and lab-cast PES ultrafiltration membrane. In 
both experiments flux was observed despite the system being unstirred, unlike the 
procedure described in Chapter 2. This key result was necessary for proof of device 
concept as the implanted system would necessarily be static.  
 
Figure 5.8: Membrane pouch containing draw solution suspended in beaker of DI water, from above and 
side view. 
Comparing the lab-cast PES UF membrane with the commercial RO membrane (Table 
5.1) the latter produced a higher flux rate (almost tenfold) despite being non-porous 
whilst the lab-cast PES membrane contains large pores due to the phase inversion 
181 
 
process. This unexpected result confirmed it was worthwhile investigating both RO and 
UF membrane devices in the 2nd generation prototypes. 
Table 5.1: 1
st
 Generation prototype in vitro testing average flux results.  
Pouch Material Sealant Draw solution Average Flux (mL/hour/cm
2
) 
Lab-cast PES  Hot melt adhesive 5% 225K NaPA 0.055 
RO membrane Epoxy resin 5% 225K NaPA 0.31 
2nd Generation Prototype In vitro Testing  
Since the RO membrane produced the higher flux in the 1st generation prototypes and 
was also available in larger quantities with high reproducibility (as a commercial 
product) when compared to the lab-fabricated UF membranes, 2nd generation in vitro 
studies focused on the RO prototypes. Additionally, the decision was made to 
investigate traditional salt based draw solutions which are compatible with a non-
porous RO membrane system and are known to generate higher flux rates due to their 
higher osmotic pressure (Chapter 2). 
 
The 2nd generation RO membrane prototype was tested in an in vitro system with both 
a deionised water feed and a Krebs physiological salt feed solution. Additionally 
different concentration salt feed solutions were investigated. As observed in previous 
studies that varied the salt draw solution concentration (Chapter 2), increasing salt 
concentration results in an increase in ‘average flux’ which in this case is taken as the 
change in fluid meniscus height per hour which is directly proportional to the fluid 
volume change. For this ‘flux value’ the units are mm/hour since it is the meniscus 
height that is being monitored. This would be expected due to the increasing osmotic 
pressure resulting from the increasing draw solution concentration. Additionally, as 
previously observed changing the feed solution from pure deionised water to Krebs 
physiological salt solution containing multiple cations/anions drastically decreases the 
flux.  
 
Figure 5.9 demonstrates the average ‘fluxes’ generated by different concentration 
saline draw solutions during the in vitro experiments with both a deionised water and 
Krebs feed. The average change in flux obtained from changing the feed solution from 
deionised water to Krebs solution was a decrease of 5.5 mm/h. Doubling the saline 
draw concentration from 5% to 10% appeared to have little effect on the flux for both 
the DI water experiments and the Krebs solution experiments the former changing from 
8.3 mm/h to 9.1 mm/h and for the latter 2.6 mm/h to 2.9 mm/h. However, comparing 
the 2% saline draw solution to the saturated 26% saline draw solution a large change 
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in flux was observed going from 5.5 mm/h to 11.9 mm/h in the deionised water 
experiments, an increase of 6.4 mm/hour. In the Krebs solution feed experiments 
changing the saline draw concentration from 2% to 26% produced an increase of 5.1 
mm/h going from 1.1 mm/h to 6.3 mm/h. 
 
Figure 5.9: Average rate of increase in fluid height (mm/hour) testing 2
nd
 Generation Prototype Device 
(RO membrane) in deionised water and Krebs solution with differing concentration sodium chloride draw 
solutions. 
5.3.3.2 Perfused Limb Model  
A porcine perfused limb model was developed to simulate the condition of oedema in 
order to test the prototype device. The basic concept involved the perfusion of a 
porcine limb from a freshly-slaughtered pig transported from a nearby abattoir, with a 
physiological salt solution. Without the usual protein content to balance the osmotic 
pressure gradient between the fluid within the blood vessels and the fluid in the 
surrounding tissues, perfusion quickly resulted in massive oedema of the interstitial 
tissues neighbouring the perfused blood vessels (see Figure 5.10). An hour long 
perfusion generated sufficient oedemic-type swelling of the limb to test the prototype 
devices. Several attempted limb perfusion studies were required to develop a 
reproducible protocol; each attempt required a round-trip to the abattoir to source limbs 
from a freshly slaughtered animal and the preparation of 10L of Krebs solution. 
0
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Figure 5.10: Perfused limb after 1 hour of perfusion (right hand side) compared to non-perfused limb (left 
hand side).  
In order to implant the prototypes an incision was made in the tissue connecting the 
skin and muscle to access a naturally occurring cavity between these two layers. After 
implantation the incision was sealed using cyanoacrylate adhesive and the device was 
filled with the draw solution. The draw solution was allowed to reach a level that meant 
the outlet tube was also filled and the starting point was marked using a cable tie. The 
limb was perfused throughout the device testing to simulate a real-life disease state. 
The fluid height within the outlet device was monitored over a set period of time. 
  
Figure 5.11: Device implantation into porcine limb model with simulated oedema. 
Both the UF and RO membrane 2nd generation prototypes were tested. In this case a 
sample of commercial 10K MWCO PES UF membrane was used to create the 
prototype. The UF membrane device was filled with a 5% 225K NaPA draw solution 
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and it was observed that the higher viscosity of the polyelectrolyte draw solution 
relative to a traditional saline draw solution (as used in the RO device) created 
problems during injection. Additionally the high viscosity complicated fluid level 
measurement in the outlet tube as it was difficult to establish a level starting point free 
of air bubbles. With the UF device, no change in fluid height was detectable even after 
an hour. 
 
The RO device was filled with a saturated saline draw solution. After implantation an 
increase in fluid height was easily detected within minutes of starting the 
measurement. A marker (cable tie) was placed at the fluid height every 10 minutes for 
30 minutes. The change in height was an increase by 1 cm in 10 minutes on average 
which using the tube dimensions was calculated to be equivalent to 2.6 mL/10mins 
which equates to 15.6 mL/hour. The porcine limb weighed 7.3 kg before perfusion and 
8.2 kg after an hour of perfusion at which point the device was implanted. Taking the 
limb weight in the oedematous state the device fluid removal rate is equivalent to 1.9 
mL/hour per kg of tissue. The human lymphatic system removes 0.1 mL/min of fluid 
per kg of tissue which is equivalent to 6 mL hour per kg of tissue.6 The prototype 
device was able to remove fluid at a rate equivalent to approximately a third of the rate 
the entire human lymphatic system. This demonstrates that the prototype device was 
able to remove fluid from the oedema limb model at a physiologically significant rate, 
therefore providing proof of concept.   
 
Figure 5.12: Fluid movement after device implantation, cable ties mark fluid height every 10 minutes. 
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5.4 Conclusions 
Following fundamental research into using forward osmosis to transport fluids in 
Chapter 2 along with consultation with researchers and clinicians in the field, 
combined with discussions with a design house specialising in medical device design, 
several potential prototypes were constructed taking into account key design 
considerations and limitations. These included: 
- Materials used which not only had to be biocompatible and also sterilisable but 
also were limited to the materials from which membranes can be fabricated; 
- a minimally invasive implantation procedure without compromising the large 
membrane area necessary for effective transport of oedemic fluids; 
- the ability to load and replace the draw solution as necessary.  
Additionally, for the purposes of this project, the design had to be simple enough to be 
fabricated in the lab without requiring over-specialised equipment. Subsequently two 
classes of prototypes were made: the 1st Generation based on extremely simple pouch 
design and the 2nd Generation of prototypes involved a more sophisticated design 
involving a sealed implantable membrane tube with concentric inlet and outlet tubing. 
Again both a UF membrane based device (with a polyelectrolyte draw) and an RO 
membrane based device with a (saline draw) were tested. 
The 1st generation prototypes were tested using a simple in vitro model and 
demonstrated that forward osmosis could be used to remove water from a deionised 
water feed solution using a novel polyelectrolyte draw solution (explored in Chapter 2) 
despite the system being unstirred. Flux was observed using both UF and RO 
membranes although the RO membrane performed better. 
The 2nd generation prototypes were designed to be suitable for implantation into an ex 
vivo perfused limb oedema model specially developed for the project. Both a UF 
membrane and and RO membrane prototype were tested, the UF prototype with a 
polyelectrolyte draw solution and the RO with a traditional salt-based draw solution. 
The RO membrane system was additionally tested using the simple in vitro model.  
In vitro experiments with the second generation RO membrane prototype showed that 
a flux of 6.22 mL/hour could be achieved with a physiological salt feed solution. Lymph 
nodes remove around 0.1 mL/min of fluid per kg of tissue in a human under normal 
physiological conditions6 which is equivalent to 6 mL/hour. Therefore the RO prototype 
device was able to produce an in vitro flux at a physiologically significant rate.  
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Testing both the UF and RO 2nd generation prototypes with the ex vivo perfused limb 
produced mixed results. No fluid removal was observed with the UF device and loading 
the polyacrylate draw solution via the silicone tube was difficult due to the high 
viscosity of the solution. In contrast, a significant level of fluid removal was observed 
when using the RO membrane device equivalent to 15.6 mL/hour offering proof of 
device concept. 
5.5 Future Work 
As a continuation of the work carried out in this chapter, more sophisticated next 
generation prototypes will need to be fabricated for testing with the perfused limb 
oedema model. During the course of the project a design house specialising in medical 
devices was consulted for prototype future designs. Additionally a manufacturer was 
also consulted for advice on device construction. Future work would necessarily 
involve collaboration with such experts in the field. Furthermore the existing prototypes 
could be used to provide further evidence for proof-of-concept i.e. via the repetition of 
in vitro studies using a feed solution containing proteins. Samples of the draw solution 
could then be analysed for protein content using the BCA assay as done in Chapter 2 
for the FO studies using proteins. Additionally the second generation UF 
membrane/polyacrylate draw device could be re-tested in the ex vivo perfused limb 
model. 
5.6 Experimental 
5.6.1 Materials 
The following supplies were sourced from Fisher Scientific (Leicestershire, UK); cable 
ties, disposable scalpels, MasterflexTM Tygon internal diameter 1.6mm peristaltic pump 
tubing, waterproof tape, epoxy adhesive, cyanoacrylate adhesive. The porcine hind 
limbs were collected as a pair within a few hours of slaughter from Newman’s Abattoir 
(Farnborough). The 225,000 MW Poly(acrylic acid) sodium salt (20% aqueous 
solution) was purchased from Polysciences, Inc. The Pall 10 K MWCO PES UF 
membrane was acquired from Pall Corporation (Portsmouth, UK) and the commercial 
RO membrane was obtained from a Vontron® Residential Membrane Element 
(Vontron®, China). All other materials were including; calcium chloride, glucose, 
magnesium sulphate, potassium chloride, potassium phosphate monobasic, sodium 
chloride, sodium hydrocarbonate and sodium hydroxide were purchased from Sigma 
Aldrich (Dorset, UK). 
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5.6.2 Equipment  
The peristaltic pump was purchased from VWR International (Leicestershire, UK) and 
the model type was the FASTLoad Manual Control peristaltic pump.  
5.6.3 Methods 
5.6.3.1 Prototype Fabrication 
1st Generation 
Two rectangles of the same size (7 cm x 15 cm) were cut from a membrane sheet. 
One rectangle was placed active side down on a clean surface and adhesive was 
applied around three edges of the sheet in a continuous line to avoid gaps. The second 
sheet was placed on top of the first, solid support layer facing down, to create a 
membrane pouch (Figure 5.6). The sheets were clamped and allowed to dry for the 
appropriate time based on the type of adhesive used. Before testing, the pouches were 
examined for defects and were filled with water to check for leaks before use with 
desired draw solution which was poured in through the opening in the membrane 
pouch. 
2nd Generation 
The chosen membrane was cut to size (rectangle; 9.5 cm long, 6 cm wide) and a 
tubular former (cylinder; 12 cm long, diameter of 1.8 cm) was employed to create a 
membrane cylinder with the active surface facing outwards. The seam was sealed with 
a strip of waterproof tape which was further reinforced by a coat of cyanoacrylate 
adhesive which was allowed to dry before the following steps. Both ends of the 
membrane tube were capped again using both waterproof tape and the cyanoacrylate 
to fix the caps; one end with a closed plastic seal, the other with a tube connector. 
Again the prototype was allowed to cure before testing for leaks, after which a 7 mm 
silicone tube containing a 4 mm silicone tube (producing a double lumen) was attached 
to the tube connector. When tested, the chosen draw solution was injected through the 
inner lumen using a syringe. The device was filled until excess fluid entered the outer 
tube and upon reaching a suitable level and removing any air bubbles the draw 
solution starting point was marked upon the tube before measurements began. 
The active membrane area was approximately 14 cm2. 
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5.6.3.2 Prototype Testing 
Prototypes were tested using both an in vitro and an ex vivo model. In both cases the 
model feed solution was either deionised water or Krebs physiological salt solution 
(Table 5.2)  
Table 5.2: Krebs Solution composition
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Component Concentration  (mM) Mass (g) in 1L 
NaCl 118 6.9 
KCl 3.4 0.25 
CaCl2 2.5 1.3 mL 
KH2PO4 1.2 0.16 
MgSO4 1.2 0.14 
NaHCO3 2.5 2.10 
Glucose 11.1 2.00 
In Vitro Testing 
The ‘bench-top’ in vitro testing involved suspending the prototype in a beaker 
containing a known volume of feed solution; either deionised water control or Krebs 
solution. The draw solution was introduced into the prototype and the volumes of both 
the feed and draw solutions were measured every hour. 
Ex vivo Perfused Limb Model Testing  
The porcine limbs were collected within hours of slaughter and if still joined together 
were separated using a saw. The femoral artery was identified and a section cleaned 
of connective tissue and fat to allow visualization of the area the cannula would be 
inserted. Additionally it was ensured there were no side branches that would mean the 
perfusion solution would leak rather than perfuse tissue. Next the femoral artery was 
cannulated with a silicone tube (bore size 3mm, 0.75mm wall thickness) and secured 
with cable ties. The cannula was then connected to the peristaltic pump tubing (1.6cm 
diameter, which was pre-loaded with Krebs solution. The Krebs solution was then 
slowly introduced into the limb using the peristaltic pump to check for leaks, blockages 
and check the security of the cannula. Flow was then steadily increased to maximal 
rate of approximately 40 mL/min in order to prevent backflow and de-cannulation. The 
system was perfused for 1 hour and was observed for evidence of oedema. When 
perfusion was successful the swelling was detectable by eye, and generally an hour’s 
perfusion produced sufficient swelling to simulate an oedemic state. An incision was 
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made through the skin and the device was introduced before the opening was sealed 
using cyanoacrylate adhesive. The draw solution was injected into the prototype device 
and the fluid level was noted before starting the experiment. The limb was perfused 
throughout the measurement.  
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